Fanlization的个人主页 - 老虎社区

Fanlization

Fanlization

暂无个人介绍

IP属地：广东

51关注

2粉丝

7主题

0勋章

06-25

好

04-25

竞猜赢虎币，寻找实盘收益王

查看详情：竞猜赢虎币，寻找实盘收益王快来参与竞猜赢虎币活动，寻找你心中的实盘收益王，邀请好友最多可得250枚虎币此帖仅开放于中国大陆用户

竞猜赢虎币，寻找实盘收益王

04-10

这篇文章不错，转发给大家看看

Kintara (KTRA) Stock Soars on Merger Agreement With TuHURA

03-07

这篇文章不错，转发给大家看看

抱歉，原内容已删除

01-15

好

01-08

这篇文章不错，转发给大家看看

@胖虎福利:2023老虎社区企业号年度公司评选榜单发布

2023-11-09

这篇文章不错，转发给大家看看

抱歉，原内容已删除

2023-11-08

这篇文章不错，转发给大家看看

@小虎产品经理:期权组合下单功能已上线，快来试试吧

2023-10-24

这篇文章不错，转发给大家看看

@发發虎:【一起发财】做空特斯拉，他赚了232%！

2023-10-13

这篇文章不错，转发给大家看看

抱歉，原内容已删除

2023-09-22

这篇文章不错，转发给大家看看

@小虎周报:港股周报：重磅利好要来了？

2023-09-08

这篇文章不错，转发给大家看看

抱歉，原内容已删除

2023-08-10

这篇文章不错，转发给大家看看

抱歉，原内容已删除

2023-08-10

这篇文章不错，转发给大家看看

抱歉，原内容已删除

2023-08-10

这篇文章不错，转发给大家看看

抱歉，原内容已删除

2023-07-31

这篇文章不错，转发给大家看看

@HoChe:除净「除得太净」 JS环球值1.92元

2023-06-30

这篇文章不错，转发给大家看看

抱歉，原内容已删除

2023-06-30

这篇文章不错，转发给大家看看

抱歉，原内容已删除

2023-06-29

这篇文章不错，转发给大家看看

抱歉，原内容已删除

2023-05-28

这篇文章不错，转发给大家看看

抱歉，原内容已删除

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":4095630847582090,"uuid":"4095630847582090","gmtCreate":1632527782524,"gmtModify":1695745889644,"name":"Fanlization","pinyin":"fanlization","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/4ff33c5fed6426a68a814ef72a46d188","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":2,"headSize":51,"tweetSize":29,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":7,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":7,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-2","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"资深虎友","description":"加入老虎社区1000天","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.06.22","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"228c86a078844d74991fff2b7ab2428d-1","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资经理虎","description":"证券账户累计交易金额达到10万美元","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"60.07%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.04","exceedPercentage":"80.97%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.06.30","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"广东","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":2,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":320637583126848,"gmtCreate":1719303767154,"gmtModify":1719303770945,"author":{"id":"4095630847582090","authorId":"4095630847582090","name":"Fanlization","avatar":"https://static.tigerbbs.com/4ff33c5fed6426a68a814ef72a46d188","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"好","listText":"好","text":"好","images":[{"img":"https://static.tigerbbs.com/22d64da41c22fee5285a35b1050f14ad","width":"1280","height":"1877"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/320637583126848","isVote":1,"tweetType":1,"viewCount":51,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":299062854197320,"gmtCreate":1714038596382,"gmtModify":1714038731115,"author":{"id":"4095630847582090","authorId":"4095630847582090","name":"Fanlization","avatar":"https://static.tigerbbs.com/4ff33c5fed6426a68a814ef72a46d188","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"title":"竞猜赢虎币 ，寻找实盘收益王","htmlText":"查看详情：<a href=\"https://tigr.link/7vd3vT\">竞猜赢虎币 ，寻找实盘收益王</a> 快来参与竞猜赢虎币活动，寻找你心中的实盘收益王，邀请好友最多可得250枚虎币 此帖仅开放于中国大陆用户","listText":"查看详情：<a href=\"https://tigr.link/7vd3vT\">竞猜赢虎币 ，寻找实盘收益王</a> 快来参与竞猜赢虎币活动，寻找你心中的实盘收益王，邀请好友最多可得250枚虎币 此帖仅开放于中国大陆用户","text":"查看详情：竞猜赢虎币 ，寻找实盘收益王 快来参与竞猜赢虎币活动，寻找你心中的实盘收益王，邀请好友最多可得250枚虎币 此帖仅开放于中国大陆用户","images":[{"img":"https://static.tigerbbs.com/f22c491ee8ae08f0d36ded0795f1fe33"}],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/299062854197320","isVote":1,"tweetType":1,"viewCount":241,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":293812433965240,"gmtCreate":1712762161740,"gmtModify":1712762163366,"author":{"id":"4095630847582090","authorId":"4095630847582090","name":"Fanlization","avatar":"https://static.tigerbbs.com/4ff33c5fed6426a68a814ef72a46d188","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"这篇文章不错，转发给大家看看","listText":"这篇文章不错，转发给大家看看","text":"这篇文章不错，转发给大家看看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/293812433965240","repostId":"2425310589","repostType":2,"repost":{"id":"2425310589","pubTimestamp":1712241480,"share":"https://www.laohu8.com/m/news/2425310589?lang=&edition=full","pubTime":"2024-04-04 22:38","market":"us","language":"en","title":"Kintara (KTRA) Stock Soars on Merger Agreement With TuHURA","url":"https://stock-news.laohu8.com/highlight/detail?id=2425310589","media":"Zacks","summary":"Kintara Therapeutics, Inc.’s KTRA shares surged 63.4% on Apr 3 after the company inked a definitive merger agreement with Florida-based privately-held company, TuHURA Biosciences Inc. Per the agreement, KTRA will merge into TuHURA to form a new company aimed at developing late-stage oncology candidates.The combined company will operate under the name of TuHURA Biosciences, Inc., and trade in the Nasdaq stock exchange under the ticker symbol \"HURA.\". Per the agreement, Kintara equity holders are expected to collectively own up to approximately 2.85%, or 5.45%, including shares underlying the contingent value rights  of the common stock of the combined company on a pro forma fully diluted basis. Meanwhile, equity holders of TuHURA are eligible to collectively own approximately 97.15%, or 94.55%, taking the distribution of the CVR shares, of the common stock of the combined company on a pro forma fully diluted basis after the merger is completed.The newly formed company will focus on adva","content":"<html><body><p><strong><a href=\"https://laohu8.com/S/KTRA\">Kintara Therapeutics, Inc.</a></strong>’s KTRA shares surged 63.4% on Apr 3 after the company inked a definitive merger agreement with Florida-based privately-held company, TuHURA Biosciences Inc. Per the agreement, KTRA will merge into TuHURA to form a new company aimed at developing late-stage oncology candidates.</p>\n<p>The combined company will operate under the name of TuHURA Biosciences, Inc., and trade in the Nasdaq stock exchange under the ticker symbol \"HURA.\"</p>\n<p>The transaction has been approved by the boards of directors of both companies and is expected to close in the third quarter of 2024, subject to customary closing conditions.</p>\n<p>Per the agreement, Kintara equity holders are expected to collectively own up to approximately 2.85%, or 5.45%, including shares underlying the contingent value rights (CVR) of the common stock of the combined company on a pro forma fully diluted basis. Meanwhile, equity holders of TuHURA are eligible to collectively own approximately 97.15%, or 94.55%, taking the distribution of the CVR shares, of the common stock of the combined company on a pro forma fully diluted basis after the merger is completed.</p>\n<p>The newly formed company will focus on advancing TuHURA's personalized cancer vaccine and first-in-class bi-functional antibody-drug conjugates (ADCs) to overcome the hurdles in the treatment of cancer with existing immunotherapies.</p>\n<p>ADCs are being considered a disruptive innovation in the pharmaceutical industry as these will allow better treatment of cancer by harnessing the targeting power of antibodies to deliver cytotoxic molecule drugs to tumors.</p>\n<p>Shares of Kintara have lost 3.3% year to date against the industry’s growth of 1.9%.</p>\n<p><img src=\"https://s1.yimg.com/uu/api/res/1.2/zBkN1feR85cSNmi8u7lm6Q--/cT03NTthcHBpZD15dmlkZW9mZWVkczs-/https://media.zenfs.com/en/zacks.com/6416afa85f382eca776c9ed90bea040a\"/><br/><span>Image Source: Zacks Investment Research</span><br/></p>\n<p>KTRA is developing its lead pipeline candidate, REM-001, a second-generation photodynamic therapy photosensitizer agent for the treatment of cutaneous metastatic breast cancer.</p>\n<p>Meanwhile, TuHURA is developing its lead personalized cancer vaccine candidate, IFx-2.0, to overcome primary resistance to checkpoint inhibitors.</p>\n<p>TuHURA is planning to initiate a phase III registration study evaluating IFx-2.0 administered as an adjunctive therapy to <strong>Merck</strong>’s MRK blockbuster cancer drug, Keytruda (pembrolizumab), for the first-line treatment of advanced merkel cell carcinoma.</p>\n<p>Merck’s biggest revenue generator, Keytruda, is approved for treating several cancer indications. Sales of Keytruda came in around $25 billion in 2023.</p>\n<p>MRK continues to evaluate Keytruda in combination studies for various other indications.</p>\n<p>Enrollment in the placebo-controlled phase III study is expected to begin in the second half of 2024. The study is likely to be conducted under the FDA's Accelerated Approval Pathway, which helps in earlier approval of drugs that address serious and unmet medical conditions.</p>\n<p>Along with the latest merger agreement, TuHURA is making $31 million subscribed financing, which is expected to fund the combined company’s operations through late 2025.</p>\n<p>The transaction should create a near and long-term value for Kintara’s shareholders as the newly formed company will be well-positioned to develop groundbreaking new therapies for treating cancer.</p>\n<h3>Zacks Rank &amp; Stocks to Consider</h3>\n<p>Kintara currently carries a Zacks Rank #4 (Sell).</p>\n<p>Some better-ranked stocks in the healthcare sector are <strong>Ligand Pharmaceuticals Incorporated</strong> LGND and <strong><a href=\"https://laohu8.com/S/ANIP\">ANI Pharmaceuticals, Inc.</a></strong> ANIP, each flaunting a Zacks Rank #1 (Strong Buy) at present. You can see <strong>the complete list of today’s Zacks #1 Rank stocks here</strong>.</p>\n<p>In the past 60 days, estimates for Ligand’s 2024 earnings per share have improved from $4.42 to $4.56. Year to date, LGND shares have gained 4.5%.</p>\n<p>Earnings of LGND beat estimates in each of the trailing four quarters, the average surprise being 84.81%.</p>\n<p>In the past 60 days, estimates for ANI Pharmaceuticals’ 2024 earnings per share have improved from $4.06 to $4.43. Year to date, ANIP shares have jumped 21.7%.</p>\n<p>Earnings of ANIP beat estimates in each of the trailing four quarters, the average surprise being 109.06%.</p>\n<p>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report</p>\n<p>Merck &amp; Co., Inc. (MRK) : Free Stock Analysis Report</p>\n<p>Ligand Pharmaceuticals Incorporated (LGND) : Free Stock Analysis Report</p>\n<p>ANI Pharmaceuticals, Inc. (ANIP) : Free Stock Analysis Report</p>\n<p>Kintara <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a>, Inc. (KTRA) : Free Stock Analysis Report</p>\n<p>To read this article on Zacks.com click here.</p>\n<p>Zacks Investment Research</p></body></html>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Kintara (KTRA) Stock Soars on Merger Agreement With TuHURA</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nKintara (KTRA) Stock Soars on Merger Agreement With TuHURA\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-04-04 22:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/kintara-ktra-stock-soars-merger-143800928.html><strong>Zacks</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Kintara Therapeutics, Inc.’s KTRA shares surged 63.4% on Apr 3 after the company inked a definitive merger agreement with Florida-based privately-held company, TuHURA Biosciences Inc. Per the ...</p>\n\n<a href=\"https://finance.yahoo.com/news/kintara-ktra-stock-soars-merger-143800928.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://s.yimg.com/uu/api/res/1.2/H9DYdttPy00EKBHhcxtlCA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9f2a2e04a053cda7a8c096e532e43d28","relate_stocks":{"MRK":"默沙东","LU0122379950.USD":"贝莱德世界健康科学A2","LU2361045086.USD":"WELLINGTON US QUALITY GROWTH \"A\" (USD) ACC","IE0002141913.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (USD) ACC","SG9999015358.SGD":"United Income Focus Trust Dis SGD-H","SG9999015341.SGD":"United Income Focus Trust Acc SGD-H","IE00B1BXHZ80.USD":"Legg Mason ClearBridge - US Appreciation A Acc USD","IE00BJJMRZ35.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (SGDHDG) ACC","SG9999014542.SGD":"United Income Focus Trust Acc SGD","LU2468319806.SGD":"MANULIFE GF HEALTHCARE \"AA\" (SGDHDG) ACC","SG9999001440.SGD":"United Global Dividend Equity Fund A SGD Dist","SG9999001176.USD":"United Global Healthcare Acc USD","LGND":"Ligand Pharmaceuticals Inc.","LU1585245621.USD":"EASTSPRING INV GLOBAL LOW VOLATILITY EQUITY FUND \"A\" (USD) ACC B","LU0211331839.USD":"FRANKLIN MUTUAL GLB DISCOVERY \"A\" (USD) ACC","IE00BLSP4239.USD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis USD Plus","SG9999013999.USD":"UOB UNITED GLOBAL HEALTHCARE FUND (USDHDG) INC","IE00BLSP4452.SGD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis SGD-H Plus","LU1917777945.USD":"安联专题基金Cl AT Acc","SG9999001176.SGD":"UOB UNITED GLOBAL HEALTHCARE \"SGD\" (ACC)","SG9999014575.USD":"UOB UNITED INCOME FOCUS TRUST FUND (USDHDG) INC","LU1989771016.USD":"东方汇理环球老龄化投资基金 A2 Acc","CVR":"芝加哥机械","LU1989772840.SGD":"CPR Invest - Climate Action A2 Acc SGD-H","IE0009355771.USD":"骏利亨德森环球生命科技A Acc","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","LU2461242641.AUD":"WELLINGTON US QUALITY GROWTH \"A\" (AUDHDG) ACC","BK4161":"工业机械","LU0208291251.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) INC","LU1989772923.USD":"CPR Invest - Climate Action A2 Acc USD-H","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","BK4534":"瑞士信贷持仓","BK4585":"ETF&股票定投概念","IE00BJT1NW94.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (SGDHDG) ACC","IE00BBT3K403.USD":"LEGG MASON CLEARBRIDGE TACTICAL DIVIDEND INCOME \"A(USD) ACC","BK4139":"生物科技","LU2023250843.SGD":"Allianz Thematica Cl AT Acc H2-SGD","BK4533":"AQR资本管理(全球第二大对冲基金)","KTRA":"Kintara Therapeutics, Inc.","LU0058720904.USD":"联博国际健康护理基金A","LU2361044949.HKD":"WELLINGTON US QUALITY GROWTH \"A\" (HKD) ACC","SG9999014559.SGD":"United Income Focus Trust Dis SGD","LU2361044865.SGD":"WELLINGTON US QUALITY GROWTH \"A\" (SGDHDG) ACC","LU1066051498.USD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM2\" (USD) INC","BK4588":"碎股","SG9999014567.USD":"UOB UNITED INCOME FOCUS TRUST FUND (USD) ACC","LU1066053197.SGD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM3\" (SGDHDG) INC","ANIP":"ANI Pharmaceuticals, Inc.","LU0965509283.SGD":"AB LOW VOLATILITY EQUITY PORTFOLIO \"AD\" (SGDHDG) INC"},"source_url":"https://finance.yahoo.com/news/kintara-ktra-stock-soars-merger-143800928.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2425310589","content_text":"Kintara Therapeutics, Inc.’s KTRA shares surged 63.4% on Apr 3 after the company inked a definitive merger agreement with Florida-based privately-held company, TuHURA Biosciences Inc. Per the agreement, KTRA will merge into TuHURA to form a new company aimed at developing late-stage oncology candidates.\nThe combined company will operate under the name of TuHURA Biosciences, Inc., and trade in the Nasdaq stock exchange under the ticker symbol \"HURA.\"\nThe transaction has been approved by the boards of directors of both companies and is expected to close in the third quarter of 2024, subject to customary closing conditions.\nPer the agreement, Kintara equity holders are expected to collectively own up to approximately 2.85%, or 5.45%, including shares underlying the contingent value rights (CVR) of the common stock of the combined company on a pro forma fully diluted basis. Meanwhile, equity holders of TuHURA are eligible to collectively own approximately 97.15%, or 94.55%, taking the distribution of the CVR shares, of the common stock of the combined company on a pro forma fully diluted basis after the merger is completed.\nThe newly formed company will focus on advancing TuHURA's personalized cancer vaccine and first-in-class bi-functional antibody-drug conjugates (ADCs) to overcome the hurdles in the treatment of cancer with existing immunotherapies.\nADCs are being considered a disruptive innovation in the pharmaceutical industry as these will allow better treatment of cancer by harnessing the targeting power of antibodies to deliver cytotoxic molecule drugs to tumors.\nShares of Kintara have lost 3.3% year to date against the industry’s growth of 1.9%.\nImage Source: Zacks Investment Research\nKTRA is developing its lead pipeline candidate, REM-001, a second-generation photodynamic therapy photosensitizer agent for the treatment of cutaneous metastatic breast cancer.\nMeanwhile, TuHURA is developing its lead personalized cancer vaccine candidate, IFx-2.0, to overcome primary resistance to checkpoint inhibitors.\nTuHURA is planning to initiate a phase III registration study evaluating IFx-2.0 administered as an adjunctive therapy to Merck’s MRK blockbuster cancer drug, Keytruda (pembrolizumab), for the first-line treatment of advanced merkel cell carcinoma.\nMerck’s biggest revenue generator, Keytruda, is approved for treating several cancer indications. Sales of Keytruda came in around $25 billion in 2023.\nMRK continues to evaluate Keytruda in combination studies for various other indications.\nEnrollment in the placebo-controlled phase III study is expected to begin in the second half of 2024. The study is likely to be conducted under the FDA's Accelerated Approval Pathway, which helps in earlier approval of drugs that address serious and unmet medical conditions.\nAlong with the latest merger agreement, TuHURA is making $31 million subscribed financing, which is expected to fund the combined company’s operations through late 2025.\nThe transaction should create a near and long-term value for Kintara’s shareholders as the newly formed company will be well-positioned to develop groundbreaking new therapies for treating cancer.\nZacks Rank & Stocks to Consider\nKintara currently carries a Zacks Rank #4 (Sell).\nSome better-ranked stocks in the healthcare sector are Ligand Pharmaceuticals Incorporated LGND and ANI Pharmaceuticals, Inc. ANIP, each flaunting a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.\nIn the past 60 days, estimates for Ligand’s 2024 earnings per share have improved from $4.42 to $4.56. Year to date, LGND shares have gained 4.5%.\nEarnings of LGND beat estimates in each of the trailing four quarters, the average surprise being 84.81%.\nIn the past 60 days, estimates for ANI Pharmaceuticals’ 2024 earnings per share have improved from $4.06 to $4.43. Year to date, ANIP shares have jumped 21.7%.\nEarnings of ANIP beat estimates in each of the trailing four quarters, the average surprise being 109.06%.\nWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report\nMerck & Co., Inc. (MRK) : Free Stock Analysis Report\nLigand Pharmaceuticals Incorporated (LGND) : Free Stock Analysis Report\nANI Pharmaceuticals, Inc. (ANIP) : Free Stock Analysis Report\nKintara Therapeutics, Inc. (KTRA) : Free Stock Analysis Report\nTo read this article on Zacks.com click here.\nZacks Investment Research","news_type":1},"isVote":1,"tweetType":1,"viewCount":248,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":281590089097520,"gmtCreate":1709775969811,"gmtModify":1709775971624,"author":{"id":"4095630847582090","authorId":"4095630847582090","name":"Fanlization","avatar":"https://static.tigerbbs.com/4ff33c5fed6426a68a814ef72a46d188","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"这篇文章不错，转发给大家看看","listText":"这篇文章不错，转发给大家看看","text":"这篇文章不错，转发给大家看看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/281590089097520","repostId":"2417029794","repostType":2,"isVote":1,"tweetType":1,"viewCount":216,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":263288843169896,"gmtCreate":1705310825861,"gmtModify":1705311452848,"author":{"id":"4095630847582090","authorId":"4095630847582090","name":"Fanlization","avatar":"https://static.tigerbbs.com/4ff33c5fed6426a68a814ef72a46d188","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"好","listText":"好","text":"好","images":[{"img":"https://static.tigerbbs.com/f76386f279afeae4a90b34b21c1b1727","width":"1442","height":"2744"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/263288843169896","isVote":1,"tweetType":1,"viewCount":268,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":260939999047912,"gmtCreate":1704716109412,"gmtModify":1704716110827,"author":{"id":"4095630847582090","authorId":"4095630847582090","name":"Fanlization","avatar":"https://static.tigerbbs.com/4ff33c5fed6426a68a814ef72a46d188","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"这篇文章不错，转发给大家看看","listText":"这篇文章不错，转发给大家看看","text":"这篇文章不错，转发给大家看看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/260939999047912","repostId":"260789601091584","repostType":1,"repost":{"id":260789601091584,"gmtCreate":1704697173051,"gmtModify":1704783002130,"author":{"id":"3527667568191018","authorId":"3527667568191018","name":"胖虎福利","avatar":"https://static.tigerbbs.com/733bbf790057cc91c5e0b1aa5569977c","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"title":"2023老虎社区企业号年度公司评选榜单发布","htmlText":"回顾2023年，全球资本市场迎来了一系列动人心魄的波折和新机遇，成为全球资本市场参与者共同见证的重要时刻。地缘政治的波动成为市场关注的焦点，宏观事件影响全球投资者，而芒格老先生的离世也引起了投资者对未来走势的深刻思考。与此同时，科技行业持续引领市场潮流，人工智能、生物技术等新兴领域涌现出众多创新企业。科技的不断演进不仅改变了产业格局，也深刻地塑造了资本市场的投资方向。在这个充满挑战和机遇的一年里，资本市场的参与者们展现出了卓越的创新意识，各个领域的变革和发展要求投资者具备更为敏锐的市场感知，并迫切需要获取更准确的信息。每一个积极通过企业号向老虎社区的虎友们即时分享行业、企业信息的公司都值得褒奖！老虎社区企业号在此隆重揭晓【2023老虎社区企业号年度公司评选榜单】。这些获奖公司秉持着为投资人负责的初心，专注于促进投资者与企业之间的畅通双向沟通，凭借卓越的业绩和积极的沟通态度，赢得了老虎平台投资者的广泛认可，展现了卓越的企业价值和社会责任。恭喜所有荣获2023年度奖项的上市公司伙伴们！这份殊荣是对你们在2023年度资本市场上卓越表现的褒奖，我们为你们的杰出成绩喝彩！此次上榜公司是在老虎社区企业号、以及港美股上市公司的范围内，基于老虎平台统计数据进行筛选的。评选过程中考虑了诸多关键因素，包括但不限于投资者关注度、品牌影响力、企业号活跃度以及与投资者互动情况等。最终产生了「最受投资者喜爱奖」、「最佳投资者陪伴奖」、「最佳品牌价值传播奖」和「最佳传播创新突破奖」四大奖项榜单，共计40个引人注目的获奖名额。老虎社区企业号由衷感谢一路以来与上市公司合作伙伴的共同努力与信任。同时，期待在新的一年里持续携手前行，共同致力于推动企业价值传播，回馈广大投资者的信赖与支持！ <a href=\"https://laohu8.com/U/3570687182203069\">@阿里巴巴集团</a>","listText":"回顾2023年，全球资本市场迎来了一系列动人心魄的波折和新机遇，成为全球资本市场参与者共同见证的重要时刻。地缘政治的波动成为市场关注的焦点，宏观事件影响全球投资者，而芒格老先生的离世也引起了投资者对未来走势的深刻思考。与此同时，科技行业持续引领市场潮流，人工智能、生物技术等新兴领域涌现出众多创新企业。科技的不断演进不仅改变了产业格局，也深刻地塑造了资本市场的投资方向。在这个充满挑战和机遇的一年里，资本市场的参与者们展现出了卓越的创新意识，各个领域的变革和发展要求投资者具备更为敏锐的市场感知，并迫切需要获取更准确的信息。每一个积极通过企业号向老虎社区的虎友们即时分享行业、企业信息的公司都值得褒奖！老虎社区企业号在此隆重揭晓【2023老虎社区企业号年度公司评选榜单】。这些获奖公司秉持着为投资人负责的初心，专注于促进投资者与企业之间的畅通双向沟通，凭借卓越的业绩和积极的沟通态度，赢得了老虎平台投资者的广泛认可，展现了卓越的企业价值和社会责任。恭喜所有荣获2023年度奖项的上市公司伙伴们！这份殊荣是对你们在2023年度资本市场上卓越表现的褒奖，我们为你们的杰出成绩喝彩！此次上榜公司是在老虎社区企业号、以及港美股上市公司的范围内，基于老虎平台统计数据进行筛选的。评选过程中考虑了诸多关键因素，包括但不限于投资者关注度、品牌影响力、企业号活跃度以及与投资者互动情况等。最终产生了「最受投资者喜爱奖」、「最佳投资者陪伴奖」、「最佳品牌价值传播奖」和「最佳传播创新突破奖」四大奖项榜单，共计40个引人注目的获奖名额。老虎社区企业号由衷感谢一路以来与上市公司合作伙伴的共同努力与信任。同时，期待在新的一年里持续携手前行，共同致力于推动企业价值传播，回馈广大投资者的信赖与支持！ <a href=\"https://laohu8.com/U/3570687182203069\">@阿里巴巴集团</a>","text":"回顾2023年，全球资本市场迎来了一系列动人心魄的波折和新机遇，成为全球资本市场参与者共同见证的重要时刻。地缘政治的波动成为市场关注的焦点，宏观事件影响全球投资者，而芒格老先生的离世也引起了投资者对未来走势的深刻思考。与此同时，科技行业持续引领市场潮流，人工智能、生物技术等新兴领域涌现出众多创新企业。科技的不断演进不仅改变了产业格局，也深刻地塑造了资本市场的投资方向。在这个充满挑战和机遇的一年里，资本市场的参与者们展现出了卓越的创新意识，各个领域的变革和发展要求投资者具备更为敏锐的市场感知，并迫切需要获取更准确的信息。每一个积极通过企业号向老虎社区的虎友们即时分享行业、企业信息的公司都值得褒奖！老虎社区企业号在此隆重揭晓【2023老虎社区企业号年度公司评选榜单】。这些获奖公司秉持着为投资人负责的初心，专注于促进投资者与企业之间的畅通双向沟通，凭借卓越的业绩和积极的沟通态度，赢得了老虎平台投资者的广泛认可，展现了卓越的企业价值和社会责任。恭喜所有荣获2023年度奖项的上市公司伙伴们！这份殊荣是对你们在2023年度资本市场上卓越表现的褒奖，我们为你们的杰出成绩喝彩！此次上榜公司是在老虎社区企业号、以及港美股上市公司的范围内，基于老虎平台统计数据进行筛选的。评选过程中考虑了诸多关键因素，包括但不限于投资者关注度、品牌影响力、企业号活跃度以及与投资者互动情况等。最终产生了「最受投资者喜爱奖」、「最佳投资者陪伴奖」、「最佳品牌价值传播奖」和「最佳传播创新突破奖」四大奖项榜单，共计40个引人注目的获奖名额。老虎社区企业号由衷感谢一路以来与上市公司合作伙伴的共同努力与信任。同时，期待在新的一年里持续携手前行，共同致力于推动企业价值传播，回馈广大投资者的信赖与支持！ @阿里巴巴集团","images":[{"img":"https://static.tigerbbs.com/2a0ed47204a08894620500891ca3ab94","width":"1080","height":"3917"},{"img":"https://static.tigerbbs.com/11793e9a71862865bc9d57eaa6c428f4","width":"1080","height":"3917"},{"img":"https://static.tigerbbs.com/e14e4df6cd6ff8ae2bff118ddbfddd63","width":"1080","height":"3917"}],"top":1,"highlighted":2,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/260789601091584","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":4,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":330,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":239705650680104,"gmtCreate":1699545565141,"gmtModify":1699545566541,"author":{"id":"4095630847582090","authorId":"4095630847582090","name":"Fanlization","avatar":"https://static.tigerbbs.com/4ff33c5fed6426a68a814ef72a46d188","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"这篇文章不错，转发给大家看看","listText":"这篇文章不错，转发给大家看看","text":"这篇文章不错，转发给大家看看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/239705650680104","repostId":"2382260679","repostType":4,"isVote":1,"tweetType":1,"viewCount":663,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":239255357862144,"gmtCreate":1699440234009,"gmtModify":1699440235292,"author":{"id":"4095630847582090","authorId":"4095630847582090","name":"Fanlization","avatar":"https://static.tigerbbs.com/4ff33c5fed6426a68a814ef72a46d188","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"这篇文章不错，转发给大家看看","listText":"这篇文章不错，转发给大家看看","text":"这篇文章不错，转发给大家看看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/239255357862144","repostId":"236711629484032","repostType":1,"repost":{"id":236711629484032,"gmtCreate":1698823619929,"gmtModify":1700031043800,"author":{"id":"3527667588142897","authorId":"3527667588142897","name":"小虎产品经理","avatar":"https://static.tigerbbs.com/a6704bebf28358e0d9c638e765403bd0","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"title":"期权组合下单功能已上线，快来试试吧","htmlText":"期权组合下单当前新版本已支持美股期权的组合期权链、K线图、添加自选及组合下单，包括垂直价差、跨式、日历等常用策略。部分组合订单及持仓享受保证金减免。期权链全新支持期权组合策略的期权链驾到，支持用户切换固定期权策略，也支持用户自定义交易策略。选中的期权组合可以直接交易，盈亏分析，也可以跳转到期权组合详情页查看更多数据。暂时只支持两腿期权组合，后期还会持续更新喔。组合期权策略可加入自选列表将心仪的期权策略加入自选列表中后，可以在美股期权分组下查看相关行情信息。点击标的可跳转到详情页快速下单。帮助您快速查找已创建好的期权策略。组合期权详情页欢迎使用我们的全新页面——组合期权详情页面！此功能旨在为您提供全面的组合期权信息，帮助您更好地了解和管理您的投资组合。以下是页面提供的详细内容：构成信息和最新价格：您可以查看组合期权的两个腿的构成信息，并获取最新的价格数据。组合价格和买卖盘盘口信息：通过页面上的组合价格，您可以得知该组合期权的当前价值。同时，您还能查看买卖盘口信息，包括当前组合期权的最佳买入和卖出价格，帮助您做出明智的交易决策。K线图：我们提供直观的K线图，让您可以观察组合期权的历史价格走势。有助于您分析市场趋势，发现潜在的投资机会。组合期权的持仓和订单信息：您可以查看自己的组合期权持仓情况，包括当前的持仓数量和成本。此外，您还可以查看与组合期权相关的订单信息，确保您对自己的交易有清晰的了解。组合期权的盈亏分析图：通过盈亏分析图，您可以直观地了解组合期权的盈利潜力和风险。这有助于您制定更好的投资策略，优化您的投资回报。当然，在页面底部，您还可以对当前组合期权进行交易或者添加自选下单页面介绍组合订单目前支持盘中提交限价单，组合限价默认为组合买卖盘的中间价，投资者可以根据自己的预期进行调整。预估收入表示这笔交易即将收到的权利金，预估支出则表示需要付出的权利金。下单页内嵌期权分析功能","listText":"期权组合下单当前新版本已支持美股期权的组合期权链、K线图、添加自选及组合下单，包括垂直价差、跨式、日历等常用策略。部分组合订单及持仓享受保证金减免。期权链全新支持期权组合策略的期权链驾到，支持用户切换固定期权策略，也支持用户自定义交易策略。选中的期权组合可以直接交易，盈亏分析，也可以跳转到期权组合详情页查看更多数据。暂时只支持两腿期权组合，后期还会持续更新喔。组合期权策略可加入自选列表将心仪的期权策略加入自选列表中后，可以在美股期权分组下查看相关行情信息。点击标的可跳转到详情页快速下单。帮助您快速查找已创建好的期权策略。组合期权详情页欢迎使用我们的全新页面——组合期权详情页面！此功能旨在为您提供全面的组合期权信息，帮助您更好地了解和管理您的投资组合。以下是页面提供的详细内容：构成信息和最新价格：您可以查看组合期权的两个腿的构成信息，并获取最新的价格数据。组合价格和买卖盘盘口信息：通过页面上的组合价格，您可以得知该组合期权的当前价值。同时，您还能查看买卖盘口信息，包括当前组合期权的最佳买入和卖出价格，帮助您做出明智的交易决策。K线图：我们提供直观的K线图，让您可以观察组合期权的历史价格走势。有助于您分析市场趋势，发现潜在的投资机会。组合期权的持仓和订单信息：您可以查看自己的组合期权持仓情况，包括当前的持仓数量和成本。此外，您还可以查看与组合期权相关的订单信息，确保您对自己的交易有清晰的了解。组合期权的盈亏分析图：通过盈亏分析图，您可以直观地了解组合期权的盈利潜力和风险。这有助于您制定更好的投资策略，优化您的投资回报。当然，在页面底部，您还可以对当前组合期权进行交易或者添加自选下单页面介绍组合订单目前支持盘中提交限价单，组合限价默认为组合买卖盘的中间价，投资者可以根据自己的预期进行调整。预估收入表示这笔交易即将收到的权利金，预估支出则表示需要付出的权利金。下单页内嵌期权分析功能","text":"期权组合下单当前新版本已支持美股期权的组合期权链、K线图、添加自选及组合下单，包括垂直价差、跨式、日历等常用策略。部分组合订单及持仓享受保证金减免。期权链全新支持期权组合策略的期权链驾到，支持用户切换固定期权策略，也支持用户自定义交易策略。选中的期权组合可以直接交易，盈亏分析，也可以跳转到期权组合详情页查看更多数据。暂时只支持两腿期权组合，后期还会持续更新喔。组合期权策略可加入自选列表将心仪的期权策略加入自选列表中后，可以在美股期权分组下查看相关行情信息。点击标的可跳转到详情页快速下单。帮助您快速查找已创建好的期权策略。组合期权详情页欢迎使用我们的全新页面——组合期权详情页面！此功能旨在为您提供全面的组合期权信息，帮助您更好地了解和管理您的投资组合。以下是页面提供的详细内容：构成信息和最新价格：您可以查看组合期权的两个腿的构成信息，并获取最新的价格数据。组合价格和买卖盘盘口信息：通过页面上的组合价格，您可以得知该组合期权的当前价值。同时，您还能查看买卖盘口信息，包括当前组合期权的最佳买入和卖出价格，帮助您做出明智的交易决策。K线图：我们提供直观的K线图，让您可以观察组合期权的历史价格走势。有助于您分析市场趋势，发现潜在的投资机会。组合期权的持仓和订单信息：您可以查看自己的组合期权持仓情况，包括当前的持仓数量和成本。此外，您还可以查看与组合期权相关的订单信息，确保您对自己的交易有清晰的了解。组合期权的盈亏分析图：通过盈亏分析图，您可以直观地了解组合期权的盈利潜力和风险。这有助于您制定更好的投资策略，优化您的投资回报。当然，在页面底部，您还可以对当前组合期权进行交易或者添加自选下单页面介绍组合订单目前支持盘中提交限价单，组合限价默认为组合买卖盘的中间价，投资者可以根据自己的预期进行调整。预估收入表示这笔交易即将收到的权利金，预估支出则表示需要付出的权利金。下单页内嵌期权分析功能","images":[{"img":"https://static.tigerbbs.com/252242c29cbb4fe141a637390ed0edf8","width":"1120","height":"1124"},{"img":"https://static.tigerbbs.com/88a1f3f14fd07d6ea893d404b8780eef","width":"1080","height":"2222"},{"img":"https://static.tigerbbs.com/b59927b89e8caa2b49401bf2bf0d6a35","width":"1242","height":"645"}],"top":1,"highlighted":1,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/236711629484032","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":9,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":414,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":234005014384872,"gmtCreate":1698158007889,"gmtModify":1698158009360,"author":{"id":"4095630847582090","authorId":"4095630847582090","name":"Fanlization","avatar":"https://static.tigerbbs.com/4ff33c5fed6426a68a814ef72a46d188","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"这篇文章不错，转发给大家看看","listText":"这篇文章不错，转发给大家看看","text":"这篇文章不错，转发给大家看看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/234005014384872","repostId":"233971103551624","repostType":1,"repost":{"id":233971103551624,"gmtCreate":1698147900409,"gmtModify":1703677936183,"author":{"id":"3527667609076620","authorId":"3527667609076620","name":"发發虎","avatar":"https://static.tigerbbs.com/a13a8024fdb84b92780aefe022e21dde","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"title":"【一起发财】做空特斯拉，他赚了232%！","htmlText":"有虎友通过做空 <a href=\"https://laohu8.com/S/TSLA\">$特斯拉(TSLA)$</a> 暴赚232%，发生了啥？他是如何做到的？这篇文章就跟大家一起探讨一下他的发财秘籍，祝所有看到的朋友们都能发财。恭喜虎友 <a href=\"https://laohu8.com/U/4126924776269962\">@壹缠</a> 通过买入特斯拉看跌期权 获利239%。恭喜虎友 <a href=\"https://laohu8.com/U/681616653300\">@还温柔的猫儿</a> 通过卖出特斯拉看涨期权 获利30%。欢迎以上虎友添加虎妞微信（微信：itiger2014），聊聊你的操作思路，获得老虎专访，赢取老虎限量周边。具体来看<a href=\"https://laohu8.com/S/TSLA\">$特斯拉(TSLA)$</a> 上周发布了差强人意的三季报，营收EPS双双低于预期，毛利率跌破18%、净利润下滑44%，在被问及对Cybertruck的交付预期时，马斯克一改往日高调，给出保守预估。受此消息影响，特斯拉财报后大跌9.3%。虎友<a href=\"https://laohu8.com/U/4126924776269962\">@壹缠</a> 在特斯拉财报前，提前入场，叠加利空消息，获得了239%的期权收益。当强烈看空一只股票时，买put（买入看跌期权）是一个不错的选择。除此之外sell call（卖出看涨期权）也是一个不错的选择，虎友<a href=\"https://laohu8.com/U/681616653300\">@还温柔的猫儿</a> 表示已经用行动告诉大家我的判断了，整体还是要跌，叠加各种负面信息，交付，利润率，产量，还有油价等因素，但长期坚定看涨，马斯克做了太多伟大的事儿。当然除了buy put 和sell call 之外，也有虎友","listText":"有虎友通过做空 <a href=\"https://laohu8.com/S/TSLA\">$特斯拉(TSLA)$</a> 暴赚232%，发生了啥？他是如何做到的？这篇文章就跟大家一起探讨一下他的发财秘籍，祝所有看到的朋友们都能发财。恭喜虎友 <a href=\"https://laohu8.com/U/4126924776269962\">@壹缠</a> 通过买入特斯拉看跌期权 获利239%。恭喜虎友 <a href=\"https://laohu8.com/U/681616653300\">@还温柔的猫儿</a> 通过卖出特斯拉看涨期权 获利30%。欢迎以上虎友添加虎妞微信（微信：itiger2014），聊聊你的操作思路，获得老虎专访，赢取老虎限量周边。具体来看<a href=\"https://laohu8.com/S/TSLA\">$特斯拉(TSLA)$</a> 上周发布了差强人意的三季报，营收EPS双双低于预期，毛利率跌破18%、净利润下滑44%，在被问及对Cybertruck的交付预期时，马斯克一改往日高调，给出保守预估。受此消息影响，特斯拉财报后大跌9.3%。虎友<a href=\"https://laohu8.com/U/4126924776269962\">@壹缠</a> 在特斯拉财报前，提前入场，叠加利空消息，获得了239%的期权收益。当强烈看空一只股票时，买put（买入看跌期权）是一个不错的选择。除此之外sell call（卖出看涨期权）也是一个不错的选择，虎友<a href=\"https://laohu8.com/U/681616653300\">@还温柔的猫儿</a> 表示已经用行动告诉大家我的判断了，整体还是要跌，叠加各种负面信息，交付，利润率，产量，还有油价等因素，但长期坚定看涨，马斯克做了太多伟大的事儿。当然除了buy put 和sell call 之外，也有虎友","text":"有虎友通过做空 $特斯拉(TSLA)$ 暴赚232%，发生了啥？他是如何做到的？这篇文章就跟大家一起探讨一下他的发财秘籍，祝所有看到的朋友们都能发财。恭喜虎友 @壹缠 通过买入特斯拉看跌期权 获利239%。恭喜虎友 @还温柔的猫儿 通过卖出特斯拉看涨期权 获利30%。欢迎以上虎友添加虎妞微信（微信：itiger2014），聊聊你的操作思路，获得老虎专访，赢取老虎限量周边。具体来看$特斯拉(TSLA)$ 上周发布了差强人意的三季报，营收EPS双双低于预期，毛利率跌破18%、净利润下滑44%，在被问及对Cybertruck的交付预期时，马斯克一改往日高调，给出保守预估。受此消息影响，特斯拉财报后大跌9.3%。虎友@壹缠 在特斯拉财报前，提前入场，叠加利空消息，获得了239%的期权收益。当强烈看空一只股票时，买put（买入看跌期权）是一个不错的选择。除此之外sell call（卖出看涨期权）也是一个不错的选择，虎友@还温柔的猫儿 表示已经用行动告诉大家我的判断了，整体还是要跌，叠加各种负面信息，交付，利润率，产量，还有油价等因素，但长期坚定看涨，马斯克做了太多伟大的事儿。当然除了buy put 和sell call 之外，也有虎友","images":[{"img":"https://static.tigerbbs.com/23127e741a31e296fa8e3d7f0cce9d81","width":"1080","height":"1080"},{"img":"https://static.tigerbbs.com/58637d566ebf5370e6546bcb6a2b93e0","width":"1382","height":"1036"},{"img":"https://static.tigerbbs.com/70a3bbcba04f6fda98a30fb209a96094","width":"1382","height":"1036"}],"top":1,"highlighted":2,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/233971103551624","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":4,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":646,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":230126338162960,"gmtCreate":1697201867945,"gmtModify":1697201869342,"author":{"id":"4095630847582090","authorId":"4095630847582090","name":"Fanlization","avatar":"https://static.tigerbbs.com/4ff33c5fed6426a68a814ef72a46d188","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"这篇文章不错，转发给大家看看","listText":"这篇文章不错，转发给大家看看","text":"这篇文章不错，转发给大家看看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/230126338162960","repostId":"1150989292","repostType":4,"isVote":1,"tweetType":1,"viewCount":503,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":222623689396336,"gmtCreate":1695378857323,"gmtModify":1695378858776,"author":{"id":"4095630847582090","authorId":"4095630847582090","name":"Fanlization","avatar":"https://static.tigerbbs.com/4ff33c5fed6426a68a814ef72a46d188","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"这篇文章不错，转发给大家看看","listText":"这篇文章不错，转发给大家看看","text":"这篇文章不错，转发给大家看看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/222623689396336","repostId":"222641661218832","repostType":1,"repost":{"id":222641661218832,"gmtCreate":1695375795415,"gmtModify":1695375827655,"author":{"id":"36979109942400","authorId":"36979109942400","name":"小虎周报","avatar":"https://static.laohu8.com/f7b172cf773c77a3f0df67695c126b51","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"title":"港股周报：重磅利好要来了？","htmlText":"本周，港股行情萎靡，但周五一根2.28%的大阳线让投资者重新看到希望。消息面上，市场盛传各类利好消息，如路透社消息:据传中国政府计划将于9月22日推出一系列救市举措，限制融券做空，成立平准基金等：再如彭博社传出的消息，称中国正考虑放宽外资对部分A股持股上限，但目前讨论尚处初期阶段。目前，该消息未获官方证实。港股方面也有好消息传来，昨天，香港行政长官李家超在出席金融服务界国庆酒会时表示，近日，促进股票市场流动性专责小组正加紧开会深入研究促进市场流动性的措施，并会向其提交建议报告，相信香港有好多“好桥”（好主意），金融界亦不例外，期待金融界人士向专责小组提出更多“好桥”建议，让小组集思广益。重磅利好或许已在路上！板块方面，本周材料和医疗保健表现较好，其他板块多数下跌，跌幅最大的依然是房地产，主要是前期大涨之后，地产销售数据并未明显改善：南下资金本周净流入144亿港币，但令人意外的是周五港股大涨之下，南下资金竟然选择获利了结：下周，港A股将迎来中秋、国庆假期，港股通将关闭数日，投资者敬请注意。本周港股大事件：1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;名创优品发布年度业绩，净利润17.69亿元，同比增加177.2%，有意购回最多价值2亿美元的美国存托股份；2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 中国最大的以平台为中心的决策类人工智能公司第四范式本周招股，下周四上市交易；3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 《十四届全国人大常委会立法规划》对外公布，房地产税立法并未出现在本次立法规划中；4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 贝莱德首席中国经济学家宋宇、贝莱德基金首席投资官陆文杰在接受中国证券报采访时表示，对中国股票态度积极，当前存在底部超配的价值；5.&nbsp;&amp;nb","listText":"本周，港股行情萎靡，但周五一根2.28%的大阳线让投资者重新看到希望。消息面上，市场盛传各类利好消息，如路透社消息:据传中国政府计划将于9月22日推出一系列救市举措，限制融券做空，成立平准基金等：再如彭博社传出的消息，称中国正考虑放宽外资对部分A股持股上限，但目前讨论尚处初期阶段。目前，该消息未获官方证实。港股方面也有好消息传来，昨天，香港行政长官李家超在出席金融服务界国庆酒会时表示，近日，促进股票市场流动性专责小组正加紧开会深入研究促进市场流动性的措施，并会向其提交建议报告，相信香港有好多“好桥”（好主意），金融界亦不例外，期待金融界人士向专责小组提出更多“好桥”建议，让小组集思广益。重磅利好或许已在路上！板块方面，本周材料和医疗保健表现较好，其他板块多数下跌，跌幅最大的依然是房地产，主要是前期大涨之后，地产销售数据并未明显改善：南下资金本周净流入144亿港币，但令人意外的是周五港股大涨之下，南下资金竟然选择获利了结：下周，港A股将迎来中秋、国庆假期，港股通将关闭数日，投资者敬请注意。本周港股大事件：1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;名创优品发布年度业绩，净利润17.69亿元，同比增加177.2%，有意购回最多价值2亿美元的美国存托股份；2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 中国最大的以平台为中心的决策类人工智能公司第四范式本周招股，下周四上市交易；3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 《十四届全国人大常委会立法规划》对外公布，房地产税立法并未出现在本次立法规划中；4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 贝莱德首席中国经济学家宋宇、贝莱德基金首席投资官陆文杰在接受中国证券报采访时表示，对中国股票态度积极，当前存在底部超配的价值；5.&nbsp;&amp;nb","text":"本周，港股行情萎靡，但周五一根2.28%的大阳线让投资者重新看到希望。消息面上，市场盛传各类利好消息，如路透社消息:据传中国政府计划将于9月22日推出一系列救市举措，限制融券做空，成立平准基金等：再如彭博社传出的消息，称中国正考虑放宽外资对部分A股持股上限，但目前讨论尚处初期阶段。目前，该消息未获官方证实。港股方面也有好消息传来，昨天，香港行政长官李家超在出席金融服务界国庆酒会时表示，近日，促进股票市场流动性专责小组正加紧开会深入研究促进市场流动性的措施，并会向其提交建议报告，相信香港有好多“好桥”（好主意），金融界亦不例外，期待金融界人士向专责小组提出更多“好桥”建议，让小组集思广益。重磅利好或许已在路上！板块方面，本周材料和医疗保健表现较好，其他板块多数下跌，跌幅最大的依然是房地产，主要是前期大涨之后，地产销售数据并未明显改善：南下资金本周净流入144亿港币，但令人意外的是周五港股大涨之下，南下资金竟然选择获利了结：下周，港A股将迎来中秋、国庆假期，港股通将关闭数日，投资者敬请注意。本周港股大事件：1. 名创优品发布年度业绩，净利润17.69亿元，同比增加177.2%，有意购回最多价值2亿美元的美国存托股份；2. 中国最大的以平台为中心的决策类人工智能公司第四范式本周招股，下周四上市交易；3. 《十四届全国人大常委会立法规划》对外公布，房地产税立法并未出现在本次立法规划中；4. 贝莱德首席中国经济学家宋宇、贝莱德基金首席投资官陆文杰在接受中国证券报采访时表示，对中国股票态度积极，当前存在底部超配的价值；5. &nb","images":[{"img":"https://static.tigerbbs.com/5a02447c1bdaea67ef96c740ef10df12","width":"800","height":"230"},{"img":"https://static.tigerbbs.com/a731beee557e7a4ecb9bfc6082b6ff70","width":"1090","height":"546"},{"img":"https://static.tigerbbs.com/ef7b274cd370cddaaa14e5c49f1a3489","width":"1110","height":"544"}],"top":1,"highlighted":1,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/222641661218832","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":4,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":661,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":217690603417688,"gmtCreate":1694181667098,"gmtModify":1694181668625,"author":{"id":"4095630847582090","authorId":"4095630847582090","name":"Fanlization","avatar":"https://static.tigerbbs.com/4ff33c5fed6426a68a814ef72a46d188","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"这篇文章不错，转发给大家看看","listText":"这篇文章不错，转发给大家看看","text":"这篇文章不错，转发给大家看看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/217690603417688","repostId":"1183967577","repostType":4,"isVote":1,"tweetType":1,"viewCount":794,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":207466783289568,"gmtCreate":1691679703058,"gmtModify":1691679704619,"author":{"id":"4095630847582090","authorId":"4095630847582090","name":"Fanlization","avatar":"https://static.tigerbbs.com/4ff33c5fed6426a68a814ef72a46d188","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"这篇文章不错，转发给大家看看","listText":"这篇文章不错，转发给大家看看","text":"这篇文章不错，转发给大家看看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/207466783289568","repostId":"1186584854","repostType":2,"isVote":1,"tweetType":1,"viewCount":524,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":207258518003896,"gmtCreate":1691629162210,"gmtModify":1691629163344,"author":{"id":"4095630847582090","authorId":"4095630847582090","name":"Fanlization","avatar":"https://static.tigerbbs.com/4ff33c5fed6426a68a814ef72a46d188","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"这篇文章不错，转发给大家看看","listText":"这篇文章不错，转发给大家看看","text":"这篇文章不错，转发给大家看看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/207258518003896","repostId":"2358020620","repostType":2,"isVote":1,"tweetType":1,"viewCount":301,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":207257724088384,"gmtCreate":1691629082200,"gmtModify":1691629083340,"author":{"id":"4095630847582090","authorId":"4095630847582090","name":"Fanlization","avatar":"https://static.tigerbbs.com/4ff33c5fed6426a68a814ef72a46d188","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"这篇文章不错，转发给大家看看","listText":"这篇文章不错，转发给大家看看","text":"这篇文章不错，转发给大家看看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/207257724088384","repostId":"2358350527","repostType":2,"isVote":1,"tweetType":1,"viewCount":439,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":203875589275840,"gmtCreate":1690812487824,"gmtModify":1690812489125,"author":{"id":"4095630847582090","authorId":"4095630847582090","name":"Fanlization","avatar":"https://static.tigerbbs.com/4ff33c5fed6426a68a814ef72a46d188","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"这篇文章不错，转发给大家看看","listText":"这篇文章不错，转发给大家看看","text":"这篇文章不错，转发给大家看看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/203875589275840","repostId":"193879170215968","repostType":1,"repost":{"id":193879170215968,"gmtCreate":1688363548614,"gmtModify":1688363548678,"author":{"id":"4140594566835972","authorId":"4140594566835972","name":"HoChe","avatar":"https://community-static.tradeup.com/news/80f3d3a2627ce910033fd9e81c64ad7b","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"title":"除净「除得太净」 JS环球值1.92元 ","htmlText":"JS 环球生活（1691）将100% SharkNinja以实物方式全部送予股东，上周四除净前8.35元，上周五除净，全日高低2.5元 / 1.29元，均价1.55元，收1.36元，较除净前低84%，公司市值由292亿元降至47亿元。「除得太净」，投机买入。 <a href=\"https://ttm.financial/S/01691\">$JS环球生活(01691)$</a> 为方便行文及方便读者易于了解，除净前的JS环球称为「旧JS环球」，除净后（现时）的JS环球称为「新JS环球」。1）理论上，新JS环球如果不升不跌，市值应相等于旧JS环球市值减SharkNinja 市值。SharkNinja 将于7月底前后在美交所挂牌，6月5日的相关通函指，参照美国同类股估值计算，SharkNinja 的参考估值为196亿元（港币．下同）。以此项估值为据，JS环球除净前后又不升不跌的话，则新JS环球的合理市值应为96亿元（292亿元减196亿元），即股价应值2.75元，较现价高出102% !假如SharkNinja的价值较前述参考估值196亿元高出15%，即225亿元，则新JS环球合理市值应为67亿元，即股价应值1.92元，较现价仍高出41% !2）SharkNinja产销吸麈机及地板护理工具（美国销量第一）、电煮锅（英国市占率59.6% ），主要业务地区是欧美，2022财年（12月年结）纯利19.3亿元。以上段假设参考估值加15%即225亿元计，PE 11.7倍。 PE仅5.3厘3）新JS环球不再拥有SharkNinja ，仍拥有九阳股份（深：002242）66.7%，及「JSG 亚太」100%。九阳主要产销气炸锅、豆浆机、果汁机、电饭煲，主要市场是中国大陆，多种小家电在国内处于领先地位。「JSG亚太」处理SharkNinja品牌在亚太区及大中华的业务，所销售小家电产品的体积较Sha","listText":"JS 环球生活（1691）将100% SharkNinja以实物方式全部送予股东，上周四除净前8.35元，上周五除净，全日高低2.5元 / 1.29元，均价1.55元，收1.36元，较除净前低84%，公司市值由292亿元降至47亿元。「除得太净」，投机买入。 <a href=\"https://ttm.financial/S/01691\">$JS环球生活(01691)$</a> 为方便行文及方便读者易于了解，除净前的JS环球称为「旧JS环球」，除净后（现时）的JS环球称为「新JS环球」。1）理论上，新JS环球如果不升不跌，市值应相等于旧JS环球市值减SharkNinja 市值。SharkNinja 将于7月底前后在美交所挂牌，6月5日的相关通函指，参照美国同类股估值计算，SharkNinja 的参考估值为196亿元（港币．下同）。以此项估值为据，JS环球除净前后又不升不跌的话，则新JS环球的合理市值应为96亿元（292亿元减196亿元），即股价应值2.75元，较现价高出102% !假如SharkNinja的价值较前述参考估值196亿元高出15%，即225亿元，则新JS环球合理市值应为67亿元，即股价应值1.92元，较现价仍高出41% !2）SharkNinja产销吸麈机及地板护理工具（美国销量第一）、电煮锅（英国市占率59.6% ），主要业务地区是欧美，2022财年（12月年结）纯利19.3亿元。以上段假设参考估值加15%即225亿元计，PE 11.7倍。 PE仅5.3厘3）新JS环球不再拥有SharkNinja ，仍拥有九阳股份（深：002242）66.7%，及「JSG 亚太」100%。九阳主要产销气炸锅、豆浆机、果汁机、电饭煲，主要市场是中国大陆，多种小家电在国内处于领先地位。「JSG亚太」处理SharkNinja品牌在亚太区及大中华的业务，所销售小家电产品的体积较Sha","text":"JS 环球生活（1691）将100% SharkNinja以实物方式全部送予股东，上周四除净前8.35元，上周五除净，全日高低2.5元 / 1.29元，均价1.55元，收1.36元，较除净前低84%，公司市值由292亿元降至47亿元。「除得太净」，投机买入。 $JS环球生活(01691)$ 为方便行文及方便读者易于了解，除净前的JS环球称为「旧JS环球」，除净后（现时）的JS环球称为「新JS环球」。1）理论上，新JS环球如果不升不跌，市值应相等于旧JS环球市值减SharkNinja 市值。SharkNinja 将于7月底前后在美交所挂牌，6月5日的相关通函指，参照美国同类股估值计算，SharkNinja 的参考估值为196亿元（港币．下同）。以此项估值为据，JS环球除净前后又不升不跌的话，则新JS环球的合理市值应为96亿元（292亿元减196亿元），即股价应值2.75元，较现价高出102% !假如SharkNinja的价值较前述参考估值196亿元高出15%，即225亿元，则新JS环球合理市值应为67亿元，即股价应值1.92元，较现价仍高出41% !2）SharkNinja产销吸麈机及地板护理工具（美国销量第一）、电煮锅（英国市占率59.6% ），主要业务地区是欧美，2022财年（12月年结）纯利19.3亿元。以上段假设参考估值加15%即225亿元计，PE 11.7倍。 PE仅5.3厘3）新JS环球不再拥有SharkNinja ，仍拥有九阳股份（深：002242）66.7%，及「JSG 亚太」100%。九阳主要产销气炸锅、豆浆机、果汁机、电饭煲，主要市场是中国大陆，多种小家电在国内处于领先地位。「JSG亚太」处理SharkNinja品牌在亚太区及大中华的业务，所销售小家电产品的体积较Sha","images":[{"img":"https://community-static.tradeup.com/news/b151cd31d02da10e67b386e977bf1f41","width":"600","height":"530"}],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/193879170215968","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":272,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":192971459387432,"gmtCreate":1688122959389,"gmtModify":1688122960606,"author":{"id":"4095630847582090","authorId":"4095630847582090","name":"Fanlization","avatar":"https://static.tigerbbs.com/4ff33c5fed6426a68a814ef72a46d188","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"这篇文章不错，转发给大家看看","listText":"这篇文章不错，转发给大家看看","text":"这篇文章不错，转发给大家看看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/192971459387432","repostId":"1149189861","repostType":2,"isVote":1,"tweetType":1,"viewCount":210,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":192886086766736,"gmtCreate":1688102135875,"gmtModify":1688102137288,"author":{"id":"4095630847582090","authorId":"4095630847582090","name":"Fanlization","avatar":"https://static.tigerbbs.com/4ff33c5fed6426a68a814ef72a46d188","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"这篇文章不错，转发给大家看看","listText":"这篇文章不错，转发给大家看看","text":"这篇文章不错，转发给大家看看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/192886086766736","repostId":"2347636428","repostType":2,"isVote":1,"tweetType":1,"viewCount":459,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":192561075679368,"gmtCreate":1688040371447,"gmtModify":1688040373175,"author":{"id":"4095630847582090","authorId":"4095630847582090","name":"Fanlization","avatar":"https://static.tigerbbs.com/4ff33c5fed6426a68a814ef72a46d188","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"这篇文章不错，转发给大家看看","listText":"这篇文章不错，转发给大家看看","text":"这篇文章不错，转发给大家看看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/192561075679368","repostId":"1138473703","repostType":4,"isVote":1,"tweetType":1,"viewCount":222,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":655312396,"gmtCreate":1685240487215,"gmtModify":1685240488623,"author":{"id":"4095630847582090","authorId":"4095630847582090","name":"Fanlization","avatar":"https://static.tigerbbs.com/4ff33c5fed6426a68a814ef72a46d188","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"这篇文章不错，转发给大家看看","listText":"这篇文章不错，转发给大家看看","text":"这篇文章不错，转发给大家看看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/655312396","repostId":"1118068579","repostType":4,"isVote":1,"tweetType":1,"viewCount":382,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":320637583126848,"gmtCreate":1719303767154,"gmtModify":1719303770945,"author":{"id":"4095630847582090","authorId":"4095630847582090","name":"Fanlization","avatar":"https://static.tigerbbs.com/4ff33c5fed6426a68a814ef72a46d188","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"好","listText":"好","text":"好","images":[{"img":"https://static.tigerbbs.com/22d64da41c22fee5285a35b1050f14ad","width":"1280","height":"1877"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/320637583126848","isVote":1,"tweetType":1,"viewCount":51,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":299062854197320,"gmtCreate":1714038596382,"gmtModify":1714038731115,"author":{"id":"4095630847582090","authorId":"4095630847582090","name":"Fanlization","avatar":"https://static.tigerbbs.com/4ff33c5fed6426a68a814ef72a46d188","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"title":"竞猜赢虎币 ，寻找实盘收益王","htmlText":"查看详情：<a href=\"https://tigr.link/7vd3vT\">竞猜赢虎币 ，寻找实盘收益王</a> 快来参与竞猜赢虎币活动，寻找你心中的实盘收益王，邀请好友最多可得250枚虎币 此帖仅开放于中国大陆用户","listText":"查看详情：<a href=\"https://tigr.link/7vd3vT\">竞猜赢虎币 ，寻找实盘收益王</a> 快来参与竞猜赢虎币活动，寻找你心中的实盘收益王，邀请好友最多可得250枚虎币 此帖仅开放于中国大陆用户","text":"查看详情：竞猜赢虎币 ，寻找实盘收益王 快来参与竞猜赢虎币活动，寻找你心中的实盘收益王，邀请好友最多可得250枚虎币 此帖仅开放于中国大陆用户","images":[{"img":"https://static.tigerbbs.com/f22c491ee8ae08f0d36ded0795f1fe33"}],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/299062854197320","isVote":1,"tweetType":1,"viewCount":241,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":293812433965240,"gmtCreate":1712762161740,"gmtModify":1712762163366,"author":{"id":"4095630847582090","authorId":"4095630847582090","name":"Fanlization","avatar":"https://static.tigerbbs.com/4ff33c5fed6426a68a814ef72a46d188","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"这篇文章不错，转发给大家看看","listText":"这篇文章不错，转发给大家看看","text":"这篇文章不错，转发给大家看看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/293812433965240","repostId":"2425310589","repostType":2,"repost":{"id":"2425310589","pubTimestamp":1712241480,"share":"https://www.laohu8.com/m/news/2425310589?lang=&edition=full","pubTime":"2024-04-04 22:38","market":"us","language":"en","title":"Kintara (KTRA) Stock Soars on Merger Agreement With TuHURA","url":"https://stock-news.laohu8.com/highlight/detail?id=2425310589","media":"Zacks","summary":"Kintara Therapeutics, Inc.’s KTRA shares surged 63.4% on Apr 3 after the company inked a definitive merger agreement with Florida-based privately-held company, TuHURA Biosciences Inc. Per the agreement, KTRA will merge into TuHURA to form a new company aimed at developing late-stage oncology candidates.The combined company will operate under the name of TuHURA Biosciences, Inc., and trade in the Nasdaq stock exchange under the ticker symbol \"HURA.\". Per the agreement, Kintara equity holders are expected to collectively own up to approximately 2.85%, or 5.45%, including shares underlying the contingent value rights  of the common stock of the combined company on a pro forma fully diluted basis. Meanwhile, equity holders of TuHURA are eligible to collectively own approximately 97.15%, or 94.55%, taking the distribution of the CVR shares, of the common stock of the combined company on a pro forma fully diluted basis after the merger is completed.The newly formed company will focus on adva","content":"<html><body><p><strong><a href=\"https://laohu8.com/S/KTRA\">Kintara Therapeutics, Inc.</a></strong>’s KTRA shares surged 63.4% on Apr 3 after the company inked a definitive merger agreement with Florida-based privately-held company, TuHURA Biosciences Inc. Per the agreement, KTRA will merge into TuHURA to form a new company aimed at developing late-stage oncology candidates.</p>\n<p>The combined company will operate under the name of TuHURA Biosciences, Inc., and trade in the Nasdaq stock exchange under the ticker symbol \"HURA.\"</p>\n<p>The transaction has been approved by the boards of directors of both companies and is expected to close in the third quarter of 2024, subject to customary closing conditions.</p>\n<p>Per the agreement, Kintara equity holders are expected to collectively own up to approximately 2.85%, or 5.45%, including shares underlying the contingent value rights (CVR) of the common stock of the combined company on a pro forma fully diluted basis. Meanwhile, equity holders of TuHURA are eligible to collectively own approximately 97.15%, or 94.55%, taking the distribution of the CVR shares, of the common stock of the combined company on a pro forma fully diluted basis after the merger is completed.</p>\n<p>The newly formed company will focus on advancing TuHURA's personalized cancer vaccine and first-in-class bi-functional antibody-drug conjugates (ADCs) to overcome the hurdles in the treatment of cancer with existing immunotherapies.</p>\n<p>ADCs are being considered a disruptive innovation in the pharmaceutical industry as these will allow better treatment of cancer by harnessing the targeting power of antibodies to deliver cytotoxic molecule drugs to tumors.</p>\n<p>Shares of Kintara have lost 3.3% year to date against the industry’s growth of 1.9%.</p>\n<p><img src=\"https://s1.yimg.com/uu/api/res/1.2/zBkN1feR85cSNmi8u7lm6Q--/cT03NTthcHBpZD15dmlkZW9mZWVkczs-/https://media.zenfs.com/en/zacks.com/6416afa85f382eca776c9ed90bea040a\"/><br/><span>Image Source: Zacks Investment Research</span><br/></p>\n<p>KTRA is developing its lead pipeline candidate, REM-001, a second-generation photodynamic therapy photosensitizer agent for the treatment of cutaneous metastatic breast cancer.</p>\n<p>Meanwhile, TuHURA is developing its lead personalized cancer vaccine candidate, IFx-2.0, to overcome primary resistance to checkpoint inhibitors.</p>\n<p>TuHURA is planning to initiate a phase III registration study evaluating IFx-2.0 administered as an adjunctive therapy to <strong>Merck</strong>’s MRK blockbuster cancer drug, Keytruda (pembrolizumab), for the first-line treatment of advanced merkel cell carcinoma.</p>\n<p>Merck’s biggest revenue generator, Keytruda, is approved for treating several cancer indications. Sales of Keytruda came in around $25 billion in 2023.</p>\n<p>MRK continues to evaluate Keytruda in combination studies for various other indications.</p>\n<p>Enrollment in the placebo-controlled phase III study is expected to begin in the second half of 2024. The study is likely to be conducted under the FDA's Accelerated Approval Pathway, which helps in earlier approval of drugs that address serious and unmet medical conditions.</p>\n<p>Along with the latest merger agreement, TuHURA is making $31 million subscribed financing, which is expected to fund the combined company’s operations through late 2025.</p>\n<p>The transaction should create a near and long-term value for Kintara’s shareholders as the newly formed company will be well-positioned to develop groundbreaking new therapies for treating cancer.</p>\n<h3>Zacks Rank &amp; Stocks to Consider</h3>\n<p>Kintara currently carries a Zacks Rank #4 (Sell).</p>\n<p>Some better-ranked stocks in the healthcare sector are <strong>Ligand Pharmaceuticals Incorporated</strong> LGND and <strong><a href=\"https://laohu8.com/S/ANIP\">ANI Pharmaceuticals, Inc.</a></strong> ANIP, each flaunting a Zacks Rank #1 (Strong Buy) at present. You can see <strong>the complete list of today’s Zacks #1 Rank stocks here</strong>.</p>\n<p>In the past 60 days, estimates for Ligand’s 2024 earnings per share have improved from $4.42 to $4.56. Year to date, LGND shares have gained 4.5%.</p>\n<p>Earnings of LGND beat estimates in each of the trailing four quarters, the average surprise being 84.81%.</p>\n<p>In the past 60 days, estimates for ANI Pharmaceuticals’ 2024 earnings per share have improved from $4.06 to $4.43. Year to date, ANIP shares have jumped 21.7%.</p>\n<p>Earnings of ANIP beat estimates in each of the trailing four quarters, the average surprise being 109.06%.</p>\n<p>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report</p>\n<p>Merck &amp; Co., Inc. (MRK) : Free Stock Analysis Report</p>\n<p>Ligand Pharmaceuticals Incorporated (LGND) : Free Stock Analysis Report</p>\n<p>ANI Pharmaceuticals, Inc. (ANIP) : Free Stock Analysis Report</p>\n<p>Kintara <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a>, Inc. (KTRA) : Free Stock Analysis Report</p>\n<p>To read this article on Zacks.com click here.</p>\n<p>Zacks Investment Research</p></body></html>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Kintara (KTRA) Stock Soars on Merger Agreement With TuHURA</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nKintara (KTRA) Stock Soars on Merger Agreement With TuHURA\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-04-04 22:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/kintara-ktra-stock-soars-merger-143800928.html><strong>Zacks</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Kintara Therapeutics, Inc.’s KTRA shares surged 63.4% on Apr 3 after the company inked a definitive merger agreement with Florida-based privately-held company, TuHURA Biosciences Inc. Per the ...</p>\n\n<a href=\"https://finance.yahoo.com/news/kintara-ktra-stock-soars-merger-143800928.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://s.yimg.com/uu/api/res/1.2/H9DYdttPy00EKBHhcxtlCA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9f2a2e04a053cda7a8c096e532e43d28","relate_stocks":{"MRK":"默沙东","LU0122379950.USD":"贝莱德世界健康科学A2","LU2361045086.USD":"WELLINGTON US QUALITY GROWTH \"A\" (USD) ACC","IE0002141913.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (USD) ACC","SG9999015358.SGD":"United Income Focus Trust Dis SGD-H","SG9999015341.SGD":"United Income Focus Trust Acc SGD-H","IE00B1BXHZ80.USD":"Legg Mason ClearBridge - US Appreciation A Acc USD","IE00BJJMRZ35.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (SGDHDG) ACC","SG9999014542.SGD":"United Income Focus Trust Acc SGD","LU2468319806.SGD":"MANULIFE GF HEALTHCARE \"AA\" (SGDHDG) ACC","SG9999001440.SGD":"United Global Dividend Equity Fund A SGD Dist","SG9999001176.USD":"United Global Healthcare Acc USD","LGND":"Ligand Pharmaceuticals Inc.","LU1585245621.USD":"EASTSPRING INV GLOBAL LOW VOLATILITY EQUITY FUND \"A\" (USD) ACC B","LU0211331839.USD":"FRANKLIN MUTUAL GLB DISCOVERY \"A\" (USD) ACC","IE00BLSP4239.USD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis USD Plus","SG9999013999.USD":"UOB UNITED GLOBAL HEALTHCARE FUND (USDHDG) INC","IE00BLSP4452.SGD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis SGD-H Plus","LU1917777945.USD":"安联专题基金Cl AT Acc","SG9999001176.SGD":"UOB UNITED GLOBAL HEALTHCARE \"SGD\" (ACC)","SG9999014575.USD":"UOB UNITED INCOME FOCUS TRUST FUND (USDHDG) INC","LU1989771016.USD":"东方汇理环球老龄化投资基金 A2 Acc","CVR":"芝加哥机械","LU1989772840.SGD":"CPR Invest - Climate Action A2 Acc SGD-H","IE0009355771.USD":"骏利亨德森环球生命科技A Acc","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","LU2461242641.AUD":"WELLINGTON US QUALITY GROWTH \"A\" (AUDHDG) ACC","BK4161":"工业机械","LU0208291251.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) INC","LU1989772923.USD":"CPR Invest - Climate Action A2 Acc USD-H","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","BK4534":"瑞士信贷持仓","BK4585":"ETF&股票定投概念","IE00BJT1NW94.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (SGDHDG) ACC","IE00BBT3K403.USD":"LEGG MASON CLEARBRIDGE TACTICAL DIVIDEND INCOME \"A(USD) ACC","BK4139":"生物科技","LU2023250843.SGD":"Allianz Thematica Cl AT Acc H2-SGD","BK4533":"AQR资本管理(全球第二大对冲基金)","KTRA":"Kintara Therapeutics, Inc.","LU0058720904.USD":"联博国际健康护理基金A","LU2361044949.HKD":"WELLINGTON US QUALITY GROWTH \"A\" (HKD) ACC","SG9999014559.SGD":"United Income Focus Trust Dis SGD","LU2361044865.SGD":"WELLINGTON US QUALITY GROWTH \"A\" (SGDHDG) ACC","LU1066051498.USD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM2\" (USD) INC","BK4588":"碎股","SG9999014567.USD":"UOB UNITED INCOME FOCUS TRUST FUND (USD) ACC","LU1066053197.SGD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM3\" (SGDHDG) INC","ANIP":"ANI Pharmaceuticals, Inc.","LU0965509283.SGD":"AB LOW VOLATILITY EQUITY PORTFOLIO \"AD\" (SGDHDG) INC"},"source_url":"https://finance.yahoo.com/news/kintara-ktra-stock-soars-merger-143800928.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2425310589","content_text":"Kintara Therapeutics, Inc.’s KTRA shares surged 63.4% on Apr 3 after the company inked a definitive merger agreement with Florida-based privately-held company, TuHURA Biosciences Inc. Per the agreement, KTRA will merge into TuHURA to form a new company aimed at developing late-stage oncology candidates.\nThe combined company will operate under the name of TuHURA Biosciences, Inc., and trade in the Nasdaq stock exchange under the ticker symbol \"HURA.\"\nThe transaction has been approved by the boards of directors of both companies and is expected to close in the third quarter of 2024, subject to customary closing conditions.\nPer the agreement, Kintara equity holders are expected to collectively own up to approximately 2.85%, or 5.45%, including shares underlying the contingent value rights (CVR) of the common stock of the combined company on a pro forma fully diluted basis. Meanwhile, equity holders of TuHURA are eligible to collectively own approximately 97.15%, or 94.55%, taking the distribution of the CVR shares, of the common stock of the combined company on a pro forma fully diluted basis after the merger is completed.\nThe newly formed company will focus on advancing TuHURA's personalized cancer vaccine and first-in-class bi-functional antibody-drug conjugates (ADCs) to overcome the hurdles in the treatment of cancer with existing immunotherapies.\nADCs are being considered a disruptive innovation in the pharmaceutical industry as these will allow better treatment of cancer by harnessing the targeting power of antibodies to deliver cytotoxic molecule drugs to tumors.\nShares of Kintara have lost 3.3% year to date against the industry’s growth of 1.9%.\nImage Source: Zacks Investment Research\nKTRA is developing its lead pipeline candidate, REM-001, a second-generation photodynamic therapy photosensitizer agent for the treatment of cutaneous metastatic breast cancer.\nMeanwhile, TuHURA is developing its lead personalized cancer vaccine candidate, IFx-2.0, to overcome primary resistance to checkpoint inhibitors.\nTuHURA is planning to initiate a phase III registration study evaluating IFx-2.0 administered as an adjunctive therapy to Merck’s MRK blockbuster cancer drug, Keytruda (pembrolizumab), for the first-line treatment of advanced merkel cell carcinoma.\nMerck’s biggest revenue generator, Keytruda, is approved for treating several cancer indications. Sales of Keytruda came in around $25 billion in 2023.\nMRK continues to evaluate Keytruda in combination studies for various other indications.\nEnrollment in the placebo-controlled phase III study is expected to begin in the second half of 2024. The study is likely to be conducted under the FDA's Accelerated Approval Pathway, which helps in earlier approval of drugs that address serious and unmet medical conditions.\nAlong with the latest merger agreement, TuHURA is making $31 million subscribed financing, which is expected to fund the combined company’s operations through late 2025.\nThe transaction should create a near and long-term value for Kintara’s shareholders as the newly formed company will be well-positioned to develop groundbreaking new therapies for treating cancer.\nZacks Rank & Stocks to Consider\nKintara currently carries a Zacks Rank #4 (Sell).\nSome better-ranked stocks in the healthcare sector are Ligand Pharmaceuticals Incorporated LGND and ANI Pharmaceuticals, Inc. ANIP, each flaunting a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.\nIn the past 60 days, estimates for Ligand’s 2024 earnings per share have improved from $4.42 to $4.56. Year to date, LGND shares have gained 4.5%.\nEarnings of LGND beat estimates in each of the trailing four quarters, the average surprise being 84.81%.\nIn the past 60 days, estimates for ANI Pharmaceuticals’ 2024 earnings per share have improved from $4.06 to $4.43. Year to date, ANIP shares have jumped 21.7%.\nEarnings of ANIP beat estimates in each of the trailing four quarters, the average surprise being 109.06%.\nWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report\nMerck & Co., Inc. (MRK) : Free Stock Analysis Report\nLigand Pharmaceuticals Incorporated (LGND) : Free Stock Analysis Report\nANI Pharmaceuticals, Inc. (ANIP) : Free Stock Analysis Report\nKintara Therapeutics, Inc. (KTRA) : Free Stock Analysis Report\nTo read this article on Zacks.com click here.\nZacks Investment Research","news_type":1},"isVote":1,"tweetType":1,"viewCount":248,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":281590089097520,"gmtCreate":1709775969811,"gmtModify":1709775971624,"author":{"id":"4095630847582090","authorId":"4095630847582090","name":"Fanlization","avatar":"https://static.tigerbbs.com/4ff33c5fed6426a68a814ef72a46d188","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"这篇文章不错，转发给大家看看","listText":"这篇文章不错，转发给大家看看","text":"这篇文章不错，转发给大家看看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/281590089097520","repostId":"2417029794","repostType":2,"repost":{"id":"2417029794","pubTimestamp":1709736365,"share":"https://www.laohu8.com/m/news/2417029794?lang=&edition=full","pubTime":"2024-03-06 22:46","market":"us","language":"zh","title":"美国OTC市场硅谷银行（SIVBQ.us）股价拉升6053.85% 市值涨2.87亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2417029794","media":"自选股智能写手","summary":"北京时间2024年03月06日22时46分，美国OTC市场硅谷银行股票出现波动，股价快速上涨6053.85%。截至发稿，该股报0.080美元/股，成交量1513股，换手率0.00%，振幅6053.85%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。美国OTC市场硅谷银行股票所在的银行行业中，整体跌幅为0.47%。美国OTC市场硅谷银行公司简介：硅谷银行金融集团为初创企业、私募股权和风险投资公司提供贷款和辅助金融服务。","content":"<html><body><article><p>北京时间2024年03月06日22时46分，美国OTC市场<a href=\"https://laohu8.com/S/SIVBQ\">硅谷银行</a>（SIVBQ.us）股票出现波动，股价快速上涨6053.85%。截至发稿，该股报0.080美元/股，成交量1513股，<span>换手率</span>0.00%，振幅6053.85%。</p><p>最近的财报数据显示，该股实现<span>营业收入</span>72.51亿美元，<span>净利润</span>16.72亿美元，<span>每股收益</span>25.58美元，<span>毛利</span>数据暂无，市盈率0.00倍。</p><p>机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。</p><p>美国OTC市场硅谷银行股票所在的银行行业中，整体跌幅为0.47%。其相关个股中，<a href=\"https://laohu8.com/S/RBKB\">Rhinebeck Bancorp, Inc.</a>、Banco Bbva Argentina S A、Enterprise Financial Services Corp 5% Dep Sh Rep Non Cum Perp Pfd Ser A涨幅较大，<a href=\"https://laohu8.com/S/NYCB\">纽约社区银行</a>、<a href=\"https://laohu8.com/S/COOP\">Mr. Cooper Group Inc.</a>、<a href=\"https://laohu8.com/S/FULT\">富尔顿金融</a>较为活跃，换手率分别为0.63%、0.29%、0.23%，振幅较大的相关个股有Rhinebeck Bancorp, Inc.、纽约社区银行、<a href=\"https://laohu8.com/S/WSBC\">韦斯银行</a>，振幅分别为8.39%、7.76%、7.06%。</p><p>美国OTC市场硅谷银行公司简介：硅谷银行金融集团为初创企业、私募股权和风险投资公司提供贷款和辅助金融服务。该银行有四个部门:全球商业银行、SVB私人银行、SVB资本和SVB证券。除了向风险资本支持的初创企业提供贷款外，该公司还投资于私募股权和基金的风险资本基金。该行在美国各地开展业务，并在加拿大、英国、以色列、中国、印度、德国、丹麦和爱尔兰设有办事处。</p><p>（以上内容为<a href=\"https://laohu8.com/S/00700\">腾讯</a>自选股基于公开消息，由程序或算法<a href=\"https://laohu8.com/S/5RE.SI\">智能</a>生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）</p></article></body></html>","source":"tencent","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>美国OTC市场硅谷银行（SIVBQ.us）股价拉升6053.85% 市值涨2.87亿美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n美国OTC市场硅谷银行（SIVBQ.us）股价拉升6053.85% 市值涨2.87亿美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-03-06 22:46 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240306224605875a91b0&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年03月06日22时46分，美国OTC市场硅谷银行（SIVBQ.us）股票出现波动，股价快速上涨6053.85%。截至发稿，该股报0.080美元/股，成交量1513股，换手率0.00%，振幅6053.85%。最近的财报数据显示，该股实现营业收入72.51亿美元，净利润16.72亿美元，每股收益25.58美元，毛利数据暂无，市盈率0.00倍。机构评级方面，目前暂无机构对该股做出“买入...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240306224605875a91b0&s=b\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SIVBQ":"硅谷银行","BK4585":"ETF&股票定投概念","BK4588":"碎股","BK4207":"综合性银行","BK4211":"区域性银行","BK4589":"SVB概念"},"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240306224605875a91b0&s=b","is_english":false,"share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","article_id":"2417029794","content_text":"北京时间2024年03月06日22时46分，美国OTC市场硅谷银行（SIVBQ.us）股票出现波动，股价快速上涨6053.85%。截至发稿，该股报0.080美元/股，成交量1513股，换手率0.00%，振幅6053.85%。最近的财报数据显示，该股实现营业收入72.51亿美元，净利润16.72亿美元，每股收益25.58美元，毛利数据暂无，市盈率0.00倍。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。美国OTC市场硅谷银行股票所在的银行行业中，整体跌幅为0.47%。其相关个股中，Rhinebeck Bancorp, Inc.、Banco Bbva Argentina S A、Enterprise Financial Services Corp 5% Dep Sh Rep Non Cum Perp Pfd Ser A涨幅较大，纽约社区银行、Mr. Cooper Group Inc.、富尔顿金融较为活跃，换手率分别为0.63%、0.29%、0.23%，振幅较大的相关个股有Rhinebeck Bancorp, Inc.、纽约社区银行、韦斯银行，振幅分别为8.39%、7.76%、7.06%。美国OTC市场硅谷银行公司简介：硅谷银行金融集团为初创企业、私募股权和风险投资公司提供贷款和辅助金融服务。该银行有四个部门:全球商业银行、SVB私人银行、SVB资本和SVB证券。除了向风险资本支持的初创企业提供贷款外，该公司还投资于私募股权和基金的风险资本基金。该行在美国各地开展业务，并在加拿大、英国、以色列、中国、印度、德国、丹麦和爱尔兰设有办事处。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","news_type":1},"isVote":1,"tweetType":1,"viewCount":216,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":263288843169896,"gmtCreate":1705310825861,"gmtModify":1705311452848,"author":{"id":"4095630847582090","authorId":"4095630847582090","name":"Fanlization","avatar":"https://static.tigerbbs.com/4ff33c5fed6426a68a814ef72a46d188","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"好","listText":"好","text":"好","images":[{"img":"https://static.tigerbbs.com/f76386f279afeae4a90b34b21c1b1727","width":"1442","height":"2744"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/263288843169896","isVote":1,"tweetType":1,"viewCount":268,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":260939999047912,"gmtCreate":1704716109412,"gmtModify":1704716110827,"author":{"id":"4095630847582090","authorId":"4095630847582090","name":"Fanlization","avatar":"https://static.tigerbbs.com/4ff33c5fed6426a68a814ef72a46d188","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"这篇文章不错，转发给大家看看","listText":"这篇文章不错，转发给大家看看","text":"这篇文章不错，转发给大家看看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/260939999047912","repostId":"260789601091584","repostType":1,"repost":{"id":260789601091584,"gmtCreate":1704697173051,"gmtModify":1704783002130,"author":{"id":"3527667568191018","authorId":"3527667568191018","name":"胖虎福利","avatar":"https://static.tigerbbs.com/733bbf790057cc91c5e0b1aa5569977c","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"title":"2023老虎社区企业号年度公司评选榜单发布","htmlText":"回顾2023年，全球资本市场迎来了一系列动人心魄的波折和新机遇，成为全球资本市场参与者共同见证的重要时刻。地缘政治的波动成为市场关注的焦点，宏观事件影响全球投资者，而芒格老先生的离世也引起了投资者对未来走势的深刻思考。与此同时，科技行业持续引领市场潮流，人工智能、生物技术等新兴领域涌现出众多创新企业。科技的不断演进不仅改变了产业格局，也深刻地塑造了资本市场的投资方向。在这个充满挑战和机遇的一年里，资本市场的参与者们展现出了卓越的创新意识，各个领域的变革和发展要求投资者具备更为敏锐的市场感知，并迫切需要获取更准确的信息。每一个积极通过企业号向老虎社区的虎友们即时分享行业、企业信息的公司都值得褒奖！老虎社区企业号在此隆重揭晓【2023老虎社区企业号年度公司评选榜单】。这些获奖公司秉持着为投资人负责的初心，专注于促进投资者与企业之间的畅通双向沟通，凭借卓越的业绩和积极的沟通态度，赢得了老虎平台投资者的广泛认可，展现了卓越的企业价值和社会责任。恭喜所有荣获2023年度奖项的上市公司伙伴们！这份殊荣是对你们在2023年度资本市场上卓越表现的褒奖，我们为你们的杰出成绩喝彩！此次上榜公司是在老虎社区企业号、以及港美股上市公司的范围内，基于老虎平台统计数据进行筛选的。评选过程中考虑了诸多关键因素，包括但不限于投资者关注度、品牌影响力、企业号活跃度以及与投资者互动情况等。最终产生了「最受投资者喜爱奖」、「最佳投资者陪伴奖」、「最佳品牌价值传播奖」和「最佳传播创新突破奖」四大奖项榜单，共计40个引人注目的获奖名额。老虎社区企业号由衷感谢一路以来与上市公司合作伙伴的共同努力与信任。同时，期待在新的一年里持续携手前行，共同致力于推动企业价值传播，回馈广大投资者的信赖与支持！ <a href=\"https://laohu8.com/U/3570687182203069\">@阿里巴巴集团</a>","listText":"回顾2023年，全球资本市场迎来了一系列动人心魄的波折和新机遇，成为全球资本市场参与者共同见证的重要时刻。地缘政治的波动成为市场关注的焦点，宏观事件影响全球投资者，而芒格老先生的离世也引起了投资者对未来走势的深刻思考。与此同时，科技行业持续引领市场潮流，人工智能、生物技术等新兴领域涌现出众多创新企业。科技的不断演进不仅改变了产业格局，也深刻地塑造了资本市场的投资方向。在这个充满挑战和机遇的一年里，资本市场的参与者们展现出了卓越的创新意识，各个领域的变革和发展要求投资者具备更为敏锐的市场感知，并迫切需要获取更准确的信息。每一个积极通过企业号向老虎社区的虎友们即时分享行业、企业信息的公司都值得褒奖！老虎社区企业号在此隆重揭晓【2023老虎社区企业号年度公司评选榜单】。这些获奖公司秉持着为投资人负责的初心，专注于促进投资者与企业之间的畅通双向沟通，凭借卓越的业绩和积极的沟通态度，赢得了老虎平台投资者的广泛认可，展现了卓越的企业价值和社会责任。恭喜所有荣获2023年度奖项的上市公司伙伴们！这份殊荣是对你们在2023年度资本市场上卓越表现的褒奖，我们为你们的杰出成绩喝彩！此次上榜公司是在老虎社区企业号、以及港美股上市公司的范围内，基于老虎平台统计数据进行筛选的。评选过程中考虑了诸多关键因素，包括但不限于投资者关注度、品牌影响力、企业号活跃度以及与投资者互动情况等。最终产生了「最受投资者喜爱奖」、「最佳投资者陪伴奖」、「最佳品牌价值传播奖」和「最佳传播创新突破奖」四大奖项榜单，共计40个引人注目的获奖名额。老虎社区企业号由衷感谢一路以来与上市公司合作伙伴的共同努力与信任。同时，期待在新的一年里持续携手前行，共同致力于推动企业价值传播，回馈广大投资者的信赖与支持！ <a href=\"https://laohu8.com/U/3570687182203069\">@阿里巴巴集团</a>","text":"回顾2023年，全球资本市场迎来了一系列动人心魄的波折和新机遇，成为全球资本市场参与者共同见证的重要时刻。地缘政治的波动成为市场关注的焦点，宏观事件影响全球投资者，而芒格老先生的离世也引起了投资者对未来走势的深刻思考。与此同时，科技行业持续引领市场潮流，人工智能、生物技术等新兴领域涌现出众多创新企业。科技的不断演进不仅改变了产业格局，也深刻地塑造了资本市场的投资方向。在这个充满挑战和机遇的一年里，资本市场的参与者们展现出了卓越的创新意识，各个领域的变革和发展要求投资者具备更为敏锐的市场感知，并迫切需要获取更准确的信息。每一个积极通过企业号向老虎社区的虎友们即时分享行业、企业信息的公司都值得褒奖！老虎社区企业号在此隆重揭晓【2023老虎社区企业号年度公司评选榜单】。这些获奖公司秉持着为投资人负责的初心，专注于促进投资者与企业之间的畅通双向沟通，凭借卓越的业绩和积极的沟通态度，赢得了老虎平台投资者的广泛认可，展现了卓越的企业价值和社会责任。恭喜所有荣获2023年度奖项的上市公司伙伴们！这份殊荣是对你们在2023年度资本市场上卓越表现的褒奖，我们为你们的杰出成绩喝彩！此次上榜公司是在老虎社区企业号、以及港美股上市公司的范围内，基于老虎平台统计数据进行筛选的。评选过程中考虑了诸多关键因素，包括但不限于投资者关注度、品牌影响力、企业号活跃度以及与投资者互动情况等。最终产生了「最受投资者喜爱奖」、「最佳投资者陪伴奖」、「最佳品牌价值传播奖」和「最佳传播创新突破奖」四大奖项榜单，共计40个引人注目的获奖名额。老虎社区企业号由衷感谢一路以来与上市公司合作伙伴的共同努力与信任。同时，期待在新的一年里持续携手前行，共同致力于推动企业价值传播，回馈广大投资者的信赖与支持！ @阿里巴巴集团","images":[{"img":"https://static.tigerbbs.com/2a0ed47204a08894620500891ca3ab94","width":"1080","height":"3917"},{"img":"https://static.tigerbbs.com/11793e9a71862865bc9d57eaa6c428f4","width":"1080","height":"3917"},{"img":"https://static.tigerbbs.com/e14e4df6cd6ff8ae2bff118ddbfddd63","width":"1080","height":"3917"}],"top":1,"highlighted":2,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/260789601091584","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":4,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":330,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":239705650680104,"gmtCreate":1699545565141,"gmtModify":1699545566541,"author":{"id":"4095630847582090","authorId":"4095630847582090","name":"Fanlization","avatar":"https://static.tigerbbs.com/4ff33c5fed6426a68a814ef72a46d188","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"这篇文章不错，转发给大家看看","listText":"这篇文章不错，转发给大家看看","text":"这篇文章不错，转发给大家看看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/239705650680104","repostId":"2382260679","repostType":4,"repost":{"id":"2382260679","pubTimestamp":1699522599,"share":"https://www.laohu8.com/m/news/2382260679?lang=&edition=full","pubTime":"2023-11-09 17:36","market":"us","language":"zh","title":"“七巨头”称霸美股背后：华尔街不敢入场做空！","url":"https://stock-news.laohu8.com/highlight/detail?id=2382260679","media":"金十数据","summary":"市场对七巨头的空头头寸已降至历史最低。","content":"<html><head></head><body><blockquote><p>华尔街现在几乎没有人敢和美股“七巨头”作对，市场对后者的空头头寸已降至历史最低。</p></blockquote><p><strong>尽管诸多分析师警告称美股今年的反弹只是由少数几只股票推动的，是“泡沫”。但华尔街现在几乎没有人敢和后者，即“七巨头”作对。</strong></p><p>美国银行量化股票策略师团队的数据显示，<strong>市场对这些公司股票的空头头寸已降至历史最低水平，仅占这些公司总市值的1%左右。</strong></p><p>FactSet的数据显示，七巨头的总市值——<a href=\"https://laohu8.com/S/AAPL\">苹果</a>（AAPL）、<a href=\"https://laohu8.com/S/MSFT\">微软</a>（MSFT）、Alphabet Inc.（GOOGL）、<a href=\"https://laohu8.com/S/AMZN\">亚马逊</a>（AMZN）、<a href=\"https://laohu8.com/S/NVDA\">英伟达</a>（NVDA）、<a href=\"https://laohu8.com/S/META\">Meta Platforms</a> Inc.（META）和<a href=\"https://laohu8.com/S/TSLA\">特斯拉</a>（TSLA）在周三接近11.3万亿美元，其中市值最高的美国公司苹果的市值超过2.8万亿美元。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/15c1a4340603b41b66839fa56f0a6555\" tg-width=\"700\" tg-height=\"904\"/></p><p>在给客户的一份报告中，该团队质疑，随着这些大型股相对于市场其他股的估值达到极度过高的水平，还有谁会继续买这些大型股？</p><p>道琼斯市场数据显示，<a href=\"https://laohu8.com/S/161125\">标普500</a>指数（SPX）在2023年的全部涨幅几乎都是由这七家公司推动的，抵消了该指数中其他493家公司股价的下跌。</p><p><strong>但根据美国银行的数据，只做多的基金增持了除苹果和特斯拉以外的所有“七巨头”。</strong></p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/45cbdcbc6da590e91731c976a0743afa\" tg-width=\"700\" tg-height=\"477\"/></p><p><strong>许多华尔街分析师认为，这些公司可以继续跑赢大盘</strong>。凯投宏观的策略师周三在一份客户报告中表示，由于这些公司强劲的资产负债表和盈利增长前景，即使在经济衰退中，它们也可能继续保持跑赢市场的表现。该团队表示：</p><blockquote><p>“鉴于我们对美国经济的悲观看法，我们认为美国股市近期将表现相当糟糕。但标普500指数中最大的成分股可能会表现得更好。”</p></blockquote><p><strong>强劲的盈利预期也促成了他们的看涨观点</strong>。在一定程度上由于人工智能的繁荣，“七巨头”未来一年的预期盈利增长将使标普500指数其他成分股相形见绌。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a54ee6ce8f8235cacc58f965297876db\" tg-width=\"700\" tg-height=\"451\"/></p><p>美股周三涨跌互现，但以科技股为主的纳斯达克综合指数与标普500指数继续收红，二者均收涨0.1%，其中前者为连续第9个交易日收涨，后者为连续8日收涨。</p><p>尽管美联储几位鹰派成员的谨慎言论抑制了利率已见顶的乐观情绪，削弱了股市上涨的动力。但根据芝商所的美联储观察工具，90%的交易员押注美联储今年不会再加息，25%的交易员预计美联储将在明年3月降息。</p></body></html>","source":"xnew_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>“七巨头”称霸美股背后：华尔街不敢入场做空！</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n“七巨头”称霸美股背后：华尔街不敢入场做空！\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-11-09 17:36 北京时间&nbsp;&nbsp;&nbsp;<a href=https://xnews.jin10.com/webapp/details.html?id=126181&type=news&data_type=0><strong>金十数据</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>华尔街现在几乎没有人敢和美股“七巨头”作对，市场对后者的空头头寸已降至历史最低。尽管诸多分析师警告称美股今年的反弹只是由少数几只股票推动的，是“泡沫”。但华尔街现在几乎没有人敢和后者，即“七巨头”作对。美国银行量化股票策略师团队的数据显示，市场对这些公司股票的空头头寸已降至历史最低水平，仅占这些公司总市值的1%左右。FactSet的数据显示，七巨头的总市值——苹果（AAPL）、微软（MSFT）、...</p>\n\n<a href=\"https://xnews.jin10.com/webapp/details.html?id=126181&type=news&data_type=0\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/55eb327f580527889cf30bafa92692ae","relate_stocks":{".DJI":"道琼斯"},"source_url":"https://xnews.jin10.com/webapp/details.html?id=126181&type=news&data_type=0","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2382260679","content_text":"华尔街现在几乎没有人敢和美股“七巨头”作对，市场对后者的空头头寸已降至历史最低。尽管诸多分析师警告称美股今年的反弹只是由少数几只股票推动的，是“泡沫”。但华尔街现在几乎没有人敢和后者，即“七巨头”作对。美国银行量化股票策略师团队的数据显示，市场对这些公司股票的空头头寸已降至历史最低水平，仅占这些公司总市值的1%左右。FactSet的数据显示，七巨头的总市值——苹果（AAPL）、微软（MSFT）、Alphabet Inc.（GOOGL）、亚马逊（AMZN）、英伟达（NVDA）、Meta Platforms Inc.（META）和特斯拉（TSLA）在周三接近11.3万亿美元，其中市值最高的美国公司苹果的市值超过2.8万亿美元。在给客户的一份报告中，该团队质疑，随着这些大型股相对于市场其他股的估值达到极度过高的水平，还有谁会继续买这些大型股？道琼斯市场数据显示，标普500指数（SPX）在2023年的全部涨幅几乎都是由这七家公司推动的，抵消了该指数中其他493家公司股价的下跌。但根据美国银行的数据，只做多的基金增持了除苹果和特斯拉以外的所有“七巨头”。许多华尔街分析师认为，这些公司可以继续跑赢大盘。凯投宏观的策略师周三在一份客户报告中表示，由于这些公司强劲的资产负债表和盈利增长前景，即使在经济衰退中，它们也可能继续保持跑赢市场的表现。该团队表示：“鉴于我们对美国经济的悲观看法，我们认为美国股市近期将表现相当糟糕。但标普500指数中最大的成分股可能会表现得更好。”强劲的盈利预期也促成了他们的看涨观点。在一定程度上由于人工智能的繁荣，“七巨头”未来一年的预期盈利增长将使标普500指数其他成分股相形见绌。美股周三涨跌互现，但以科技股为主的纳斯达克综合指数与标普500指数继续收红，二者均收涨0.1%，其中前者为连续第9个交易日收涨，后者为连续8日收涨。尽管美联储几位鹰派成员的谨慎言论抑制了利率已见顶的乐观情绪，削弱了股市上涨的动力。但根据芝商所的美联储观察工具，90%的交易员押注美联储今年不会再加息，25%的交易员预计美联储将在明年3月降息。","news_type":1},"isVote":1,"tweetType":1,"viewCount":663,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":239255357862144,"gmtCreate":1699440234009,"gmtModify":1699440235292,"author":{"id":"4095630847582090","authorId":"4095630847582090","name":"Fanlization","avatar":"https://static.tigerbbs.com/4ff33c5fed6426a68a814ef72a46d188","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"这篇文章不错，转发给大家看看","listText":"这篇文章不错，转发给大家看看","text":"这篇文章不错，转发给大家看看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/239255357862144","repostId":"236711629484032","repostType":1,"repost":{"id":236711629484032,"gmtCreate":1698823619929,"gmtModify":1700031043800,"author":{"id":"3527667588142897","authorId":"3527667588142897","name":"小虎产品经理","avatar":"https://static.tigerbbs.com/a6704bebf28358e0d9c638e765403bd0","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"title":"期权组合下单功能已上线，快来试试吧","htmlText":"期权组合下单当前新版本已支持美股期权的组合期权链、K线图、添加自选及组合下单，包括垂直价差、跨式、日历等常用策略。部分组合订单及持仓享受保证金减免。期权链全新支持期权组合策略的期权链驾到，支持用户切换固定期权策略，也支持用户自定义交易策略。选中的期权组合可以直接交易，盈亏分析，也可以跳转到期权组合详情页查看更多数据。暂时只支持两腿期权组合，后期还会持续更新喔。组合期权策略可加入自选列表将心仪的期权策略加入自选列表中后，可以在美股期权分组下查看相关行情信息。点击标的可跳转到详情页快速下单。帮助您快速查找已创建好的期权策略。组合期权详情页欢迎使用我们的全新页面——组合期权详情页面！此功能旨在为您提供全面的组合期权信息，帮助您更好地了解和管理您的投资组合。以下是页面提供的详细内容：构成信息和最新价格：您可以查看组合期权的两个腿的构成信息，并获取最新的价格数据。组合价格和买卖盘盘口信息：通过页面上的组合价格，您可以得知该组合期权的当前价值。同时，您还能查看买卖盘口信息，包括当前组合期权的最佳买入和卖出价格，帮助您做出明智的交易决策。K线图：我们提供直观的K线图，让您可以观察组合期权的历史价格走势。有助于您分析市场趋势，发现潜在的投资机会。组合期权的持仓和订单信息：您可以查看自己的组合期权持仓情况，包括当前的持仓数量和成本。此外，您还可以查看与组合期权相关的订单信息，确保您对自己的交易有清晰的了解。组合期权的盈亏分析图：通过盈亏分析图，您可以直观地了解组合期权的盈利潜力和风险。这有助于您制定更好的投资策略，优化您的投资回报。当然，在页面底部，您还可以对当前组合期权进行交易或者添加自选下单页面介绍组合订单目前支持盘中提交限价单，组合限价默认为组合买卖盘的中间价，投资者可以根据自己的预期进行调整。预估收入表示这笔交易即将收到的权利金，预估支出则表示需要付出的权利金。下单页内嵌期权分析功能","listText":"期权组合下单当前新版本已支持美股期权的组合期权链、K线图、添加自选及组合下单，包括垂直价差、跨式、日历等常用策略。部分组合订单及持仓享受保证金减免。期权链全新支持期权组合策略的期权链驾到，支持用户切换固定期权策略，也支持用户自定义交易策略。选中的期权组合可以直接交易，盈亏分析，也可以跳转到期权组合详情页查看更多数据。暂时只支持两腿期权组合，后期还会持续更新喔。组合期权策略可加入自选列表将心仪的期权策略加入自选列表中后，可以在美股期权分组下查看相关行情信息。点击标的可跳转到详情页快速下单。帮助您快速查找已创建好的期权策略。组合期权详情页欢迎使用我们的全新页面——组合期权详情页面！此功能旨在为您提供全面的组合期权信息，帮助您更好地了解和管理您的投资组合。以下是页面提供的详细内容：构成信息和最新价格：您可以查看组合期权的两个腿的构成信息，并获取最新的价格数据。组合价格和买卖盘盘口信息：通过页面上的组合价格，您可以得知该组合期权的当前价值。同时，您还能查看买卖盘口信息，包括当前组合期权的最佳买入和卖出价格，帮助您做出明智的交易决策。K线图：我们提供直观的K线图，让您可以观察组合期权的历史价格走势。有助于您分析市场趋势，发现潜在的投资机会。组合期权的持仓和订单信息：您可以查看自己的组合期权持仓情况，包括当前的持仓数量和成本。此外，您还可以查看与组合期权相关的订单信息，确保您对自己的交易有清晰的了解。组合期权的盈亏分析图：通过盈亏分析图，您可以直观地了解组合期权的盈利潜力和风险。这有助于您制定更好的投资策略，优化您的投资回报。当然，在页面底部，您还可以对当前组合期权进行交易或者添加自选下单页面介绍组合订单目前支持盘中提交限价单，组合限价默认为组合买卖盘的中间价，投资者可以根据自己的预期进行调整。预估收入表示这笔交易即将收到的权利金，预估支出则表示需要付出的权利金。下单页内嵌期权分析功能","text":"期权组合下单当前新版本已支持美股期权的组合期权链、K线图、添加自选及组合下单，包括垂直价差、跨式、日历等常用策略。部分组合订单及持仓享受保证金减免。期权链全新支持期权组合策略的期权链驾到，支持用户切换固定期权策略，也支持用户自定义交易策略。选中的期权组合可以直接交易，盈亏分析，也可以跳转到期权组合详情页查看更多数据。暂时只支持两腿期权组合，后期还会持续更新喔。组合期权策略可加入自选列表将心仪的期权策略加入自选列表中后，可以在美股期权分组下查看相关行情信息。点击标的可跳转到详情页快速下单。帮助您快速查找已创建好的期权策略。组合期权详情页欢迎使用我们的全新页面——组合期权详情页面！此功能旨在为您提供全面的组合期权信息，帮助您更好地了解和管理您的投资组合。以下是页面提供的详细内容：构成信息和最新价格：您可以查看组合期权的两个腿的构成信息，并获取最新的价格数据。组合价格和买卖盘盘口信息：通过页面上的组合价格，您可以得知该组合期权的当前价值。同时，您还能查看买卖盘口信息，包括当前组合期权的最佳买入和卖出价格，帮助您做出明智的交易决策。K线图：我们提供直观的K线图，让您可以观察组合期权的历史价格走势。有助于您分析市场趋势，发现潜在的投资机会。组合期权的持仓和订单信息：您可以查看自己的组合期权持仓情况，包括当前的持仓数量和成本。此外，您还可以查看与组合期权相关的订单信息，确保您对自己的交易有清晰的了解。组合期权的盈亏分析图：通过盈亏分析图，您可以直观地了解组合期权的盈利潜力和风险。这有助于您制定更好的投资策略，优化您的投资回报。当然，在页面底部，您还可以对当前组合期权进行交易或者添加自选下单页面介绍组合订单目前支持盘中提交限价单，组合限价默认为组合买卖盘的中间价，投资者可以根据自己的预期进行调整。预估收入表示这笔交易即将收到的权利金，预估支出则表示需要付出的权利金。下单页内嵌期权分析功能","images":[{"img":"https://static.tigerbbs.com/252242c29cbb4fe141a637390ed0edf8","width":"1120","height":"1124"},{"img":"https://static.tigerbbs.com/88a1f3f14fd07d6ea893d404b8780eef","width":"1080","height":"2222"},{"img":"https://static.tigerbbs.com/b59927b89e8caa2b49401bf2bf0d6a35","width":"1242","height":"645"}],"top":1,"highlighted":1,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/236711629484032","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":9,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":414,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":234005014384872,"gmtCreate":1698158007889,"gmtModify":1698158009360,"author":{"id":"4095630847582090","authorId":"4095630847582090","name":"Fanlization","avatar":"https://static.tigerbbs.com/4ff33c5fed6426a68a814ef72a46d188","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"这篇文章不错，转发给大家看看","listText":"这篇文章不错，转发给大家看看","text":"这篇文章不错，转发给大家看看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/234005014384872","repostId":"233971103551624","repostType":1,"repost":{"id":233971103551624,"gmtCreate":1698147900409,"gmtModify":1703677936183,"author":{"id":"3527667609076620","authorId":"3527667609076620","name":"发發虎","avatar":"https://static.tigerbbs.com/a13a8024fdb84b92780aefe022e21dde","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"title":"【一起发财】做空特斯拉，他赚了232%！","htmlText":"有虎友通过做空 <a href=\"https://laohu8.com/S/TSLA\">$特斯拉(TSLA)$</a> 暴赚232%，发生了啥？他是如何做到的？这篇文章就跟大家一起探讨一下他的发财秘籍，祝所有看到的朋友们都能发财。恭喜虎友 <a href=\"https://laohu8.com/U/4126924776269962\">@壹缠</a> 通过买入特斯拉看跌期权 获利239%。恭喜虎友 <a href=\"https://laohu8.com/U/681616653300\">@还温柔的猫儿</a> 通过卖出特斯拉看涨期权 获利30%。欢迎以上虎友添加虎妞微信（微信：itiger2014），聊聊你的操作思路，获得老虎专访，赢取老虎限量周边。具体来看<a href=\"https://laohu8.com/S/TSLA\">$特斯拉(TSLA)$</a> 上周发布了差强人意的三季报，营收EPS双双低于预期，毛利率跌破18%、净利润下滑44%，在被问及对Cybertruck的交付预期时，马斯克一改往日高调，给出保守预估。受此消息影响，特斯拉财报后大跌9.3%。虎友<a href=\"https://laohu8.com/U/4126924776269962\">@壹缠</a> 在特斯拉财报前，提前入场，叠加利空消息，获得了239%的期权收益。当强烈看空一只股票时，买put（买入看跌期权）是一个不错的选择。除此之外sell call（卖出看涨期权）也是一个不错的选择，虎友<a href=\"https://laohu8.com/U/681616653300\">@还温柔的猫儿</a> 表示已经用行动告诉大家我的判断了，整体还是要跌，叠加各种负面信息，交付，利润率，产量，还有油价等因素，但长期坚定看涨，马斯克做了太多伟大的事儿。当然除了buy put 和sell call 之外，也有虎友","listText":"有虎友通过做空 <a href=\"https://laohu8.com/S/TSLA\">$特斯拉(TSLA)$</a> 暴赚232%，发生了啥？他是如何做到的？这篇文章就跟大家一起探讨一下他的发财秘籍，祝所有看到的朋友们都能发财。恭喜虎友 <a href=\"https://laohu8.com/U/4126924776269962\">@壹缠</a> 通过买入特斯拉看跌期权 获利239%。恭喜虎友 <a href=\"https://laohu8.com/U/681616653300\">@还温柔的猫儿</a> 通过卖出特斯拉看涨期权 获利30%。欢迎以上虎友添加虎妞微信（微信：itiger2014），聊聊你的操作思路，获得老虎专访，赢取老虎限量周边。具体来看<a href=\"https://laohu8.com/S/TSLA\">$特斯拉(TSLA)$</a> 上周发布了差强人意的三季报，营收EPS双双低于预期，毛利率跌破18%、净利润下滑44%，在被问及对Cybertruck的交付预期时，马斯克一改往日高调，给出保守预估。受此消息影响，特斯拉财报后大跌9.3%。虎友<a href=\"https://laohu8.com/U/4126924776269962\">@壹缠</a> 在特斯拉财报前，提前入场，叠加利空消息，获得了239%的期权收益。当强烈看空一只股票时，买put（买入看跌期权）是一个不错的选择。除此之外sell call（卖出看涨期权）也是一个不错的选择，虎友<a href=\"https://laohu8.com/U/681616653300\">@还温柔的猫儿</a> 表示已经用行动告诉大家我的判断了，整体还是要跌，叠加各种负面信息，交付，利润率，产量，还有油价等因素，但长期坚定看涨，马斯克做了太多伟大的事儿。当然除了buy put 和sell call 之外，也有虎友","text":"有虎友通过做空 $特斯拉(TSLA)$ 暴赚232%，发生了啥？他是如何做到的？这篇文章就跟大家一起探讨一下他的发财秘籍，祝所有看到的朋友们都能发财。恭喜虎友 @壹缠 通过买入特斯拉看跌期权 获利239%。恭喜虎友 @还温柔的猫儿 通过卖出特斯拉看涨期权 获利30%。欢迎以上虎友添加虎妞微信（微信：itiger2014），聊聊你的操作思路，获得老虎专访，赢取老虎限量周边。具体来看$特斯拉(TSLA)$ 上周发布了差强人意的三季报，营收EPS双双低于预期，毛利率跌破18%、净利润下滑44%，在被问及对Cybertruck的交付预期时，马斯克一改往日高调，给出保守预估。受此消息影响，特斯拉财报后大跌9.3%。虎友@壹缠 在特斯拉财报前，提前入场，叠加利空消息，获得了239%的期权收益。当强烈看空一只股票时，买put（买入看跌期权）是一个不错的选择。除此之外sell call（卖出看涨期权）也是一个不错的选择，虎友@还温柔的猫儿 表示已经用行动告诉大家我的判断了，整体还是要跌，叠加各种负面信息，交付，利润率，产量，还有油价等因素，但长期坚定看涨，马斯克做了太多伟大的事儿。当然除了buy put 和sell call 之外，也有虎友","images":[{"img":"https://static.tigerbbs.com/23127e741a31e296fa8e3d7f0cce9d81","width":"1080","height":"1080"},{"img":"https://static.tigerbbs.com/58637d566ebf5370e6546bcb6a2b93e0","width":"1382","height":"1036"},{"img":"https://static.tigerbbs.com/70a3bbcba04f6fda98a30fb209a96094","width":"1382","height":"1036"}],"top":1,"highlighted":2,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/233971103551624","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":4,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":646,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":230126338162960,"gmtCreate":1697201867945,"gmtModify":1697201869342,"author":{"id":"4095630847582090","authorId":"4095630847582090","name":"Fanlization","avatar":"https://static.tigerbbs.com/4ff33c5fed6426a68a814ef72a46d188","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"这篇文章不错，转发给大家看看","listText":"这篇文章不错，转发给大家看看","text":"这篇文章不错，转发给大家看看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/230126338162960","repostId":"1150989292","repostType":4,"repost":{"id":"1150989292","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1697200466,"share":"https://www.laohu8.com/m/news/1150989292?lang=&edition=full","pubTime":"2023-10-13 20:34","market":"us","language":"zh","title":"盘前 | 一中概股暴涨56%，京东跌超4%，油价、金价拉升","url":"https://stock-news.laohu8.com/highlight/detail?id=1150989292","media":"老虎资讯综合","summary":"美股三大指数期货在盘前时段涨跌不一。","content":"<html><head></head><body><p>10月13日周五，美股三大指数期货在盘前时段涨跌不一。美国9月CPI高于预期，加剧了人们对美联储再次加息的预期。同时，中东地区紧张的局势强化了市场的谨慎情绪。</p><p></p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a7467e44822245180062e42d1eb29da6\" title=\"\" tg-width=\"884\" tg-height=\"326\"/></p><h3 id=\"id_1377664035\">个股盘前走势</h3><p>中国无人机巨头亿航智能盘前暴涨56%，消息面上，公司无人驾驶载人航空器系统取得中国民航局颁发的合格证。</p><p></p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ab5219ba4ca43721075ede29c0972370\" title=\"\" tg-width=\"450\" tg-height=\"129\"/></p><p>京东跌超4%。今日京东港股大跌11.47%。消息面上，京东股价被国际投行一致看淡：摩根士丹利将目标价从55美元大削四成至33美元；花旗将目标价从64美元下调至43美元；杰弗瑞将目标价从97美元下调至80美元；野村将目标价从48美元下调至45美元，港股目标价从187港元下调至174港元。</p><p><strong>同时，京东发言人表示：关注到有谣言称“刘姓商人涉嫌违法被抓”，已报案。</strong></p><p></p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/101e849923cec14ace5b6ee7825efc35\" title=\"\" tg-width=\"450\" tg-height=\"129\"/></p><p>阿里巴巴跌0.24%。中国证监会已于近日接收菜鸟在香港上市的申请材料。</p><p>摩根大通涨约1%。三季度营收为407亿美元，超过399亿美元的普遍预期，同比飙升了21%。净利润增至132亿美元，也大幅高于分析师预测的119亿美元。</p><p>富国银行涨2.57%。第三季度EPS为1.48美元，高于分析师预期的1.24美元。不过，当季营收为208.6亿美元，低于市场普遍预期的2011.1亿美元。</p><p>花旗涨2.6%。三季度营收、净利润、每股收益均高于预期。</p><p>贝莱德跌1.76%。贝莱德三季度营收45.22亿美元，市场预期45.44亿美元，去年同期43.11亿美元。</p><p>联合健康涨0.5%。联合健康Q3营收924亿美元，市场预估911.5亿美元；调整后每股收益6.56美元，市场预估6.32美元。</p><p>波音跌2.41%。波音和Spirit航空系统公司已经加强了对737 Max 8飞机尾部压力舱壁结构的检查力度。加强检查可能会减慢飞机生产速度，而波音急需增加产量。</p><p>微软跌0.12%.英国竞争与市场管理局批准了经调整后的微软-动视暴雪交易。</p><p>雪佛龙涨1.53%。传雪佛龙与澳洲LNG工会谈判取得进展，但未达成协议。</p><h3 id=\"id_1052657966\">大宗商品</h3><p><strong>WTI原油期货价格持续拉升，涨幅超4%。有迹象显示以色列在为地面进攻加沙做准备。此外，美国首次制裁运载俄罗斯原油的油轮船东，可能令本已紧张的全球供应承压。</strong></p><p></p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/616bbf5dd8b794ed6fc36ff78f51cc92\" title=\"\" tg-width=\"560\" tg-height=\"240\"/></p><p>国际金价持续拉升，涨幅超2%。</p><p></p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/f6ca5dff05f72d6eef513f15a812b80c\" title=\"\" tg-width=\"560\" tg-height=\"240\"/></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>盘前 | 一中概股暴涨56%，京东跌超4%，油价、金价拉升</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n盘前 | 一中概股暴涨56%，京东跌超4%，油价、金价拉升\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2023-10-13 20:34</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>10月13日周五，美股三大指数期货在盘前时段涨跌不一。美国9月CPI高于预期，加剧了人们对美联储再次加息的预期。同时，中东地区紧张的局势强化了市场的谨慎情绪。</p><p></p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a7467e44822245180062e42d1eb29da6\" title=\"\" tg-width=\"884\" tg-height=\"326\"/></p><h3 id=\"id_1377664035\">个股盘前走势</h3><p>中国无人机巨头亿航智能盘前暴涨56%，消息面上，公司无人驾驶载人航空器系统取得中国民航局颁发的合格证。</p><p></p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ab5219ba4ca43721075ede29c0972370\" title=\"\" tg-width=\"450\" tg-height=\"129\"/></p><p>京东跌超4%。今日京东港股大跌11.47%。消息面上，京东股价被国际投行一致看淡：摩根士丹利将目标价从55美元大削四成至33美元；花旗将目标价从64美元下调至43美元；杰弗瑞将目标价从97美元下调至80美元；野村将目标价从48美元下调至45美元，港股目标价从187港元下调至174港元。</p><p><strong>同时，京东发言人表示：关注到有谣言称“刘姓商人涉嫌违法被抓”，已报案。</strong></p><p></p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/101e849923cec14ace5b6ee7825efc35\" title=\"\" tg-width=\"450\" tg-height=\"129\"/></p><p>阿里巴巴跌0.24%。中国证监会已于近日接收菜鸟在香港上市的申请材料。</p><p>摩根大通涨约1%。三季度营收为407亿美元，超过399亿美元的普遍预期，同比飙升了21%。净利润增至132亿美元，也大幅高于分析师预测的119亿美元。</p><p>富国银行涨2.57%。第三季度EPS为1.48美元，高于分析师预期的1.24美元。不过，当季营收为208.6亿美元，低于市场普遍预期的2011.1亿美元。</p><p>花旗涨2.6%。三季度营收、净利润、每股收益均高于预期。</p><p>贝莱德跌1.76%。贝莱德三季度营收45.22亿美元，市场预期45.44亿美元，去年同期43.11亿美元。</p><p>联合健康涨0.5%。联合健康Q3营收924亿美元，市场预估911.5亿美元；调整后每股收益6.56美元，市场预估6.32美元。</p><p>波音跌2.41%。波音和Spirit航空系统公司已经加强了对737 Max 8飞机尾部压力舱壁结构的检查力度。加强检查可能会减慢飞机生产速度，而波音急需增加产量。</p><p>微软跌0.12%.英国竞争与市场管理局批准了经调整后的微软-动视暴雪交易。</p><p>雪佛龙涨1.53%。传雪佛龙与澳洲LNG工会谈判取得进展，但未达成协议。</p><h3 id=\"id_1052657966\">大宗商品</h3><p><strong>WTI原油期货价格持续拉升，涨幅超4%。有迹象显示以色列在为地面进攻加沙做准备。此外，美国首次制裁运载俄罗斯原油的油轮船东，可能令本已紧张的全球供应承压。</strong></p><p></p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/616bbf5dd8b794ed6fc36ff78f51cc92\" title=\"\" tg-width=\"560\" tg-height=\"240\"/></p><p>国际金价持续拉升，涨幅超2%。</p><p></p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/f6ca5dff05f72d6eef513f15a812b80c\" title=\"\" tg-width=\"560\" tg-height=\"240\"/></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/ed4ee39e6b0f45214393093d70ba81a8","relate_stocks":{"EH":"亿航智能","JD":"京东"},"source_url":"","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1150989292","content_text":"10月13日周五，美股三大指数期货在盘前时段涨跌不一。美国9月CPI高于预期，加剧了人们对美联储再次加息的预期。同时，中东地区紧张的局势强化了市场的谨慎情绪。个股盘前走势中国无人机巨头亿航智能盘前暴涨56%，消息面上，公司无人驾驶载人航空器系统取得中国民航局颁发的合格证。京东跌超4%。今日京东港股大跌11.47%。消息面上，京东股价被国际投行一致看淡：摩根士丹利将目标价从55美元大削四成至33美元；花旗将目标价从64美元下调至43美元；杰弗瑞将目标价从97美元下调至80美元；野村将目标价从48美元下调至45美元，港股目标价从187港元下调至174港元。同时，京东发言人表示：关注到有谣言称“刘姓商人涉嫌违法被抓”，已报案。阿里巴巴跌0.24%。中国证监会已于近日接收菜鸟在香港上市的申请材料。摩根大通涨约1%。三季度营收为407亿美元，超过399亿美元的普遍预期，同比飙升了21%。净利润增至132亿美元，也大幅高于分析师预测的119亿美元。富国银行涨2.57%。第三季度EPS为1.48美元，高于分析师预期的1.24美元。不过，当季营收为208.6亿美元，低于市场普遍预期的2011.1亿美元。花旗涨2.6%。三季度营收、净利润、每股收益均高于预期。贝莱德跌1.76%。贝莱德三季度营收45.22亿美元，市场预期45.44亿美元，去年同期43.11亿美元。联合健康涨0.5%。联合健康Q3营收924亿美元，市场预估911.5亿美元；调整后每股收益6.56美元，市场预估6.32美元。波音跌2.41%。波音和Spirit航空系统公司已经加强了对737 Max 8飞机尾部压力舱壁结构的检查力度。加强检查可能会减慢飞机生产速度，而波音急需增加产量。微软跌0.12%.英国竞争与市场管理局批准了经调整后的微软-动视暴雪交易。雪佛龙涨1.53%。传雪佛龙与澳洲LNG工会谈判取得进展，但未达成协议。大宗商品WTI原油期货价格持续拉升，涨幅超4%。有迹象显示以色列在为地面进攻加沙做准备。此外，美国首次制裁运载俄罗斯原油的油轮船东，可能令本已紧张的全球供应承压。国际金价持续拉升，涨幅超2%。","news_type":1},"isVote":1,"tweetType":1,"viewCount":503,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":222623689396336,"gmtCreate":1695378857323,"gmtModify":1695378858776,"author":{"id":"4095630847582090","authorId":"4095630847582090","name":"Fanlization","avatar":"https://static.tigerbbs.com/4ff33c5fed6426a68a814ef72a46d188","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"这篇文章不错，转发给大家看看","listText":"这篇文章不错，转发给大家看看","text":"这篇文章不错，转发给大家看看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/222623689396336","repostId":"222641661218832","repostType":1,"repost":{"id":222641661218832,"gmtCreate":1695375795415,"gmtModify":1695375827655,"author":{"id":"36979109942400","authorId":"36979109942400","name":"小虎周报","avatar":"https://static.laohu8.com/f7b172cf773c77a3f0df67695c126b51","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"title":"港股周报：重磅利好要来了？","htmlText":"本周，港股行情萎靡，但周五一根2.28%的大阳线让投资者重新看到希望。消息面上，市场盛传各类利好消息，如路透社消息:据传中国政府计划将于9月22日推出一系列救市举措，限制融券做空，成立平准基金等：再如彭博社传出的消息，称中国正考虑放宽外资对部分A股持股上限，但目前讨论尚处初期阶段。目前，该消息未获官方证实。港股方面也有好消息传来，昨天，香港行政长官李家超在出席金融服务界国庆酒会时表示，近日，促进股票市场流动性专责小组正加紧开会深入研究促进市场流动性的措施，并会向其提交建议报告，相信香港有好多“好桥”（好主意），金融界亦不例外，期待金融界人士向专责小组提出更多“好桥”建议，让小组集思广益。重磅利好或许已在路上！板块方面，本周材料和医疗保健表现较好，其他板块多数下跌，跌幅最大的依然是房地产，主要是前期大涨之后，地产销售数据并未明显改善：南下资金本周净流入144亿港币，但令人意外的是周五港股大涨之下，南下资金竟然选择获利了结：下周，港A股将迎来中秋、国庆假期，港股通将关闭数日，投资者敬请注意。本周港股大事件：1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;名创优品发布年度业绩，净利润17.69亿元，同比增加177.2%，有意购回最多价值2亿美元的美国存托股份；2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 中国最大的以平台为中心的决策类人工智能公司第四范式本周招股，下周四上市交易；3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 《十四届全国人大常委会立法规划》对外公布，房地产税立法并未出现在本次立法规划中；4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 贝莱德首席中国经济学家宋宇、贝莱德基金首席投资官陆文杰在接受中国证券报采访时表示，对中国股票态度积极，当前存在底部超配的价值；5.&nbsp;&amp;nb","listText":"本周，港股行情萎靡，但周五一根2.28%的大阳线让投资者重新看到希望。消息面上，市场盛传各类利好消息，如路透社消息:据传中国政府计划将于9月22日推出一系列救市举措，限制融券做空，成立平准基金等：再如彭博社传出的消息，称中国正考虑放宽外资对部分A股持股上限，但目前讨论尚处初期阶段。目前，该消息未获官方证实。港股方面也有好消息传来，昨天，香港行政长官李家超在出席金融服务界国庆酒会时表示，近日，促进股票市场流动性专责小组正加紧开会深入研究促进市场流动性的措施，并会向其提交建议报告，相信香港有好多“好桥”（好主意），金融界亦不例外，期待金融界人士向专责小组提出更多“好桥”建议，让小组集思广益。重磅利好或许已在路上！板块方面，本周材料和医疗保健表现较好，其他板块多数下跌，跌幅最大的依然是房地产，主要是前期大涨之后，地产销售数据并未明显改善：南下资金本周净流入144亿港币，但令人意外的是周五港股大涨之下，南下资金竟然选择获利了结：下周，港A股将迎来中秋、国庆假期，港股通将关闭数日，投资者敬请注意。本周港股大事件：1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;名创优品发布年度业绩，净利润17.69亿元，同比增加177.2%，有意购回最多价值2亿美元的美国存托股份；2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 中国最大的以平台为中心的决策类人工智能公司第四范式本周招股，下周四上市交易；3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 《十四届全国人大常委会立法规划》对外公布，房地产税立法并未出现在本次立法规划中；4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 贝莱德首席中国经济学家宋宇、贝莱德基金首席投资官陆文杰在接受中国证券报采访时表示，对中国股票态度积极，当前存在底部超配的价值；5.&nbsp;&amp;nb","text":"本周，港股行情萎靡，但周五一根2.28%的大阳线让投资者重新看到希望。消息面上，市场盛传各类利好消息，如路透社消息:据传中国政府计划将于9月22日推出一系列救市举措，限制融券做空，成立平准基金等：再如彭博社传出的消息，称中国正考虑放宽外资对部分A股持股上限，但目前讨论尚处初期阶段。目前，该消息未获官方证实。港股方面也有好消息传来，昨天，香港行政长官李家超在出席金融服务界国庆酒会时表示，近日，促进股票市场流动性专责小组正加紧开会深入研究促进市场流动性的措施，并会向其提交建议报告，相信香港有好多“好桥”（好主意），金融界亦不例外，期待金融界人士向专责小组提出更多“好桥”建议，让小组集思广益。重磅利好或许已在路上！板块方面，本周材料和医疗保健表现较好，其他板块多数下跌，跌幅最大的依然是房地产，主要是前期大涨之后，地产销售数据并未明显改善：南下资金本周净流入144亿港币，但令人意外的是周五港股大涨之下，南下资金竟然选择获利了结：下周，港A股将迎来中秋、国庆假期，港股通将关闭数日，投资者敬请注意。本周港股大事件：1. 名创优品发布年度业绩，净利润17.69亿元，同比增加177.2%，有意购回最多价值2亿美元的美国存托股份；2. 中国最大的以平台为中心的决策类人工智能公司第四范式本周招股，下周四上市交易；3. 《十四届全国人大常委会立法规划》对外公布，房地产税立法并未出现在本次立法规划中；4. 贝莱德首席中国经济学家宋宇、贝莱德基金首席投资官陆文杰在接受中国证券报采访时表示，对中国股票态度积极，当前存在底部超配的价值；5. &nb","images":[{"img":"https://static.tigerbbs.com/5a02447c1bdaea67ef96c740ef10df12","width":"800","height":"230"},{"img":"https://static.tigerbbs.com/a731beee557e7a4ecb9bfc6082b6ff70","width":"1090","height":"546"},{"img":"https://static.tigerbbs.com/ef7b274cd370cddaaa14e5c49f1a3489","width":"1110","height":"544"}],"top":1,"highlighted":1,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/222641661218832","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":4,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":661,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":217690603417688,"gmtCreate":1694181667098,"gmtModify":1694181668625,"author":{"id":"4095630847582090","authorId":"4095630847582090","name":"Fanlization","avatar":"https://static.tigerbbs.com/4ff33c5fed6426a68a814ef72a46d188","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"这篇文章不错，转发给大家看看","listText":"这篇文章不错，转发给大家看看","text":"这篇文章不错，转发给大家看看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/217690603417688","repostId":"1183967577","repostType":4,"repost":{"id":"1183967577","pubTimestamp":1694181202,"share":"https://www.laohu8.com/m/news/1183967577?lang=&edition=full","pubTime":"2023-09-08 21:53","market":"us","language":"zh","title":"空中出租车公司Archer Aviation年内暴涨，木头姐继续抢筹","url":"https://stock-news.laohu8.com/highlight/detail?id=1183967577","media":"智通财经网","summary":"Archer Aviation生产可在城市运行的电动垂直起降飞机。","content":"<html><head></head><body><p>“木头姐”凯西·伍德旗下的方舟投资(ARK INVEST)周四继续抢购Archer Aviation。旗舰基金ARK Innovation ETF(ARKK)买入199,949股Archer Aviation股票，ARK Autonomous Technology &amp; Robotics ETF (ARKQ)购买了26,067股， ARK Space Exploration &amp; Innovation ETF (ARKX) 购买了7,334股。</p><p style=\"text-align: justify;\">总部位于加州圣克拉拉的Archer Aviation年内涨幅234%，目前位列ARKQ基金的前十大持仓股。</p><p></p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/7e25e4104d23fe58f2eb83396fd0c51c\" tg-width=\"560\" tg-height=\"240\"/></p><p style=\"text-align: justify;\">Archer Aviation生产可在城市运行的电动垂直起降飞机，目标是创建一个强大的空中出租车服务。</p><p style=\"text-align: justify;\">Archer Aviation最近获得了一笔2.15亿美元的投资，投资方包括Stellantis NV、波音、联合大陆航空、方舟投资。这轮投资包括今年早些时候达成的战略融资协议规定的Stellantis 加速投资7000万美元，该协议下还有5500万美元的剩余资金。</p><p style=\"text-align: justify;\">Archer Aviation在声明中表示：“Stellantis的承诺是无与伦比的，从其提供加速Archer业务目标所需的制造专业知识和资本的远见，到首席执行官Carlos Tavares和首席工程技术官Ned Curic的战略愿景和坚定支持。”</p><p style=\"text-align: justify;\">Archer Aviation还表示，已与波音和Wisk达成协议，将开展自主飞行合作，并解决诉讼事宜。</p></body></html>","source":"highlight_zhitongcaijin","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>空中出租车公司Archer Aviation年内暴涨，木头姐继续抢筹</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n空中出租车公司Archer Aviation年内暴涨，木头姐继续抢筹\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-09-08 21:53 北京时间&nbsp;&nbsp;&nbsp;<a href=https://www.zhitongcaijing.com/content/detail/992759.html><strong>智通财经网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>“木头姐”凯西·伍德旗下的方舟投资(ARK INVEST)周四继续抢购Archer Aviation。旗舰基金ARK Innovation ETF(ARKK)买入199,949股Archer Aviation股票，ARK Autonomous Technology & Robotics ETF (ARKQ)购买了26,067股， ARK Space Exploration & Innovation...</p>\n\n<a href=\"https://www.zhitongcaijing.com/content/detail/992759.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/8b5705930e46389507e8b9cc4f61907c","relate_stocks":{"ACHR":"Archer Aviation Inc."},"source_url":"https://www.zhitongcaijing.com/content/detail/992759.html","is_english":false,"share_image_url":"https://static.laohu8.com/6ca2dcdccfa2217fb20a0351f4efe814","article_id":"1183967577","content_text":"“木头姐”凯西·伍德旗下的方舟投资(ARK INVEST)周四继续抢购Archer Aviation。旗舰基金ARK Innovation ETF(ARKK)买入199,949股Archer Aviation股票，ARK Autonomous Technology & Robotics ETF (ARKQ)购买了26,067股， ARK Space Exploration & Innovation ETF (ARKX) 购买了7,334股。总部位于加州圣克拉拉的Archer Aviation年内涨幅234%，目前位列ARKQ基金的前十大持仓股。Archer Aviation生产可在城市运行的电动垂直起降飞机，目标是创建一个强大的空中出租车服务。Archer Aviation最近获得了一笔2.15亿美元的投资，投资方包括Stellantis NV、波音、联合大陆航空、方舟投资。这轮投资包括今年早些时候达成的战略融资协议规定的Stellantis 加速投资7000万美元，该协议下还有5500万美元的剩余资金。Archer Aviation在声明中表示：“Stellantis的承诺是无与伦比的，从其提供加速Archer业务目标所需的制造专业知识和资本的远见，到首席执行官Carlos Tavares和首席工程技术官Ned Curic的战略愿景和坚定支持。”Archer Aviation还表示，已与波音和Wisk达成协议，将开展自主飞行合作，并解决诉讼事宜。","news_type":1},"isVote":1,"tweetType":1,"viewCount":794,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":207466783289568,"gmtCreate":1691679703058,"gmtModify":1691679704619,"author":{"id":"4095630847582090","authorId":"4095630847582090","name":"Fanlization","avatar":"https://static.tigerbbs.com/4ff33c5fed6426a68a814ef72a46d188","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"这篇文章不错，转发给大家看看","listText":"这篇文章不错，转发给大家看看","text":"这篇文章不错，转发给大家看看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/207466783289568","repostId":"1186584854","repostType":2,"repost":{"id":"1186584854","pubTimestamp":1691630102,"share":"https://www.laohu8.com/m/news/1186584854?lang=&edition=full","pubTime":"2023-08-10 09:15","market":"us","language":"zh","title":"“股神”奥尼尔：26个月内大赚20倍的投资方法","url":"https://stock-news.laohu8.com/highlight/detail?id=1186584854","media":"红与绿","summary":"在你的决策错误时，尽量亏最少的钱。","content":"<html><head></head><body><blockquote>在股市赢大钱的秘密，并不是每次都做出正确的决定，而是要在你的决策错误时，尽量亏最少的钱。</blockquote><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/3116fd644eafa27b63de82197dfd80d5\" title=\"\" tg-width=\"660\" tg-height=\"697\"/></p><p style=\"text-align: justify;\">能够建立一套有效的投资法则是每一位交易者梦寐以求的事情，而每个成功的交易者都拥有一套属于自己的投资体系。今天向大家介绍的是美国知名投资家、企业家兼作家及股票经纪人威廉·奥尼尔（William J. O’Neil）是如何自创著名的“CANSLIM”选股投资法则，并在投资实操中创下26个月内大赚20倍的纪录。奥尼尔以及其投资策略“CANSLIM”被人称为“散户灯塔”，该策略究竟有什么过人之处？</p><h2 id=\"id_1701131234\" style=\"text-align: justify;\">1、 用500美元投资变20万美元</h2><p style=\"text-align: justify;\">奥尼尔于1933年出在俄克拉荷马城，毕业于南卫理公会大学（Southern Methodist University，在获得商科学士后，便在美国空军服役。1962年-1963年期间，21岁的他开始以500美元展开其投资生涯，通过宝洁、克莱斯勒、Syntex等两三只股票的交易，8年后，他的投资由当初的500美元变成了20万美元。</p><p style=\"text-align: justify;\">奥尼尔曾经提到，“一般来说，<strong>股票交易要成功，需要具备三项要素：有效的股票选择程序，风险的控制以及对所述的前两项要素严格执行的纪律。”</strong></p><h2 id=\"id_30360874\" style=\"text-align: justify;\">2、创下26个月内大赚20倍纪录</h2><p style=\"text-align: justify;\">从空军退役后，奥尼尔在洛杉矶的海登·斯通（Hayden, Stone &amp; Company）证券公司担任经纪人及在哈佛大学的管理发展所（PMD：Program for Management Development）研究期间，开始研究美国股票史上涨幅最大的股票所具有的特性，发展出著名的“CANSLIM”选股投资法则，他以CANSLIM的方法进行实际投资，创下在26个月内大赚20倍的纪录。</p><h2 id=\"id_1293127763\" style=\"text-align: justify;\">3、投资大亨、企业家与作家多重身份</h2><p style=\"text-align: justify;\">29岁的奥尼尔创立威廉·奥尼尔公司（William O’Neil &amp; Co.,Inc.），30岁买下纽交所席位，成为当时最年轻的交易席位拥有者。1984年创立了知名的财经日报和网站——商业报纸《投资者商业日报》（IBD），成为唯一可以和华尔街日报（The Wall Street Journal）媲美的投资日报。值得一提的是，2021年5月，“媒体大亨”默多克执掌的新闻集团以2.75亿美元收购了《投资者商业日报》，并将其纳入道琼斯公司。</p><p style=\"text-align: justify;\">另外，奥尼尔还有曾经写过4本投资著作，其中《股票投资的24堂必修课》，从选股、选基金，再到寻找买卖点等投资策略都有提及到；另外，还有一本著名的书籍就是《笑傲股市》，该书堪称交易界的经典之作。奥尼尔是技术分析的坚定拥护者，在著述本书的过程中，他分析了100多年的股票价格数据，以便更好地了解技术分析的各种原则。</p><p style=\"text-align: justify;\">本书为全球畅销书，作者通过各式各样的市场，向全球数百万个人投资者传授累积财富的秘密。该书通过奥尼尔的CANSLIM®投资系统，一套让风险极小化且通过考验的七步骤流程，拥有强大的力量，已经对数个时代的交易者造成深远的影响。</p><h2 id=\"id_673927369\" style=\"text-align: justify;\">4、“CANSLIM”选股投资法则</h2><p style=\"text-align: justify;\">十余年前，威廉·奥尼尔公司就已成为全球主要基金经理人最喜爱的投资顾问公司之一，有超过600位基金经理人听取威廉·奥尼尔的投资建议，而《投资者商业日报》的全美订阅人数曾超过30万人，对股市的影响非常大，威廉·奥尼尔公司目前仍担任其旗下五家公司的董事长，并持续以演讲的方式宣扬其“CANSLIM”的投资策略。</p><p style=\"text-align: justify;\">接下来让我们来认识一下CANSLIM投资法则。CANSLIM各个字母分别代表一项个股特性，其中CAN为个股基本面，SLIM为技术面。</p><p style=\"text-align: justify;\">以下将为大家介绍这个投资理论。</p><p style=\"text-align: justify;\"><strong>C - 目前盈利：</strong>寻找当前净盈利同比大幅增长的公司，增幅越大越好，最少要有18%-20%（Current quarterly earning per share must be up at least 18~20%）。</p><p style=\"text-align: justify;\"><strong>A - 年收益：</strong>寻找年度盈利正持续增长的公司。过去5年盈余显著增长，复合增长率15%-50%或以上（Annual earning per share should be meaningful growth over the last five years, the annual compounded growth rate of earnings in the superior firms should be from 15% to 50%, or even more per year）。</p><p style=\"text-align: justify;\"><strong>N - 新因素：</strong>CAN SLIM最大赢家是有一些创新因素，包括新产品，新管理层，价格创新高等，忘了低价股，低价股通常有其理由存在。（Buy companies with new products, new management, or significant new changes in their industry conditions, and most important, buy stocks as they initially make new highs in price. Forget cheap stocks—they are usually cheap for a good reason）。</p><p style=\"text-align: justify;\"><strong>S - 供给与需求：</strong>假如数量有限的股票遇上强劲需求将推动价格上升。相反，股份发行过量碰上需求疲软将导致价格下降。流通在外股份数量少或在合理水平范围内（Shares outstanding should be small or of reasonable number, not large capitalization, older companies）。</p><p style=\"text-align: justify;\"><strong>L - 强势股还是弱势股：</strong>强势股是代表那些表现出最大的盈利增长，强劲的销售，和优越的股价表现的企业，并且公司处于领先的行业当中。并要适应在高价位买入，在更高的价位卖出。(Leader or Laggard：the 500 best performing stocks from 1953 to 1990 averaged a relative price strength of 87)</p><p style=\"text-align: justify;\"><strong>I - 机构持股：</strong>基金，银行和其他专业投资机构都是推动市场的动力要素。一只股票有最佳表现，必须有机构投资者的支持，去推动其价格走势。(Institutional sponsorship：Buy stocks with at least a few institutional sponsors with better than average recent performance records)</p><p style=\"text-align: justify;\"><strong>M - 市场趋势：</strong>跟随市场趋势，并确认于市场涨势的情况下入市，并在调整时静观其变。(Market Direction)</p><h2 id=\"id_1942924333\" style=\"text-align: justify;\">5、给散户的忠告</h2><p style=\"text-align: justify;\">他提到，即使是最成功的投资者都会犯错。这些不好的决策，将导致人们产生亏损，而如果你没有遵守纪律、不够谨慎，其中某些亏损甚至可能变得非常糟糕。</p><p style=\"text-align: justify;\"><strong>你必须接受一个事实，选股与时机的掌握经常都会出错，即使是最有经验的专业投资者也会犯错，而放任亏损不断扩大，是所有投资错误中最严重的一个。</strong></p><p style=\"text-align: justify;\">散户投资者一定要设定坚定的法则，把投资到每一只股票的最大损失，限制在原始资本的7%-8%之间。</p><p style=\"text-align: justify;\">当股价下跌时，即使你不卖出，你还是得承担损失，所以最好卖掉股票并换回现金，这时候你才能够以更客观的态度来思考一切的事情。</p><p style=\"text-align: justify;\">奥尼尔认为那些会对自己说“我不担心我的股价下跌，因为它们是好股票，而且还继续收到股利”是非常危险，而且可能很愚蠢的。</p><p style=\"text-align: justify;\">在错的时机买进的好股票，也可能会跌得和烂股票一样多，而且它们可能根本就不是那么好的股票，只不过是你自己一厢情愿认为它们好而已。</p><p style=\"text-align: justify;\">股市里没有什么事是确定的，也没有安全的股票，任何股票都可能在任何时刻下跌，而且你绝对无法知道它会跌多少。</p><p style=\"text-align: justify;\">超级成功的散户投资者第一条法则：一定要执行止损，限制每一笔亏损的金额，要做到这一点，需要无限的纪律和勇气。</p><p style=\"text-align: justify;\">当你的决策可能错误时，必须承认错误，并毫不犹豫地卖出，在亏损尚未扩大前执行止损。你必须顺势而为，不要试图要求市场来配合你。</p><p style=\"text-align: justify;\"><strong>在股市赢大钱的秘密，并不是每次都做出正确的决定，而是要在你的决策错误时，尽量亏最少的钱。</strong></p><h2 id=\"id_2838690789\" style=\"text-align: justify;\">6、总结</h2><p style=\"text-align: justify;\">一般而言，投资股票要获得成功需要三项基本要件：即一套有效的选股策略、风险管理以及遵守上述两项要件的纪律。而威廉·欧奥尼尔就是一个最好的范例。他设计出一套非常高明的选股方法CANSLIM，和一套控制风险的原则。同时，他也很有纪律地执行自己的选股策略与风险管理原则。</p></body></html>","source":"lsy1584353588345","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>“股神”奥尼尔：26个月内大赚20倍的投资方法</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n“股神”奥尼尔：26个月内大赚20倍的投资方法\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-08-10 09:15 北京时间&nbsp;&nbsp;&nbsp;<a href=https://mp.weixin.qq.com/s/fk_w3N8JGx4Z6xYWvmm2mQ?global_content=%7B%22promote_id%22%3A13766%2C%22sub_promote_id%22%3A4%7D><strong>红与绿</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>在股市赢大钱的秘密，并不是每次都做出正确的决定，而是要在你的决策错误时，尽量亏最少的钱。能够建立一套有效的投资法则是每一位交易者梦寐以求的事情，而每个成功的交易者都拥有一套属于自己的投资体系。今天向大家介绍的是美国知名投资家、企业家兼作家及股票经纪人威廉·奥尼尔（William J. O’Neil）是如何自创著名的“CANSLIM”选股投资法则，并在投资实操中创下26个月内大赚20倍的纪录。奥尼尔...</p>\n\n<a href=\"https://mp.weixin.qq.com/s/fk_w3N8JGx4Z6xYWvmm2mQ?global_content=%7B%22promote_id%22%3A13766%2C%22sub_promote_id%22%3A4%7D\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/3116fd644eafa27b63de82197dfd80d5","relate_stocks":{".SPX":"S&P 500 Index",".DJI":"道琼斯",".IXIC":"NASDAQ Composite"},"source_url":"https://mp.weixin.qq.com/s/fk_w3N8JGx4Z6xYWvmm2mQ?global_content=%7B%22promote_id%22%3A13766%2C%22sub_promote_id%22%3A4%7D","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1186584854","content_text":"在股市赢大钱的秘密，并不是每次都做出正确的决定，而是要在你的决策错误时，尽量亏最少的钱。能够建立一套有效的投资法则是每一位交易者梦寐以求的事情，而每个成功的交易者都拥有一套属于自己的投资体系。今天向大家介绍的是美国知名投资家、企业家兼作家及股票经纪人威廉·奥尼尔（William J. O’Neil）是如何自创著名的“CANSLIM”选股投资法则，并在投资实操中创下26个月内大赚20倍的纪录。奥尼尔以及其投资策略“CANSLIM”被人称为“散户灯塔”，该策略究竟有什么过人之处？1、 用500美元投资变20万美元奥尼尔于1933年出在俄克拉荷马城，毕业于南卫理公会大学（Southern Methodist University，在获得商科学士后，便在美国空军服役。1962年-1963年期间，21岁的他开始以500美元展开其投资生涯，通过宝洁、克莱斯勒、Syntex等两三只股票的交易，8年后，他的投资由当初的500美元变成了20万美元。奥尼尔曾经提到，“一般来说，股票交易要成功，需要具备三项要素：有效的股票选择程序，风险的控制以及对所述的前两项要素严格执行的纪律。”2、创下26个月内大赚20倍纪录从空军退役后，奥尼尔在洛杉矶的海登·斯通（Hayden, Stone & Company）证券公司担任经纪人及在哈佛大学的管理发展所（PMD：Program for Management Development）研究期间，开始研究美国股票史上涨幅最大的股票所具有的特性，发展出著名的“CANSLIM”选股投资法则，他以CANSLIM的方法进行实际投资，创下在26个月内大赚20倍的纪录。3、投资大亨、企业家与作家多重身份29岁的奥尼尔创立威廉·奥尼尔公司（William O’Neil & Co.,Inc.），30岁买下纽交所席位，成为当时最年轻的交易席位拥有者。1984年创立了知名的财经日报和网站——商业报纸《投资者商业日报》（IBD），成为唯一可以和华尔街日报（The Wall Street Journal）媲美的投资日报。值得一提的是，2021年5月，“媒体大亨”默多克执掌的新闻集团以2.75亿美元收购了《投资者商业日报》，并将其纳入道琼斯公司。另外，奥尼尔还有曾经写过4本投资著作，其中《股票投资的24堂必修课》，从选股、选基金，再到寻找买卖点等投资策略都有提及到；另外，还有一本著名的书籍就是《笑傲股市》，该书堪称交易界的经典之作。奥尼尔是技术分析的坚定拥护者，在著述本书的过程中，他分析了100多年的股票价格数据，以便更好地了解技术分析的各种原则。本书为全球畅销书，作者通过各式各样的市场，向全球数百万个人投资者传授累积财富的秘密。该书通过奥尼尔的CANSLIM®投资系统，一套让风险极小化且通过考验的七步骤流程，拥有强大的力量，已经对数个时代的交易者造成深远的影响。4、“CANSLIM”选股投资法则十余年前，威廉·奥尼尔公司就已成为全球主要基金经理人最喜爱的投资顾问公司之一，有超过600位基金经理人听取威廉·奥尼尔的投资建议，而《投资者商业日报》的全美订阅人数曾超过30万人，对股市的影响非常大，威廉·奥尼尔公司目前仍担任其旗下五家公司的董事长，并持续以演讲的方式宣扬其“CANSLIM”的投资策略。接下来让我们来认识一下CANSLIM投资法则。CANSLIM各个字母分别代表一项个股特性，其中CAN为个股基本面，SLIM为技术面。以下将为大家介绍这个投资理论。C - 目前盈利：寻找当前净盈利同比大幅增长的公司，增幅越大越好，最少要有18%-20%（Current quarterly earning per share must be up at least 18~20%）。A - 年收益：寻找年度盈利正持续增长的公司。过去5年盈余显著增长，复合增长率15%-50%或以上（Annual earning per share should be meaningful growth over the last five years, the annual compounded growth rate of earnings in the superior firms should be from 15% to 50%, or even more per year）。N - 新因素：CAN SLIM最大赢家是有一些创新因素，包括新产品，新管理层，价格创新高等，忘了低价股，低价股通常有其理由存在。（Buy companies with new products, new management, or significant new changes in their industry conditions, and most important, buy stocks as they initially make new highs in price. Forget cheap stocks—they are usually cheap for a good reason）。S - 供给与需求：假如数量有限的股票遇上强劲需求将推动价格上升。相反，股份发行过量碰上需求疲软将导致价格下降。流通在外股份数量少或在合理水平范围内（Shares outstanding should be small or of reasonable number, not large capitalization, older companies）。L - 强势股还是弱势股：强势股是代表那些表现出最大的盈利增长，强劲的销售，和优越的股价表现的企业，并且公司处于领先的行业当中。并要适应在高价位买入，在更高的价位卖出。(Leader or Laggard：the 500 best performing stocks from 1953 to 1990 averaged a relative price strength of 87)I - 机构持股：基金，银行和其他专业投资机构都是推动市场的动力要素。一只股票有最佳表现，必须有机构投资者的支持，去推动其价格走势。(Institutional sponsorship：Buy stocks with at least a few institutional sponsors with better than average recent performance records)M - 市场趋势：跟随市场趋势，并确认于市场涨势的情况下入市，并在调整时静观其变。(Market Direction)5、给散户的忠告他提到，即使是最成功的投资者都会犯错。这些不好的决策，将导致人们产生亏损，而如果你没有遵守纪律、不够谨慎，其中某些亏损甚至可能变得非常糟糕。你必须接受一个事实，选股与时机的掌握经常都会出错，即使是最有经验的专业投资者也会犯错，而放任亏损不断扩大，是所有投资错误中最严重的一个。散户投资者一定要设定坚定的法则，把投资到每一只股票的最大损失，限制在原始资本的7%-8%之间。当股价下跌时，即使你不卖出，你还是得承担损失，所以最好卖掉股票并换回现金，这时候你才能够以更客观的态度来思考一切的事情。奥尼尔认为那些会对自己说“我不担心我的股价下跌，因为它们是好股票，而且还继续收到股利”是非常危险，而且可能很愚蠢的。在错的时机买进的好股票，也可能会跌得和烂股票一样多，而且它们可能根本就不是那么好的股票，只不过是你自己一厢情愿认为它们好而已。股市里没有什么事是确定的，也没有安全的股票，任何股票都可能在任何时刻下跌，而且你绝对无法知道它会跌多少。超级成功的散户投资者第一条法则：一定要执行止损，限制每一笔亏损的金额，要做到这一点，需要无限的纪律和勇气。当你的决策可能错误时，必须承认错误，并毫不犹豫地卖出，在亏损尚未扩大前执行止损。你必须顺势而为，不要试图要求市场来配合你。在股市赢大钱的秘密，并不是每次都做出正确的决定，而是要在你的决策错误时，尽量亏最少的钱。6、总结一般而言，投资股票要获得成功需要三项基本要件：即一套有效的选股策略、风险管理以及遵守上述两项要件的纪律。而威廉·欧奥尼尔就是一个最好的范例。他设计出一套非常高明的选股方法CANSLIM，和一套控制风险的原则。同时，他也很有纪律地执行自己的选股策略与风险管理原则。","news_type":1},"isVote":1,"tweetType":1,"viewCount":524,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":207258518003896,"gmtCreate":1691629162210,"gmtModify":1691629163344,"author":{"id":"4095630847582090","authorId":"4095630847582090","name":"Fanlization","avatar":"https://static.tigerbbs.com/4ff33c5fed6426a68a814ef72a46d188","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"这篇文章不错，转发给大家看看","listText":"这篇文章不错，转发给大家看看","text":"这篇文章不错，转发给大家看看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/207258518003896","repostId":"2358020620","repostType":2,"repost":{"id":"2358020620","pubTimestamp":1691548200,"share":"https://www.laohu8.com/m/news/2358020620?lang=&edition=full","pubTime":"2023-08-09 10:30","market":"us","language":"en","title":"Benitec Biopharma Inc. Announces Pricing of $30 Million Underwritten Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2358020620","media":"StreetInsider","summary":"HAYWARD, Calif., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (Nasdaq: BNTC) (“Benitec” or the “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel ge","content":"<html><body><div>\n<p>HAYWARD, Calif., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (Nasdaq: BNTC) (“Benitec” or the “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary DNA-directed RNA interference (\"ddRNAi\") “Silence and Replace” platform, today announced the pricing of its underwritten public offering of 15,544,041 shares of its common stock (or pre-funded warrants to purchase common stock in lieu thereof) and accompanying warrants to purchase up to 15,544,041 shares of common stock. Each share of common stock is being sold together with one common warrant to purchase one share of common stock at a combined offering price of $1.93 and each pre-funded warrant, if any, is being sold together with one common warrant to purchase one share of common stock at a combined offering price of $1.9299. The pre-funded warrants, if any, will be immediately exercisable until exercised in full at an exercise price of $0.0001 per share of common stock. The common warrants will be immediately exercisable at an exercise price of $3.86 per share of common stock and will expire on the fifth anniversary of such initial exercise date. The offering is expected to close on August 11, 2023, subject to customary closing conditions. In addition, Benitec has granted the underwriter a 30 day option to purchase an additional 2,331,606 shares of common stock and/or common warrants to purchase up to an additional 2,331,606 shares of common stock at the public offering price, less discounts and commissions.</p> <p>The aggregate gross proceeds to Benitec from the public offering are expected to be approximately $30 million, prior to deducting underwriting discounts, commissions and other estimated offering expenses. The institutional investors participating in the offering are expected to include Adage Capital Partners LP, Janus Henderson Investors and Suvretta Capital, as well as other new and existing investors.</p> <p>The Company intends to use the net proceeds from this financing to support the clinical development of BB-301, including the natural history lead-in study and the Phase 1b/2a BB-301 treatment study, for the continued advancement of development activities for other existing and new product candidates, for general corporate purposes and for strategic growth opportunities.</p> <p>JMP Securities, A Citizens Company, is acting as sole book-running manager for the offering.</p> <p>The Securities and Exchange Commission (“SEC”) declared effective a registration statement on Form S-1 relating to these securities on August 8, 2023. A final prospectus relating to this offering will be filed with the SEC. The offering is being made only by means of a prospectus. Copies of the prospectus relating to the offering may be obtained, when available, from Citizens JMP Securities, LLC, 600 Montgomery Street, 10th Floor, San Francisco, CA 94111, Attention: Prospectus Department, or by calling (415) 835-8985, or by email at <span>[email protected]</span>. Investors may also obtain these documents at no cost by visiting the SEC’s website at http://www.sec.gov.</p> <p>Before you invest, you should read the prospectus and other documents the Company has filed or will file with the SEC for more complete information about the Company and the offering.</p> <p>This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.</p> <p><strong>About Benitec Biopharma Inc.</strong></p><div><div><div></div></div></div> <p>Benitec Biopharma Inc. (“Benitec” or the “Company”) is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines with headquarters in Hayward, California. The proprietary DNA-directed RNA interference “Silence and Replace” platform combines RNA interference, or RNAi, with gene therapy to create medicines that simultaneously facilitate sustained silencing of disease-causing genes and concomitant delivery of wildtype replacement genes following a single administration of the therapeutic construct. The Company is developing Silence and Replace-based therapeutics for chronic and life-threatening human conditions including Oculopharyngeal Muscular Dystrophy (OPMD). A comprehensive overview of the Company can be found on Benitec’s website at www.benitec.com.</p> <p><strong>Cautionary Note Concerning Forward-Looking Statements</strong></p> <p>This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including with respect to the proposed offering. No assurance can be given that the offering discussed above will be completed on the terms described, or at all, or that the proceeds of the offering will be used as indicated. Factors that could cause actual results to differ materially include, but are not limited to, the risk factors described in Benitec’s filings with the SEC. Benitec’s filings can be obtained free of charge on the SEC’s website at www.sec.gov. Except to the extent required by law, Benitec expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in Benitec’s expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based.</p> <p><strong>Investor Relations Contacts</strong>:</p> <p>William WindhamVP, Solebury Strategic CommunicationsPhone: 646-378-2946Email: <span>[email protected]</span></p> <img src=\"https://www.globenewswire.com/newsroom/ti?nf=ODg5MDM0OCM1NzQ1NTI5IzIyNTEwNzE=\"/> <img referrerpolicy=\"no-referrer-when-downgrade\" src=\"https://ml.globenewswire.com/media/ZmI0ZWVmOGQtZmM4Yi00NTZiLTk5MjEtMWUwODlmNmVlNThhLTEyNjI2MjQ=/tiny/Benitec-Biopharma-Inc-.png\"/><p><img border=\"0\" height=\"47\" src=\"https://ml.globenewswire.com/media/627c78fb-57b8-41c6-89da-62599af40dd1/small/logo-png.png\" width=\"150\"/></p>\nSource: Benitec Biopharma Inc. </div></body></html>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Benitec Biopharma Inc. Announces Pricing of $30 Million Underwritten Public Offering</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBenitec Biopharma Inc. Announces Pricing of $30 Million Underwritten Public Offering\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-08-09 10:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=22016003><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>HAYWARD, Calif., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (Nasdaq: BNTC) (“Benitec” or the “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=22016003\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTC":"Benitec Biopharma Limited","BK4139":"生物科技"},"source_url":"https://www.streetinsider.com/dr/news.php?id=22016003","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2358020620","content_text":"HAYWARD, Calif., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (Nasdaq: BNTC) (“Benitec” or the “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary DNA-directed RNA interference (\"ddRNAi\") “Silence and Replace” platform, today announced the pricing of its underwritten public offering of 15,544,041 shares of its common stock (or pre-funded warrants to purchase common stock in lieu thereof) and accompanying warrants to purchase up to 15,544,041 shares of common stock. Each share of common stock is being sold together with one common warrant to purchase one share of common stock at a combined offering price of $1.93 and each pre-funded warrant, if any, is being sold together with one common warrant to purchase one share of common stock at a combined offering price of $1.9299. The pre-funded warrants, if any, will be immediately exercisable until exercised in full at an exercise price of $0.0001 per share of common stock. The common warrants will be immediately exercisable at an exercise price of $3.86 per share of common stock and will expire on the fifth anniversary of such initial exercise date. The offering is expected to close on August 11, 2023, subject to customary closing conditions. In addition, Benitec has granted the underwriter a 30 day option to purchase an additional 2,331,606 shares of common stock and/or common warrants to purchase up to an additional 2,331,606 shares of common stock at the public offering price, less discounts and commissions. The aggregate gross proceeds to Benitec from the public offering are expected to be approximately $30 million, prior to deducting underwriting discounts, commissions and other estimated offering expenses. The institutional investors participating in the offering are expected to include Adage Capital Partners LP, Janus Henderson Investors and Suvretta Capital, as well as other new and existing investors. The Company intends to use the net proceeds from this financing to support the clinical development of BB-301, including the natural history lead-in study and the Phase 1b/2a BB-301 treatment study, for the continued advancement of development activities for other existing and new product candidates, for general corporate purposes and for strategic growth opportunities. JMP Securities, A Citizens Company, is acting as sole book-running manager for the offering. The Securities and Exchange Commission (“SEC”) declared effective a registration statement on Form S-1 relating to these securities on August 8, 2023. A final prospectus relating to this offering will be filed with the SEC. The offering is being made only by means of a prospectus. Copies of the prospectus relating to the offering may be obtained, when available, from Citizens JMP Securities, LLC, 600 Montgomery Street, 10th Floor, San Francisco, CA 94111, Attention: Prospectus Department, or by calling (415) 835-8985, or by email at [email protected]. Investors may also obtain these documents at no cost by visiting the SEC’s website at http://www.sec.gov. Before you invest, you should read the prospectus and other documents the Company has filed or will file with the SEC for more complete information about the Company and the offering. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. About Benitec Biopharma Inc. Benitec Biopharma Inc. (“Benitec” or the “Company”) is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines with headquarters in Hayward, California. The proprietary DNA-directed RNA interference “Silence and Replace” platform combines RNA interference, or RNAi, with gene therapy to create medicines that simultaneously facilitate sustained silencing of disease-causing genes and concomitant delivery of wildtype replacement genes following a single administration of the therapeutic construct. The Company is developing Silence and Replace-based therapeutics for chronic and life-threatening human conditions including Oculopharyngeal Muscular Dystrophy (OPMD). A comprehensive overview of the Company can be found on Benitec’s website at www.benitec.com. Cautionary Note Concerning Forward-Looking Statements This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including with respect to the proposed offering. No assurance can be given that the offering discussed above will be completed on the terms described, or at all, or that the proceeds of the offering will be used as indicated. Factors that could cause actual results to differ materially include, but are not limited to, the risk factors described in Benitec’s filings with the SEC. Benitec’s filings can be obtained free of charge on the SEC’s website at www.sec.gov. Except to the extent required by law, Benitec expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in Benitec’s expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based. Investor Relations Contacts: William WindhamVP, Solebury Strategic CommunicationsPhone: 646-378-2946Email: [email protected]  \nSource: Benitec Biopharma Inc.","news_type":1},"isVote":1,"tweetType":1,"viewCount":301,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":207257724088384,"gmtCreate":1691629082200,"gmtModify":1691629083340,"author":{"id":"4095630847582090","authorId":"4095630847582090","name":"Fanlization","avatar":"https://static.tigerbbs.com/4ff33c5fed6426a68a814ef72a46d188","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"这篇文章不错，转发给大家看看","listText":"这篇文章不错，转发给大家看看","text":"这篇文章不错，转发给大家看看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/207257724088384","repostId":"2358350527","repostType":2,"repost":{"id":"2358350527","pubTimestamp":1691576377,"share":"https://www.laohu8.com/m/news/2358350527?lang=&edition=full","pubTime":"2023-08-09 18:19","market":"us","language":"en","title":"Benitec Biopharma prices $30M equity offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2358350527","media":"seekingalpha","summary":"Benitec Biopharma  priced its underwritten public offering of ~15.54M shares and warrants to purchase up to ~15.54M shares. The offering is expected to close on August 11, 2023. Underwriters have a 30 day option to purchase an additional ~2.33M shares. The aggregate gross proceeds are expected to be ~$30M. Net proceeds from this financing to support the clinical development of BB-301, including the natural history lead-in study and the Phase 1b/2a BB-301 treatment study, for the continued advancement of development activities for other existing and new product candidates, for general corporate purposes and for strategic growth opportunities. The stock price is down 1% before Wednesday market open.","content":"<html><body><p>Benitec Biopharma (<span>NASDAQ:BNTC</span>) priced its underwritten public offering of ~15.54M shares and warrants to purchase up to ~15.54M shares.</p> <p>The offering is expected to close on August 11, 2023.</p> <p>Underwriters have a 30 day option to purchase an additional ~2.33M shares.</p> <p>The aggregate gross proceeds are expected to be ~$30M.</p> <p>Net proceeds from this financing to support the clinical development of BB-301, including the natural history lead-in study and the Phase 1b/2a BB-301 treatment study, for the continued advancement of development activities for other existing and new product candidates, for general corporate purposes and for strategic growth opportunities.</p> <p>The stock price is <span>down 1%</span> before Wednesday market open.</p></body></html>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Benitec Biopharma prices $30M equity offering</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBenitec Biopharma prices $30M equity offering\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-08-09 18:19 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3999845-benitec-biopharma-prices-30m-equity-offering><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Benitec Biopharma (NASDAQ:BNTC) priced its underwritten public offering of ~15.54M shares and warrants to purchase up to ~15.54M shares. The offering is expected to close on August 11, 2023. ...</p>\n\n<a href=\"https://seekingalpha.com/news/3999845-benitec-biopharma-prices-30m-equity-offering\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4139":"生物科技","BNTC":"Benitec Biopharma Limited"},"source_url":"https://seekingalpha.com/news/3999845-benitec-biopharma-prices-30m-equity-offering","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"2358350527","content_text":"Benitec Biopharma (NASDAQ:BNTC) priced its underwritten public offering of ~15.54M shares and warrants to purchase up to ~15.54M shares. The offering is expected to close on August 11, 2023. Underwriters have a 30 day option to purchase an additional ~2.33M shares. The aggregate gross proceeds are expected to be ~$30M. Net proceeds from this financing to support the clinical development of BB-301, including the natural history lead-in study and the Phase 1b/2a BB-301 treatment study, for the continued advancement of development activities for other existing and new product candidates, for general corporate purposes and for strategic growth opportunities. The stock price is down 1% before Wednesday market open.","news_type":1},"isVote":1,"tweetType":1,"viewCount":439,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":203875589275840,"gmtCreate":1690812487824,"gmtModify":1690812489125,"author":{"id":"4095630847582090","authorId":"4095630847582090","name":"Fanlization","avatar":"https://static.tigerbbs.com/4ff33c5fed6426a68a814ef72a46d188","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"这篇文章不错，转发给大家看看","listText":"这篇文章不错，转发给大家看看","text":"这篇文章不错，转发给大家看看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/203875589275840","repostId":"193879170215968","repostType":1,"repost":{"id":193879170215968,"gmtCreate":1688363548614,"gmtModify":1688363548678,"author":{"id":"4140594566835972","authorId":"4140594566835972","name":"HoChe","avatar":"https://community-static.tradeup.com/news/80f3d3a2627ce910033fd9e81c64ad7b","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"title":"除净「除得太净」 JS环球值1.92元 ","htmlText":"JS 环球生活（1691）将100% SharkNinja以实物方式全部送予股东，上周四除净前8.35元，上周五除净，全日高低2.5元 / 1.29元，均价1.55元，收1.36元，较除净前低84%，公司市值由292亿元降至47亿元。「除得太净」，投机买入。 <a href=\"https://ttm.financial/S/01691\">$JS环球生活(01691)$</a> 为方便行文及方便读者易于了解，除净前的JS环球称为「旧JS环球」，除净后（现时）的JS环球称为「新JS环球」。1）理论上，新JS环球如果不升不跌，市值应相等于旧JS环球市值减SharkNinja 市值。SharkNinja 将于7月底前后在美交所挂牌，6月5日的相关通函指，参照美国同类股估值计算，SharkNinja 的参考估值为196亿元（港币．下同）。以此项估值为据，JS环球除净前后又不升不跌的话，则新JS环球的合理市值应为96亿元（292亿元减196亿元），即股价应值2.75元，较现价高出102% !假如SharkNinja的价值较前述参考估值196亿元高出15%，即225亿元，则新JS环球合理市值应为67亿元，即股价应值1.92元，较现价仍高出41% !2）SharkNinja产销吸麈机及地板护理工具（美国销量第一）、电煮锅（英国市占率59.6% ），主要业务地区是欧美，2022财年（12月年结）纯利19.3亿元。以上段假设参考估值加15%即225亿元计，PE 11.7倍。 PE仅5.3厘3）新JS环球不再拥有SharkNinja ，仍拥有九阳股份（深：002242）66.7%，及「JSG 亚太」100%。九阳主要产销气炸锅、豆浆机、果汁机、电饭煲，主要市场是中国大陆，多种小家电在国内处于领先地位。「JSG亚太」处理SharkNinja品牌在亚太区及大中华的业务，所销售小家电产品的体积较Sha","listText":"JS 环球生活（1691）将100% SharkNinja以实物方式全部送予股东，上周四除净前8.35元，上周五除净，全日高低2.5元 / 1.29元，均价1.55元，收1.36元，较除净前低84%，公司市值由292亿元降至47亿元。「除得太净」，投机买入。 <a href=\"https://ttm.financial/S/01691\">$JS环球生活(01691)$</a> 为方便行文及方便读者易于了解，除净前的JS环球称为「旧JS环球」，除净后（现时）的JS环球称为「新JS环球」。1）理论上，新JS环球如果不升不跌，市值应相等于旧JS环球市值减SharkNinja 市值。SharkNinja 将于7月底前后在美交所挂牌，6月5日的相关通函指，参照美国同类股估值计算，SharkNinja 的参考估值为196亿元（港币．下同）。以此项估值为据，JS环球除净前后又不升不跌的话，则新JS环球的合理市值应为96亿元（292亿元减196亿元），即股价应值2.75元，较现价高出102% !假如SharkNinja的价值较前述参考估值196亿元高出15%，即225亿元，则新JS环球合理市值应为67亿元，即股价应值1.92元，较现价仍高出41% !2）SharkNinja产销吸麈机及地板护理工具（美国销量第一）、电煮锅（英国市占率59.6% ），主要业务地区是欧美，2022财年（12月年结）纯利19.3亿元。以上段假设参考估值加15%即225亿元计，PE 11.7倍。 PE仅5.3厘3）新JS环球不再拥有SharkNinja ，仍拥有九阳股份（深：002242）66.7%，及「JSG 亚太」100%。九阳主要产销气炸锅、豆浆机、果汁机、电饭煲，主要市场是中国大陆，多种小家电在国内处于领先地位。「JSG亚太」处理SharkNinja品牌在亚太区及大中华的业务，所销售小家电产品的体积较Sha","text":"JS 环球生活（1691）将100% SharkNinja以实物方式全部送予股东，上周四除净前8.35元，上周五除净，全日高低2.5元 / 1.29元，均价1.55元，收1.36元，较除净前低84%，公司市值由292亿元降至47亿元。「除得太净」，投机买入。 $JS环球生活(01691)$ 为方便行文及方便读者易于了解，除净前的JS环球称为「旧JS环球」，除净后（现时）的JS环球称为「新JS环球」。1）理论上，新JS环球如果不升不跌，市值应相等于旧JS环球市值减SharkNinja 市值。SharkNinja 将于7月底前后在美交所挂牌，6月5日的相关通函指，参照美国同类股估值计算，SharkNinja 的参考估值为196亿元（港币．下同）。以此项估值为据，JS环球除净前后又不升不跌的话，则新JS环球的合理市值应为96亿元（292亿元减196亿元），即股价应值2.75元，较现价高出102% !假如SharkNinja的价值较前述参考估值196亿元高出15%，即225亿元，则新JS环球合理市值应为67亿元，即股价应值1.92元，较现价仍高出41% !2）SharkNinja产销吸麈机及地板护理工具（美国销量第一）、电煮锅（英国市占率59.6% ），主要业务地区是欧美，2022财年（12月年结）纯利19.3亿元。以上段假设参考估值加15%即225亿元计，PE 11.7倍。 PE仅5.3厘3）新JS环球不再拥有SharkNinja ，仍拥有九阳股份（深：002242）66.7%，及「JSG 亚太」100%。九阳主要产销气炸锅、豆浆机、果汁机、电饭煲，主要市场是中国大陆，多种小家电在国内处于领先地位。「JSG亚太」处理SharkNinja品牌在亚太区及大中华的业务，所销售小家电产品的体积较Sha","images":[{"img":"https://community-static.tradeup.com/news/b151cd31d02da10e67b386e977bf1f41","width":"600","height":"530"}],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/193879170215968","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":272,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":192971459387432,"gmtCreate":1688122959389,"gmtModify":1688122960606,"author":{"id":"4095630847582090","authorId":"4095630847582090","name":"Fanlization","avatar":"https://static.tigerbbs.com/4ff33c5fed6426a68a814ef72a46d188","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"这篇文章不错，转发给大家看看","listText":"这篇文章不错，转发给大家看看","text":"这篇文章不错，转发给大家看看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/192971459387432","repostId":"1149189861","repostType":2,"repost":{"id":"1149189861","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1688116671,"share":"https://www.laohu8.com/m/news/1149189861?lang=&edition=full","pubTime":"2023-06-30 17:17","market":"hk","language":"zh","title":"年中盘点 | 超级大牛股涨超870%！港股上半年涨幅TOP10出炉","url":"https://stock-news.laohu8.com/highlight/detail?id=1149189861","media":"老虎资讯综合","summary":"尽管大盘一度缺乏方向，仍有不少亮眼板个股异军突起，其中，最猛大牛股半年竟然疯涨870%！在上半年涨幅靠前的牛股中，$艾美疫苗$累计大涨88%。该股上市于2022年10月，是中国的大型民营疫苗制造商，因三月份纳入港股通而飙涨。机构指出，随着汽车销售数据环比向好，新能源车渗透率稳步提升，有望迎来新一轮向上周期。","content":"<html><head></head><body><blockquote><strong>摘要：在上半年涨幅靠前的牛股中，<a href=\"https://laohu8.com/S/01942\">马可数字科技</a>大涨居前，累计涨幅超870%！<a href=\"https://laohu8.com/S/06660\">艾美疫苗</a>紧随其后，累计涨幅达88%。另外，随着政策支持力度加大与行业需求改善，汽车板块牛股涌现，理想汽车半年累涨超76%，<a href=\"https://laohu8.com/S/09863\">零跑汽车</a>涨超53%。</strong></blockquote><p>回顾上半年，港股开局一度让人充满期待，但随后受紧缩预期升温、衰退担忧加剧等多重逆风因素影响，主要指数陆续回吐了涨幅。截至6月30日收盘，恒指半年累跌4.37%，恒生科技指数累跌5.27%，国指累跌4.18%。</p><p>尽管大盘一度缺乏方向，仍有不少亮眼板个股异军突起，其中，最猛大牛股半年竟然疯涨870%！</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/30bb412d67f70d66ef53fe06e63f009d\" title=\"\" tg-width=\"1280\" tg-height=\"2680\"/></p><p>在上半年涨幅靠前的牛股中，<a href=\"https://laohu8.com/S/06660\">艾美疫苗</a>累计大涨88%。该股上市于2022年10月，是中国的大型民营疫苗制造商，因三月份纳入港股通而飙涨。据官网介绍，目前该公司拥有8款商业化疫苗，包括重组乙型肝炎疫苗（汉逊酵母）、冻干人用狂犬病疫苗（Vero细胞）等。</p><p>在中特估和AI概念双重加持之下，千亿白马股<a href=\"https://laohu8.com/S/000063\">中兴通讯</a>大象起舞，今年累升85%。<a href=\"https://laohu8.com/S/601788\">光大证券</a>指出，<a href=\"https://laohu8.com/S/00763\">中兴通讯</a>芯片自研长期主义开花结果，毛利率大幅改善；公司服务器业务进入快速增长轨道，是AI算力时代下的核心受益者。</p><p>随着政策支持力度加大与行业需求改善，汽车板块牛股涌现，<a href=\"https://laohu8.com/S/02015\">理想汽车-W</a>半年累涨超76%，<a href=\"https://laohu8.com/S/09863\">零跑汽车</a>涨超53%。机构指出，随着汽车销售数据环比向好，新能源车渗透率稳步提升，有望迎来新一轮向上周期。</p><p><strong>港股下半年怎么投？</strong></p><p>港股何时言底尚不清晰，但不少机构对于下半年的走势较为乐观。分析师认为，下半年恒生指数的合理高低波幅在17650至22183点，策略上先价值后成长。继续看多电讯及能源，同时关注科技、材料、可选消费、工业等顺周期板块。</p><p>在服务业支持下，预计消费者信心逐步回升。尽管消费者信心仍然低迷，但随着要素流动恢复和服务业前景改善，企业信心和资本支出逐渐恢复，推动就业增长和家庭消费信心改善，大额可选消费将逐渐回升。</p><p><strong>政策方面，</strong>稳增长政策出台为经济托底。从央行下调7天逆回购利率，到下调MLF及LPR利率，再到国家发改委提出6个方面的政策，财政部、税务总局、工信部宣布继续免征新能源车购置税，已说明新一轮稳增长政策展开序幕。7月政治局会议是比较重要的政策决断点，政府部门集中调研结束，更多财政政策和产业政策有望协同发力，与“宽货币”形成合力，助力经济预期企稳。</p><p><strong>资金流方面，</strong>分析师认为加息周期已达尾声，但利率会在高位一段很长时间。在暂停加息以后，主要交易估值的修复，核心在于无风险利率不会再更高，只有边际向下，中长期下来反而对提高估值有正面贡献。分母端(利率)对股市估值的负面影响越来越小的，加上当前港股的估值处于历史低位，较低的估值也给予下行保护，港股将迎来较好的布局机会。</p><p><strong>估值方面，</strong>港股当前在相对估值上已经非常便宜，以标普500指数的预测PE除以恒生指数的预测PE得出相对估值，比率已经处于2020年以来的相对高点。再比较MSCI新兴指数与MSCI中国指数的预测PE，当前比率亦处于2016年以来的高点，反映港股的估值相对其他新兴市场的估值是7年来最吸引的水平。再比较标普500指数与MSCI中国指数的预测PE，比率也处于2020年以来的相对高点。因此，无论对标美股还是其他新兴市场，港股的相对估值已经处于较低的水平。</p><p>此外，“中特估”是港股新核心资产，低估值、高股息率属性导致其在弱市中相对抗跌，更具防御性，高股息策略在港股中长盛不衰，尤其是在弱市中，在新经济公司涌入前，港股在很长时间内由“中特估”资产主导，建议关注央国企收入占比高的能源、通信、金融等板块，以及大市值、低估值、高股息率、高ROE央国企标的。</p><p>建议下半年关注港股三大主线：一是AI引领下港股互联网板块，在引领新技术革新的浪潮中，港股互联网龙头AI公司以中文大模型开发为核心，为未来应用端降本增效，赋能各行业创新驱动力；二是经济修复下港股消费板块，关注K型复苏下的新型消费趋势、中老年健康消费的增长以及其他消费领域的复苏机会，包括游戏、中药、医疗服务、酒店旅游等；三是技术迭代下制造业龙头，港股市场中传统制造业和技术自主革新领域具有不错机遇，细分领域包括纺织、机械、轻工、配件、半导体、航空航天、国防军工等。</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>年中盘点 | 超级大牛股涨超870%！港股上半年涨幅TOP10出炉</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n年中盘点 | 超级大牛股涨超870%！港股上半年涨幅TOP10出炉\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2023-06-30 17:17</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><blockquote><strong>摘要：在上半年涨幅靠前的牛股中，<a href=\"https://laohu8.com/S/01942\">马可数字科技</a>大涨居前，累计涨幅超870%！<a href=\"https://laohu8.com/S/06660\">艾美疫苗</a>紧随其后，累计涨幅达88%。另外，随着政策支持力度加大与行业需求改善，汽车板块牛股涌现，理想汽车半年累涨超76%，<a href=\"https://laohu8.com/S/09863\">零跑汽车</a>涨超53%。</strong></blockquote><p>回顾上半年，港股开局一度让人充满期待，但随后受紧缩预期升温、衰退担忧加剧等多重逆风因素影响，主要指数陆续回吐了涨幅。截至6月30日收盘，恒指半年累跌4.37%，恒生科技指数累跌5.27%，国指累跌4.18%。</p><p>尽管大盘一度缺乏方向，仍有不少亮眼板个股异军突起，其中，最猛大牛股半年竟然疯涨870%！</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/30bb412d67f70d66ef53fe06e63f009d\" title=\"\" tg-width=\"1280\" tg-height=\"2680\"/></p><p>在上半年涨幅靠前的牛股中，<a href=\"https://laohu8.com/S/06660\">艾美疫苗</a>累计大涨88%。该股上市于2022年10月，是中国的大型民营疫苗制造商，因三月份纳入港股通而飙涨。据官网介绍，目前该公司拥有8款商业化疫苗，包括重组乙型肝炎疫苗（汉逊酵母）、冻干人用狂犬病疫苗（Vero细胞）等。</p><p>在中特估和AI概念双重加持之下，千亿白马股<a href=\"https://laohu8.com/S/000063\">中兴通讯</a>大象起舞，今年累升85%。<a href=\"https://laohu8.com/S/601788\">光大证券</a>指出，<a href=\"https://laohu8.com/S/00763\">中兴通讯</a>芯片自研长期主义开花结果，毛利率大幅改善；公司服务器业务进入快速增长轨道，是AI算力时代下的核心受益者。</p><p>随着政策支持力度加大与行业需求改善，汽车板块牛股涌现，<a href=\"https://laohu8.com/S/02015\">理想汽车-W</a>半年累涨超76%，<a href=\"https://laohu8.com/S/09863\">零跑汽车</a>涨超53%。机构指出，随着汽车销售数据环比向好，新能源车渗透率稳步提升，有望迎来新一轮向上周期。</p><p><strong>港股下半年怎么投？</strong></p><p>港股何时言底尚不清晰，但不少机构对于下半年的走势较为乐观。分析师认为，下半年恒生指数的合理高低波幅在17650至22183点，策略上先价值后成长。继续看多电讯及能源，同时关注科技、材料、可选消费、工业等顺周期板块。</p><p>在服务业支持下，预计消费者信心逐步回升。尽管消费者信心仍然低迷，但随着要素流动恢复和服务业前景改善，企业信心和资本支出逐渐恢复，推动就业增长和家庭消费信心改善，大额可选消费将逐渐回升。</p><p><strong>政策方面，</strong>稳增长政策出台为经济托底。从央行下调7天逆回购利率，到下调MLF及LPR利率，再到国家发改委提出6个方面的政策，财政部、税务总局、工信部宣布继续免征新能源车购置税，已说明新一轮稳增长政策展开序幕。7月政治局会议是比较重要的政策决断点，政府部门集中调研结束，更多财政政策和产业政策有望协同发力，与“宽货币”形成合力，助力经济预期企稳。</p><p><strong>资金流方面，</strong>分析师认为加息周期已达尾声，但利率会在高位一段很长时间。在暂停加息以后，主要交易估值的修复，核心在于无风险利率不会再更高，只有边际向下，中长期下来反而对提高估值有正面贡献。分母端(利率)对股市估值的负面影响越来越小的，加上当前港股的估值处于历史低位，较低的估值也给予下行保护，港股将迎来较好的布局机会。</p><p><strong>估值方面，</strong>港股当前在相对估值上已经非常便宜，以标普500指数的预测PE除以恒生指数的预测PE得出相对估值，比率已经处于2020年以来的相对高点。再比较MSCI新兴指数与MSCI中国指数的预测PE，当前比率亦处于2016年以来的高点，反映港股的估值相对其他新兴市场的估值是7年来最吸引的水平。再比较标普500指数与MSCI中国指数的预测PE，比率也处于2020年以来的相对高点。因此，无论对标美股还是其他新兴市场，港股的相对估值已经处于较低的水平。</p><p>此外，“中特估”是港股新核心资产，低估值、高股息率属性导致其在弱市中相对抗跌，更具防御性，高股息策略在港股中长盛不衰，尤其是在弱市中，在新经济公司涌入前，港股在很长时间内由“中特估”资产主导，建议关注央国企收入占比高的能源、通信、金融等板块，以及大市值、低估值、高股息率、高ROE央国企标的。</p><p>建议下半年关注港股三大主线：一是AI引领下港股互联网板块，在引领新技术革新的浪潮中，港股互联网龙头AI公司以中文大模型开发为核心，为未来应用端降本增效，赋能各行业创新驱动力；二是经济修复下港股消费板块，关注K型复苏下的新型消费趋势、中老年健康消费的增长以及其他消费领域的复苏机会，包括游戏、中药、医疗服务、酒店旅游等；三是技术迭代下制造业龙头，港股市场中传统制造业和技术自主革新领域具有不错机遇，细分领域包括纺织、机械、轻工、配件、半导体、航空航天、国防军工等。</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/09caddfc0c2d2ea28b3db992baa72dbf","relate_stocks":{"BK1607":"新IT概念","BK1529":"电讯设备","BK4585":"ETF&股票定投概念","02015":"理想汽车-W","BK1539":"汽车股","02833":"恒指ETF","BK1526":"科网股","BK1506":"5G概念","BK1588":"回港中概股","LU1720050803.USD":"安联全方位中国股票基金","BK1575":"同股不同权","09863":"零跑汽车","BK4526":"热门中概股","BK1119":"汽车制造商","06660":"艾美疫苗","LU1794554557.SGD":"Allianz All China Equity AT Acc H2-SGD","BK1587":"次新股","LI":"理想汽车","01942":"马可数字科技","BK1161":"生物科技","HSI":"恒生指数","HSTECH":"恒生科技指数","00763":"中兴通讯","EVS.SI":"MSCI China Electric Vehicles and Future Mobility ETF-NikkoAM","BK1149":"通信设备"},"source_url":"","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1149189861","content_text":"摘要：在上半年涨幅靠前的牛股中，马可数字科技大涨居前，累计涨幅超870%！艾美疫苗紧随其后，累计涨幅达88%。另外，随着政策支持力度加大与行业需求改善，汽车板块牛股涌现，理想汽车半年累涨超76%，零跑汽车涨超53%。回顾上半年，港股开局一度让人充满期待，但随后受紧缩预期升温、衰退担忧加剧等多重逆风因素影响，主要指数陆续回吐了涨幅。截至6月30日收盘，恒指半年累跌4.37%，恒生科技指数累跌5.27%，国指累跌4.18%。尽管大盘一度缺乏方向，仍有不少亮眼板个股异军突起，其中，最猛大牛股半年竟然疯涨870%！在上半年涨幅靠前的牛股中，艾美疫苗累计大涨88%。该股上市于2022年10月，是中国的大型民营疫苗制造商，因三月份纳入港股通而飙涨。据官网介绍，目前该公司拥有8款商业化疫苗，包括重组乙型肝炎疫苗（汉逊酵母）、冻干人用狂犬病疫苗（Vero细胞）等。在中特估和AI概念双重加持之下，千亿白马股中兴通讯大象起舞，今年累升85%。光大证券指出，中兴通讯芯片自研长期主义开花结果，毛利率大幅改善；公司服务器业务进入快速增长轨道，是AI算力时代下的核心受益者。随着政策支持力度加大与行业需求改善，汽车板块牛股涌现，理想汽车-W半年累涨超76%，零跑汽车涨超53%。机构指出，随着汽车销售数据环比向好，新能源车渗透率稳步提升，有望迎来新一轮向上周期。港股下半年怎么投？港股何时言底尚不清晰，但不少机构对于下半年的走势较为乐观。分析师认为，下半年恒生指数的合理高低波幅在17650至22183点，策略上先价值后成长。继续看多电讯及能源，同时关注科技、材料、可选消费、工业等顺周期板块。在服务业支持下，预计消费者信心逐步回升。尽管消费者信心仍然低迷，但随着要素流动恢复和服务业前景改善，企业信心和资本支出逐渐恢复，推动就业增长和家庭消费信心改善，大额可选消费将逐渐回升。政策方面，稳增长政策出台为经济托底。从央行下调7天逆回购利率，到下调MLF及LPR利率，再到国家发改委提出6个方面的政策，财政部、税务总局、工信部宣布继续免征新能源车购置税，已说明新一轮稳增长政策展开序幕。7月政治局会议是比较重要的政策决断点，政府部门集中调研结束，更多财政政策和产业政策有望协同发力，与“宽货币”形成合力，助力经济预期企稳。资金流方面，分析师认为加息周期已达尾声，但利率会在高位一段很长时间。在暂停加息以后，主要交易估值的修复，核心在于无风险利率不会再更高，只有边际向下，中长期下来反而对提高估值有正面贡献。分母端(利率)对股市估值的负面影响越来越小的，加上当前港股的估值处于历史低位，较低的估值也给予下行保护，港股将迎来较好的布局机会。估值方面，港股当前在相对估值上已经非常便宜，以标普500指数的预测PE除以恒生指数的预测PE得出相对估值，比率已经处于2020年以来的相对高点。再比较MSCI新兴指数与MSCI中国指数的预测PE，当前比率亦处于2016年以来的高点，反映港股的估值相对其他新兴市场的估值是7年来最吸引的水平。再比较标普500指数与MSCI中国指数的预测PE，比率也处于2020年以来的相对高点。因此，无论对标美股还是其他新兴市场，港股的相对估值已经处于较低的水平。此外，“中特估”是港股新核心资产，低估值、高股息率属性导致其在弱市中相对抗跌，更具防御性，高股息策略在港股中长盛不衰，尤其是在弱市中，在新经济公司涌入前，港股在很长时间内由“中特估”资产主导，建议关注央国企收入占比高的能源、通信、金融等板块，以及大市值、低估值、高股息率、高ROE央国企标的。建议下半年关注港股三大主线：一是AI引领下港股互联网板块，在引领新技术革新的浪潮中，港股互联网龙头AI公司以中文大模型开发为核心，为未来应用端降本增效，赋能各行业创新驱动力；二是经济修复下港股消费板块，关注K型复苏下的新型消费趋势、中老年健康消费的增长以及其他消费领域的复苏机会，包括游戏、中药、医疗服务、酒店旅游等；三是技术迭代下制造业龙头，港股市场中传统制造业和技术自主革新领域具有不错机遇，细分领域包括纺织、机械、轻工、配件、半导体、航空航天、国防军工等。","news_type":1},"isVote":1,"tweetType":1,"viewCount":210,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":192886086766736,"gmtCreate":1688102135875,"gmtModify":1688102137288,"author":{"id":"4095630847582090","authorId":"4095630847582090","name":"Fanlization","avatar":"https://static.tigerbbs.com/4ff33c5fed6426a68a814ef72a46d188","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"这篇文章不错，转发给大家看看","listText":"这篇文章不错，转发给大家看看","text":"这篇文章不错，转发给大家看看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/192886086766736","repostId":"2347636428","repostType":2,"repost":{"id":"2347636428","pubTimestamp":1688088706,"share":"https://www.laohu8.com/m/news/2347636428?lang=&edition=full","pubTime":"2023-06-30 09:31","market":"hk","language":"zh","title":"JS环球生活盘中异动 早盘急速跳水72.33%报2.311港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2347636428","media":"自选股智能写手","summary":"2023年06月30日早盘09时31分，JS环球生活股票出现波动，股价大幅下跌72.33%。JS环球生活股票所在的家庭电器行业中，整体涨幅为0.10%。消息层面，截至09时31分，JS环球生活股票正面舆情新闻比例25%。该信息摘要如下：消息方面，JS环球生活发布公告，于2023年6月28日，SharkNinja向美国证券交易委员会公开提交上市有关的F-1表格的注册声明。JS环球生活早在今年2月24日宣布建议分拆SharkNinja 分部于美国独立上市。","content":"<html><body><article><p>2023年06月30日早盘09时31分，<a href=\"https://laohu8.com/S/01691\">JS环球生活</a>（01691.hk）股票出现波动，股价大幅下跌72.33%。截至发稿，该股报2.311港元/股，成交量1881.45万股，<span>换手率</span>0.54%，振幅12.81%。</p><p>资金方面，该股资金流入1226.09万港元，流出884.422万港元。</p><p>最近的财报数据显示，该股实现<span>营业收入</span>393.05亿港元，<span>净利润</span>25.91亿港元，<span>每股收益</span>0.76港元，<span>毛利</span>146.59亿港元，市盈率3.12倍。</p><p>机构评级方面，在所有16家参与评级的机构中，81%的券商给予买入建议，13%的券商给予持有建议，6%的券商给予卖出建议。</p><p>JS环球生活股票所在的家庭电器行业中，整体涨幅为0.10%。其相关个股中，<a href=\"https://laohu8.com/S/000921\">海信家电</a>、<a href=\"https://laohu8.com/S/600690\">海尔智家</a>、<a href=\"https://laohu8.com/S/02381\">蚬壳电业</a>涨幅较大，振幅较大的相关个股有JS环球生活、<a href=\"https://laohu8.com/S/00921\">海信家电</a>、<a href=\"https://laohu8.com/S/06690\">海尔智家</a>，振幅分别为12.81%、2.94%、1.23%。</p><p>JS环球生活公司简介：JS环球生活有限公司是一家主要从事设计、生产、营销、出口及分销家电业务的投资控股公司。连同其附属公司,该公司通过两个业务分部进行运营。九阳分部通过线上及线下经销商销售九阳品牌旗下产品。产品包括蒸汽饭煲等烹饪电器,破壁机等食物料理电器,清洁电器和净水器等。SharkNinja分部提供Shark及Ninja品牌的小家电。产品包括吸尘器等清洁电器,食物料理电器,烹饪煲等烹饪电器和衣物护理产品等。</p><p>消息层面，截至09时31分，JS环球生活股票正面舆情新闻比例25%。《<snpa>JS环球生活子公司赴美上市有进展 股价逆势涨超5％</snpa>》资讯为影响JS环球生活的重要信息。该信息摘要如下：消息方面，JS环球生活发布公告，于2023年6月28日，SharkNinja向美国证券交易委员会公开提交上市有关的F-1表格的注册声明。截至本公告日期，该公司直接持有SharkNinja的100%已发行股份。JS环球生活早在今年2月24日宣布建议分拆SharkNinja 分部于美国独立上市。</p><p>（以上内容为自选股<a href=\"https://laohu8.com/S/5RE.SI\">智能</a>机器写手Money Call完成，仅作为用户看盘参考，不作为交易依据。）</p></article></body></html>","source":"tencent","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>JS环球生活盘中异动 早盘急速跳水72.33%报2.311港元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJS环球生活盘中异动 早盘急速跳水72.33%报2.311港元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-06-30 09:31 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023063009314682d86640&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>2023年06月30日早盘09时31分，JS环球生活（01691.hk）股票出现波动，股价大幅下跌72.33%。截至发稿，该股报2.311港元/股，成交量1881.45万股，换手率0.54%，振幅12.81%。资金方面，该股资金流入1226.09万港元，流出884.422万港元。最近的财报数据显示，该股实现营业收入393.05亿港元，净利润25.91亿港元，每股收益0.76港元，毛利146.59...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023063009314682d86640&s=b\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SG9999001069.SGD":"UOB UNITED ASIA PACIFIC GROWTH (SGD) ACC","BK1214":"家用电器","01691":"JS环球生活","BK1557":"家电股","BK1502":"双十一"},"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023063009314682d86640&s=b","is_english":false,"share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","article_id":"2347636428","content_text":"2023年06月30日早盘09时31分，JS环球生活（01691.hk）股票出现波动，股价大幅下跌72.33%。截至发稿，该股报2.311港元/股，成交量1881.45万股，换手率0.54%，振幅12.81%。资金方面，该股资金流入1226.09万港元，流出884.422万港元。最近的财报数据显示，该股实现营业收入393.05亿港元，净利润25.91亿港元，每股收益0.76港元，毛利146.59亿港元，市盈率3.12倍。机构评级方面，在所有16家参与评级的机构中，81%的券商给予买入建议，13%的券商给予持有建议，6%的券商给予卖出建议。JS环球生活股票所在的家庭电器行业中，整体涨幅为0.10%。其相关个股中，海信家电、海尔智家、蚬壳电业涨幅较大，振幅较大的相关个股有JS环球生活、海信家电、海尔智家，振幅分别为12.81%、2.94%、1.23%。JS环球生活公司简介：JS环球生活有限公司是一家主要从事设计、生产、营销、出口及分销家电业务的投资控股公司。连同其附属公司,该公司通过两个业务分部进行运营。九阳分部通过线上及线下经销商销售九阳品牌旗下产品。产品包括蒸汽饭煲等烹饪电器,破壁机等食物料理电器,清洁电器和净水器等。SharkNinja分部提供Shark及Ninja品牌的小家电。产品包括吸尘器等清洁电器,食物料理电器,烹饪煲等烹饪电器和衣物护理产品等。消息层面，截至09时31分，JS环球生活股票正面舆情新闻比例25%。《JS环球生活子公司赴美上市有进展 股价逆势涨超5％》资讯为影响JS环球生活的重要信息。该信息摘要如下：消息方面，JS环球生活发布公告，于2023年6月28日，SharkNinja向美国证券交易委员会公开提交上市有关的F-1表格的注册声明。截至本公告日期，该公司直接持有SharkNinja的100%已发行股份。JS环球生活早在今年2月24日宣布建议分拆SharkNinja 分部于美国独立上市。（以上内容为自选股智能机器写手Money Call完成，仅作为用户看盘参考，不作为交易依据。）","news_type":1},"isVote":1,"tweetType":1,"viewCount":459,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":192561075679368,"gmtCreate":1688040371447,"gmtModify":1688040373175,"author":{"id":"4095630847582090","authorId":"4095630847582090","name":"Fanlization","avatar":"https://static.tigerbbs.com/4ff33c5fed6426a68a814ef72a46d188","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"这篇文章不错，转发给大家看看","listText":"这篇文章不错，转发给大家看看","text":"这篇文章不错，转发给大家看看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/192561075679368","repostId":"1138473703","repostType":4,"repost":{"id":"1138473703","pubTimestamp":1688038070,"share":"https://www.laohu8.com/m/news/1138473703?lang=&edition=full","pubTime":"2023-06-29 19:27","market":"hk","language":"zh","title":"李嘉诚又杀回来了，抄楼市的底","url":"https://stock-news.laohu8.com/highlight/detail?id=1138473703","media":"华尔街见闻","summary":"曾经的华人首富频频露面，欲收购香港半山海景豪宅凯玥，货值超300亿港元。","content":"<html><head></head><body><p>作者 | 刘亦、周智宇</p><p style=\"text-align: justify;\">自2018年宣布退休后，长和系创始人李嘉诚已很少出现在公众面前。但最近，这位95岁、曾经的华人首富频频露面，欲收购香港半山海景豪宅凯玥，货值超300亿港元。</p><p style=\"text-align: justify;\">该项目由龙光地产和合景泰富联合持有。华尔街见闻也从这两家房企处确认，长实集团确实在与项目债权人之一的汇丰银行接触，拟获得控制权。</p><p style=\"text-align: justify;\">以李嘉诚为代表的“老钱”每一次出手，都牵动着市场的心。这一次李嘉诚出手，让人们嗅到了不一样的气息。不少业内人士认为，他是准备“抄底”了。</p><p style=\"text-align: justify;\">李嘉诚对这宗地块似乎有执念。6年前，正是龙光与合景泰富组成联合体，以高出市场最高估值53%的溢价，从长实地产等一众房企手中抢下该地块。</p><p style=\"text-align: justify;\">6年后，长实集团又将收购之手伸向了这个项目。</p><p style=\"text-align: justify;\">华尔街见闻了解到，此前龙光、合景泰富曾以凯玥作为抵押担保，从汇丰银行等银团获取102亿港元开发贷。近期，有接近该笔银团人士称，长实集团向银团提出收购这笔贷款的多数权益；汇丰也主动召集其他银行开会商议此事；目前，只有汇丰等少数银行支持此次收购。</p><p style=\"text-align: justify;\">汇丰有自己的考量。受房地产行情影响，汇丰去年的贷款损失拨备36亿美元，它需要处置一些债权，控制整体风险敞口。</p><p style=\"text-align: justify;\">有知情人士透露，目前凯玥给银团债券兑付情况正常，项目运作也正常。“虽然去化速度并不算快，不过可以带来比较稳定的现金流，长远来看项目价值可以充分释放”。</p><p style=\"text-align: justify;\">如今，李嘉诚的突然杀入，为这个项目的归属平添了变数。</p><p style=\"text-align: justify;\">不过，透过这起久违的楼市收购，市场又看到了那个以房地产发家的、熟悉的“李超人”。</p><p style=\"text-align: justify;\">“低买高卖”，这个商场获利的基本原理，李嘉诚深谙此道，且最早用在了房地产，助他获得资产飞升。</p><p style=\"text-align: justify;\">早在2013年，李嘉诚就意识到，内地房地产持续上涨，往往以高于市值的价格也无法投得土地，这样的投资会有危险。</p><p style=\"text-align: justify;\">因此，长实开始“高位逃顶”，密集卖出广州西城都荟广场和上海东方汇金中心项目，到2016年，又以200亿元的价格出售了上海陆家嘴的“世纪汇”。之后，又陆续减少了对内地和香港的地产投资。</p><p style=\"text-align: justify;\">虽然长实错过了2015-2016年的楼市大爆发，但确实也遵循了他“不赚最后一个铜板”的商业准则。这期间，李嘉诚将家族投资更多转向了英国和欧洲，引发诸多争议。</p><p style=\"text-align: justify;\">2018年的秋天，万科喊出“活下去”，房地产进入下行周期，此时一些高杠杆房企仍在积极扩张，比如蓝光、阳光城等，全然不知风险已经逼近。</p><p style=\"text-align: justify;\">此后四年，三道红线、两集中等强力的楼市管控政策出台，叠加疫情影响，房地产开始出现频繁违约，不少房企陷入资金困境，至今没能走出。</p><p style=\"text-align: justify;\">而在2022年，长和系开始出手，在香港拿下多宗地块，并且不少都是住宅用地。</p><p style=\"text-align: justify;\">海通国际估计，在过去12个月里，长实集团已在港投入了近205亿港元的新土地成本。去年5月广州土拍，和记黄埔旗下公司也参与了举牌竞价，上一次和记黄埔参与内地土拍，还是在十年之前。</p><p style=\"text-align: justify;\">此外，长实集团也关注出险房企的资产。去年7月，公司欲购买恒大香港总部大楼，彼时，该楼估值比高点折价约42%；此次通过收购债权以获得凯玥项目控制权，也是一次典型的杠杆投资，以最小的代价获得更多利益。</p><p style=\"text-align: justify;\">在5月的股东大会上，长江集团主席李泽钜表示，不论投地或收购，只要属于优质资产及具有合理回报，均会展开研究。他强调，集团作出投资考虑主要基于稳健性、回报及项目自身质量，而不是在于地点。</p><p style=\"text-align: justify;\">也就是说，当优质资产足够便宜，便是李嘉诚出手的时机。</p><p style=\"text-align: justify;\">频频出手背后，是李嘉诚等“老钱”家族对房地产市场的判断变了。当前一些出险房企少有的优质资产也被摆上货架，同时有竞争力的买家却少了许多。以不错的价格“围猎”这些优质资产，机会显现。</p><p style=\"text-align: justify;\">于是，在市场收并购所向披靡的“李超人”，也瞄准了自己心仪的猎物，时不时下场，撩拨市场的神经。</p><p style=\"text-align: justify;\">李嘉诚也深谙周期之道。正如他在自传中所言，市场旺盛的时候要看到潜伏的危机，在不景气的时候要大力发展。周期起伏之间，便是巨大的机会。</p><p style=\"text-align: justify;\">当前的房地产，是否也是这种机会节点？李嘉诚，这位过去50年里总能精准“踩点”的地产大佬已然出手，或许预示着，一个全新的地产周期也开始了。</p></body></html>","source":"live_wallstreetcn","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>李嘉诚又杀回来了，抄楼市的底</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n李嘉诚又杀回来了，抄楼市的底\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-06-29 19:27 北京时间&nbsp;&nbsp;&nbsp;<a href=https://wallstreetcn.com/articles/3692125><strong>华尔街见闻</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>作者 | 刘亦、周智宇自2018年宣布退休后，长和系创始人李嘉诚已很少出现在公众面前。但最近，这位95岁、曾经的华人首富频频露面，欲收购香港半山海景豪宅凯玥，货值超300亿港元。该项目由龙光地产和合景泰富联合持有。华尔街见闻也从这两家房企处确认，长实集团确实在与项目债权人之一的汇丰银行接触，拟获得控制权。以李嘉诚为代表的“老钱”每一次出手，都牵动着市场的心。这一次李嘉诚出手，让人们嗅到了不一样的...</p>\n\n<a href=\"https://wallstreetcn.com/articles/3692125\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/f1188ff6a38ceeb1a3b5f5106679cc6b","relate_stocks":{"01113":"长实集团","00001":"长和"},"source_url":"https://wallstreetcn.com/articles/3692125","is_english":false,"share_image_url":"https://static.laohu8.com/cc96873d3d23ee6ac10685520df9c100","article_id":"1138473703","content_text":"作者 | 刘亦、周智宇自2018年宣布退休后，长和系创始人李嘉诚已很少出现在公众面前。但最近，这位95岁、曾经的华人首富频频露面，欲收购香港半山海景豪宅凯玥，货值超300亿港元。该项目由龙光地产和合景泰富联合持有。华尔街见闻也从这两家房企处确认，长实集团确实在与项目债权人之一的汇丰银行接触，拟获得控制权。以李嘉诚为代表的“老钱”每一次出手，都牵动着市场的心。这一次李嘉诚出手，让人们嗅到了不一样的气息。不少业内人士认为，他是准备“抄底”了。李嘉诚对这宗地块似乎有执念。6年前，正是龙光与合景泰富组成联合体，以高出市场最高估值53%的溢价，从长实地产等一众房企手中抢下该地块。6年后，长实集团又将收购之手伸向了这个项目。华尔街见闻了解到，此前龙光、合景泰富曾以凯玥作为抵押担保，从汇丰银行等银团获取102亿港元开发贷。近期，有接近该笔银团人士称，长实集团向银团提出收购这笔贷款的多数权益；汇丰也主动召集其他银行开会商议此事；目前，只有汇丰等少数银行支持此次收购。汇丰有自己的考量。受房地产行情影响，汇丰去年的贷款损失拨备36亿美元，它需要处置一些债权，控制整体风险敞口。有知情人士透露，目前凯玥给银团债券兑付情况正常，项目运作也正常。“虽然去化速度并不算快，不过可以带来比较稳定的现金流，长远来看项目价值可以充分释放”。如今，李嘉诚的突然杀入，为这个项目的归属平添了变数。不过，透过这起久违的楼市收购，市场又看到了那个以房地产发家的、熟悉的“李超人”。“低买高卖”，这个商场获利的基本原理，李嘉诚深谙此道，且最早用在了房地产，助他获得资产飞升。早在2013年，李嘉诚就意识到，内地房地产持续上涨，往往以高于市值的价格也无法投得土地，这样的投资会有危险。因此，长实开始“高位逃顶”，密集卖出广州西城都荟广场和上海东方汇金中心项目，到2016年，又以200亿元的价格出售了上海陆家嘴的“世纪汇”。之后，又陆续减少了对内地和香港的地产投资。虽然长实错过了2015-2016年的楼市大爆发，但确实也遵循了他“不赚最后一个铜板”的商业准则。这期间，李嘉诚将家族投资更多转向了英国和欧洲，引发诸多争议。2018年的秋天，万科喊出“活下去”，房地产进入下行周期，此时一些高杠杆房企仍在积极扩张，比如蓝光、阳光城等，全然不知风险已经逼近。此后四年，三道红线、两集中等强力的楼市管控政策出台，叠加疫情影响，房地产开始出现频繁违约，不少房企陷入资金困境，至今没能走出。而在2022年，长和系开始出手，在香港拿下多宗地块，并且不少都是住宅用地。海通国际估计，在过去12个月里，长实集团已在港投入了近205亿港元的新土地成本。去年5月广州土拍，和记黄埔旗下公司也参与了举牌竞价，上一次和记黄埔参与内地土拍，还是在十年之前。此外，长实集团也关注出险房企的资产。去年7月，公司欲购买恒大香港总部大楼，彼时，该楼估值比高点折价约42%；此次通过收购债权以获得凯玥项目控制权，也是一次典型的杠杆投资，以最小的代价获得更多利益。在5月的股东大会上，长江集团主席李泽钜表示，不论投地或收购，只要属于优质资产及具有合理回报，均会展开研究。他强调，集团作出投资考虑主要基于稳健性、回报及项目自身质量，而不是在于地点。也就是说，当优质资产足够便宜，便是李嘉诚出手的时机。频频出手背后，是李嘉诚等“老钱”家族对房地产市场的判断变了。当前一些出险房企少有的优质资产也被摆上货架，同时有竞争力的买家却少了许多。以不错的价格“围猎”这些优质资产，机会显现。于是，在市场收并购所向披靡的“李超人”，也瞄准了自己心仪的猎物，时不时下场，撩拨市场的神经。李嘉诚也深谙周期之道。正如他在自传中所言，市场旺盛的时候要看到潜伏的危机，在不景气的时候要大力发展。周期起伏之间，便是巨大的机会。当前的房地产，是否也是这种机会节点？李嘉诚，这位过去50年里总能精准“踩点”的地产大佬已然出手，或许预示着，一个全新的地产周期也开始了。","news_type":1},"isVote":1,"tweetType":1,"viewCount":222,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":655312396,"gmtCreate":1685240487215,"gmtModify":1685240488623,"author":{"id":"4095630847582090","authorId":"4095630847582090","name":"Fanlization","avatar":"https://static.tigerbbs.com/4ff33c5fed6426a68a814ef72a46d188","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"这篇文章不错，转发给大家看看","listText":"这篇文章不错，转发给大家看看","text":"这篇文章不错，转发给大家看看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/655312396","repostId":"1118068579","repostType":4,"repost":{"id":"1118068579","pubTimestamp":1685238130,"share":"https://www.laohu8.com/m/news/1118068579?lang=&edition=full","pubTime":"2023-05-28 09:42","market":"us","language":"zh","title":"黄仁勋：无论是追逐食物、或不被人当食物，你都要不停跑下去","url":"https://stock-news.laohu8.com/highlight/detail?id=1118068579","media":"芯榜 ","summary":"台湾大学 5 月 27 日举行毕业典礼，并邀请英伟达（Nvidia）创办人黄仁勋担任致词嘉宾。黄仁勋全程演讲 20 分钟，以下为演讲内容：（台语）大家好，我今天本来想跟你们说台语，但是⋯⋯我越想越紧张","content":"<html><head></head><body><p>台湾大学 5 月 27 日举行毕业典礼，并邀请英伟达（Nvidia）创办人黄仁勋担任致词嘉宾。黄仁勋全程演讲 20 分钟，以下为演讲内容：</p><p>（台语）大家好，我今天本来想跟你们说台语，但是⋯⋯我越想越紧张。我在美国长大的，所以我的台语不是很标准，所以我今天跟你们说英文好不好？(台下掌声)</p><p>Okay，那我们开始吧！</p><p>（英语）各位贵宾、各位家长，2023 年的台大毕业生，大家好！</p><p>今天是你们的特别日子，也是梦想成真的日子——属于你们父母的，你们要赶快离家。</p><p>今天是荣耀的日子，父母亲牺牲了他们自己，成就了你们。我爸爸妈妈在这， 我哥哥也在这，让我们向养育我们的父母亲展现我们的感谢。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1ea119c17a2a2fa829ee7888f7ab7f14\" title=\"（右起）黄仁勋的母亲、父亲及哥哥\" tg-width=\"800\" tg-height=\"452\"/><span>（右起）黄仁勋的母亲、父亲及哥哥</span></p><p>十年前我第一次来台大，陈教授邀请我来看他的物理实验室。我记得他的儿子在硅谷得知了 Nvidia 发明的 CUDA（Compute Unified Device Architecture，统一计算架构）技术，建议陈教授在量子物理模拟使用它。 </p><p>当我抵达的时候，他秀给我看他创造的东西：整个房间的 Nvidia 游戏显卡， 插在开放式电脑的主机板上，金属架上都是散热用的大同电扇。</p><p>他以台湾人的方式，用游戏显卡做了一个超级电脑。他在这裡，做了早期Nvidia JOURNEY 示范。他很骄傲，他说：“黄先生，因为你的关係，我可以完成我的事业。”</p><p><strong>他说的那些话至今仍感动我，完美诠释了我们公司的价值：帮助这个时代的爱因斯坦与达文西完成他们的事业。</strong></p><p>我很高兴能再次回到台大，担任你们的致词嘉宾。</p><p><strong>给毕业生们： </strong></p><p><strong>你们所处的年代很複杂，却也是你们的机会！</strong></p><p>当我从俄勒冈州立大学毕业时，世界还比较简单。电视还很大一台，没有无线电视跟 MTV、没有手机和行动电话。那是 1994 年，IBM 个人电脑跟 MAC麦金塔开始了个人电脑革命。开始日后晶片与运算程式的发展。 </p><p>你们正处在的世界更复杂，面临著地缘政治、社会和环境上的变化和挑战，被科技包围著。我们处于一个永远连接和沉浸的数据世界，与现实世界平行存在。在 40 年前，当电脑产业创造了家用 PC，持续研究 AI 技术，我们的运算程式驾驶著汽车、或研读 X 光片影像。AI 为电脑自动化开启了大门，其服务涵盖了世界最大的兆级产业：健康照护、金融服务、运输与制造产业。</p><p><strong>AI 为我们带来了巨大的机遇，反应敏捷的企业将利用 AI 技术提升竞争力， 而未能善用 AI 的企业将面临衰退。很多企业家，包含今天在场的许多人，未来将会开创新公司。 </strong></p><p>如同过去的每个计算机时代能创造新的产业，AI 也创造了以前不存在的新 工作机会，像是：数据工程师、咏唱工程师、AI 工厂操作员和 AI 安全工程师等，这些工作以前从未存在过。 </p><p>自动化工作将淘汰一些工作，并且毫无疑问的，AI 会改变每一个工作，大幅 加强程式设计师、设计师、艺术家、行销人员和制造计划者的工作表现。就像在你们之前的每个世代，拥抱科技以获得成功。每个公司与你必须学会利 用 AI 的优势，在 AI 的帮助下做出惊人成就。</p><p>有些人担心 AI 可能会抢走你的工作，有些人可能会让 AI 发展出自我意志。</p><p>我们正处于一个新领域的开始，就像个人电脑、网路、移动设备与云端技术一样。但是 AI 的影响更为根本，每个运算层面都会被重新改写。它改变了我们撰写软件的方式、执行软件的方式。 </p><p>从各方面来看，这是电脑产业的再生契机，对于台湾企业而言更是一个黄金机遇。你们正是这个产业的重要基石。</p><p><strong><u>在下个十年，我们的产业将使用新型AI 电脑取代价值上兆美元的传统电脑。 </u></strong></p><p>我的旅程始于你们 40 年之前，1984 年是一个完美的毕业年份，我预测 2023年也将如此。我能告诉你什麽呢？今天是迄今为止你们最成功的一天，你们从台大毕业了，我也曾经成功过。</p><p>在我创办了 Nvidia 前，我经历过失败，而 且是大失败，说起来令人耻辱和尴尬，甚至几乎让我们走向毁灭。</p><p>让我给你们讲 3 个故事，这些故事定义了 Nvidia 今天的样貌。 </p><blockquote><strong>1、坦诚面对错误，谦卑寻求帮助，是聪明、成功人士最难学会的</strong></blockquote><p>我们创办 Nvidia 是为了创造加速运算技术。我们的第一个应用是用于个人电脑游戏的 3D 图形，我们发明了一种非传统的前向纹理处理技术，而且成本相对低廉。我们赢得了与 SEGA 建造游戏主机的合约。这吸引了游戏开发商用我们的平台开发游戏，并提供我们公司资金。</p><p>但经过了一年的开发期程，我们意识到我们设计的架构是错误策略，从技术端来看是不合格的。而与此同时，微软即将宣布基于反向纹理映射和三角形的 Windows 95 Direct3D。这代表如果我们完成了 SEGA 的游戏机，我们将会创造出与 Windows 不相容的产品；但如果我们不完成这个合约，我们就会破产。无论如何，我们都会面临倒闭的命运。 </p><p>我联络了SEGA 执行长，向他解释我们的发明是错误的，我们无法完成合约以及游戏主机，并建议 SEGA 寻找其他合作伙伴。我对他说：“我们必须停下来。”</p><p>但我需要 SEGA 全额支付我们的费用，否则 Nvidia 将无法继续经营。</p><p>我很难为情的向 SEGA 执行长生提出这个要求，但令我惊讶的是，他同意了。</p><p>他的理解和慷慨让我们多活了 3 个月，在那段时间，我们建造了 Riva 128， 就在我们差点没钱时，Riva 128 震撼了新兴的 3D 市场，让我们开始受到关注，也拯救了公司营运。 </p><p>市场对我们的晶片需求旺盛，让我从 4 岁离开台湾后又回到了台湾。<strong>我与台积电的张忠谋先生会面，并开始一段持续 25 年的合作关係。</strong></p><p><strong>我们坦诚面对错误、谦卑的寻求帮助，拯救 Nvidia 的存续。这些特质对于像你们这样最聪明、最成功的人而言，是最难养成的。</strong></p><blockquote><strong>2、追求愿景的艰苦过程，塑造我们的品格</strong></blockquote><p>在 2007 年，我们宣布了 CUDA GPU 加速计算技术，我们的期望是让 CUDA成为一个程式设计模型，在科学运算、物理模拟到图像处理方面，都能提升应用程式的效能。 </p><p>创建一个全新的运算模型非常困难，且在历史上实属罕见。自从 IBM System360 以来，CPU 的运算模型已经成为标准已有 60 年的时间。CUDA 需要开发人员撰写应用程式，并展示 GPU 的优势；开发人员需要一个大型的使用者基础；大型的 CUDA 使用者基础，需要市场上有人购买新的应用程式。</p><p>因此，为了解决先有鸡还是先有蛋的问题。</p><p>我们利用我们的游戏显卡 GPU GeForce，它已经拥有庞大的游戏市场，以建 立使用者基础。但 CUDA 的成本非常高，Nvidia 的利润在多年来遭受巨大的打击，我们的市值仅仅维持在 10 亿美元上下。我们多年的低迷表现，让股 东们对 CUDA 持怀疑态度，并希望我们专注于提高盈利能力。</p><p>但我们坚持下来，我们相信加速运算的时代将会到来，我们创建了一个名为GTC 的会议，并在全球不辞辛劳的推广 CUDA 技术。然后 CT 重建、分子动力学、粒子物理学、流体动力学和图像处理等应用程式开始大量出现，我们的开发人员撰写算法，并加快了晶片运算速度。</p><p>2014 年，Alex 在我们的 GPU 上进行了训练，开启 AI 的大爆炸，幸运的是，我们意识到了深度学习的潜力，我们冒著一切风险去追求深度学习。多年后，AI 革命开始了，Nvidia 成为了推动引擎。</p><p><strong>我们为 AI 发明了 CUDA，这个旅程锻造了我们的品格，承受痛苦和苦难，是在追求愿景的路上必经之痛。 </strong></p><blockquote><strong>3、学会放弃是迈向成功的核心关键 </strong></blockquote><p>再讲一个故事，在 2010 年，Google 将 Android 系统打造成出色图形的平台，而手机行业也有调制解调器的晶片公司。Nvidia 优秀的运算能力，让 Nvidia成为 Android 系统良好的合作伙伴。我们取得成功、股价飙升，但竞争对手也很快就涌入，调制解调器制造商们也在学习如何生产运算晶片，而我们却 在学习调制解调器。</p><p>因为手机市场庞大，我们能抢佔市占率。然而，我们却做出艰难的决定，放弃这块市场。因为 Nvidia 的使命，是创造出能解决“普通电脑解决的问题” 的电脑，我们应该专注在愿景上，发挥我们的独特贡献。</p><p><strong>我们的放弃获得了回报，我们创造了一个新的市场——机器人技术，拥有神经网路处理器和运行 AI 算法的安全架构。</strong></p><p>当时，这还是个看不见规模的市场。从巨大的从手机市场撤退，再创造一个不知道市场规模的机器人市场。然而，现在的我们拥有数十亿美元的自动驾驶、机器人技术的事业，也开创一个新的产业。</p><p>“撤退”对像你们如此聪明且成功的人来说并不容易。然而，战略性的撤退、牺牲、决定放弃什麽是成功的核心，非常关键的核心。 </p><p><strong>跑吧！无论如何都要保持著奔跑！</strong></p><p>2023 年毕业的同学们，你们即将进入一个正在经历巨大变革的世界，就像我毕业时遇到个人电脑和晶片革命时一样，你们正处于 AI 的起跑线上。每个行业都将被革命、重生，为新思想做好准备 - 你们的思想。</p><p>在 40 年的时间裡，我们创造了个人电脑、网路、移动设备、云端技术。现在的 AI 时代，你们将创造什么？</p><p>无论是什么，像我们一样全力以赴去追求它，跑吧！不要慢慢走。</p><p><strong>不论是为了食物而奔跑，或不被他人当做食物而奔跑。你往往无法知道自己正处在哪一种情况，但无论如何，都要保持奔跑。</strong></p><p>在你的旅程中，带上一些我犯过的错、有过的经验。希望你们能谦卑的面对失败，承认错误并寻求帮助。你们将承受实现梦想所需的痛苦和苦难，并做出牺牲，致力于有意义的生活，冲刺你们人生的事业。</p><p>2023 年毕业的同学们，我致以衷心向你们每一位祝贺。 </p><p>加油！</p></body></html>","source":"lsy1685238158152","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>黄仁勋：无论是追逐食物、或不被人当食物，你都要不停跑下去</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n黄仁勋：无论是追逐食物、或不被人当食物，你都要不停跑下去\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-05-28 09:42 北京时间&nbsp;&nbsp;&nbsp;<a href=https://mp.weixin.qq.com/s/VBdHSSFjWFNQkzLNfq_lBg><strong>芯榜 </strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>台湾大学 5 月 27 日举行毕业典礼，并邀请英伟达（Nvidia）创办人黄仁勋担任致词嘉宾。黄仁勋全程演讲 20 分钟，以下为演讲内容：（台语）大家好，我今天本来想跟你们说台语，但是⋯⋯我越想越紧张。我在美国长大的，所以我的台语不是很标准，所以我今天跟你们说英文好不好？(台下掌声)Okay，那我们开始吧！（英语）各位贵宾、各位家长，2023 年的台大毕业生，大家好！今天是你们的特别日子，也是...</p>\n\n<a href=\"https://mp.weixin.qq.com/s/VBdHSSFjWFNQkzLNfq_lBg\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/7a7c73400b3c6e5a8acfd9199fd443d9","relate_stocks":{"NVDA":"英伟达"},"source_url":"https://mp.weixin.qq.com/s/VBdHSSFjWFNQkzLNfq_lBg","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1118068579","content_text":"台湾大学 5 月 27 日举行毕业典礼，并邀请英伟达（Nvidia）创办人黄仁勋担任致词嘉宾。黄仁勋全程演讲 20 分钟，以下为演讲内容：（台语）大家好，我今天本来想跟你们说台语，但是⋯⋯我越想越紧张。我在美国长大的，所以我的台语不是很标准，所以我今天跟你们说英文好不好？(台下掌声)Okay，那我们开始吧！（英语）各位贵宾、各位家长，2023 年的台大毕业生，大家好！今天是你们的特别日子，也是梦想成真的日子——属于你们父母的，你们要赶快离家。今天是荣耀的日子，父母亲牺牲了他们自己，成就了你们。我爸爸妈妈在这， 我哥哥也在这，让我们向养育我们的父母亲展现我们的感谢。（右起）黄仁勋的母亲、父亲及哥哥十年前我第一次来台大，陈教授邀请我来看他的物理实验室。我记得他的儿子在硅谷得知了 Nvidia 发明的 CUDA（Compute Unified Device Architecture，统一计算架构）技术，建议陈教授在量子物理模拟使用它。 当我抵达的时候，他秀给我看他创造的东西：整个房间的 Nvidia 游戏显卡， 插在开放式电脑的主机板上，金属架上都是散热用的大同电扇。他以台湾人的方式，用游戏显卡做了一个超级电脑。他在这裡，做了早期Nvidia JOURNEY 示范。他很骄傲，他说：“黄先生，因为你的关係，我可以完成我的事业。”他说的那些话至今仍感动我，完美诠释了我们公司的价值：帮助这个时代的爱因斯坦与达文西完成他们的事业。我很高兴能再次回到台大，担任你们的致词嘉宾。给毕业生们： 你们所处的年代很複杂，却也是你们的机会！当我从俄勒冈州立大学毕业时，世界还比较简单。电视还很大一台，没有无线电视跟 MTV、没有手机和行动电话。那是 1994 年，IBM 个人电脑跟 MAC麦金塔开始了个人电脑革命。开始日后晶片与运算程式的发展。 你们正处在的世界更复杂，面临著地缘政治、社会和环境上的变化和挑战，被科技包围著。我们处于一个永远连接和沉浸的数据世界，与现实世界平行存在。在 40 年前，当电脑产业创造了家用 PC，持续研究 AI 技术，我们的运算程式驾驶著汽车、或研读 X 光片影像。AI 为电脑自动化开启了大门，其服务涵盖了世界最大的兆级产业：健康照护、金融服务、运输与制造产业。AI 为我们带来了巨大的机遇，反应敏捷的企业将利用 AI 技术提升竞争力， 而未能善用 AI 的企业将面临衰退。很多企业家，包含今天在场的许多人，未来将会开创新公司。 如同过去的每个计算机时代能创造新的产业，AI 也创造了以前不存在的新 工作机会，像是：数据工程师、咏唱工程师、AI 工厂操作员和 AI 安全工程师等，这些工作以前从未存在过。 自动化工作将淘汰一些工作，并且毫无疑问的，AI 会改变每一个工作，大幅 加强程式设计师、设计师、艺术家、行销人员和制造计划者的工作表现。就像在你们之前的每个世代，拥抱科技以获得成功。每个公司与你必须学会利 用 AI 的优势，在 AI 的帮助下做出惊人成就。有些人担心 AI 可能会抢走你的工作，有些人可能会让 AI 发展出自我意志。我们正处于一个新领域的开始，就像个人电脑、网路、移动设备与云端技术一样。但是 AI 的影响更为根本，每个运算层面都会被重新改写。它改变了我们撰写软件的方式、执行软件的方式。 从各方面来看，这是电脑产业的再生契机，对于台湾企业而言更是一个黄金机遇。你们正是这个产业的重要基石。在下个十年，我们的产业将使用新型AI 电脑取代价值上兆美元的传统电脑。 我的旅程始于你们 40 年之前，1984 年是一个完美的毕业年份，我预测 2023年也将如此。我能告诉你什麽呢？今天是迄今为止你们最成功的一天，你们从台大毕业了，我也曾经成功过。在我创办了 Nvidia 前，我经历过失败，而 且是大失败，说起来令人耻辱和尴尬，甚至几乎让我们走向毁灭。让我给你们讲 3 个故事，这些故事定义了 Nvidia 今天的样貌。 1、坦诚面对错误，谦卑寻求帮助，是聪明、成功人士最难学会的我们创办 Nvidia 是为了创造加速运算技术。我们的第一个应用是用于个人电脑游戏的 3D 图形，我们发明了一种非传统的前向纹理处理技术，而且成本相对低廉。我们赢得了与 SEGA 建造游戏主机的合约。这吸引了游戏开发商用我们的平台开发游戏，并提供我们公司资金。但经过了一年的开发期程，我们意识到我们设计的架构是错误策略，从技术端来看是不合格的。而与此同时，微软即将宣布基于反向纹理映射和三角形的 Windows 95 Direct3D。这代表如果我们完成了 SEGA 的游戏机，我们将会创造出与 Windows 不相容的产品；但如果我们不完成这个合约，我们就会破产。无论如何，我们都会面临倒闭的命运。 我联络了SEGA 执行长，向他解释我们的发明是错误的，我们无法完成合约以及游戏主机，并建议 SEGA 寻找其他合作伙伴。我对他说：“我们必须停下来。”但我需要 SEGA 全额支付我们的费用，否则 Nvidia 将无法继续经营。我很难为情的向 SEGA 执行长生提出这个要求，但令我惊讶的是，他同意了。他的理解和慷慨让我们多活了 3 个月，在那段时间，我们建造了 Riva 128， 就在我们差点没钱时，Riva 128 震撼了新兴的 3D 市场，让我们开始受到关注，也拯救了公司营运。 市场对我们的晶片需求旺盛，让我从 4 岁离开台湾后又回到了台湾。我与台积电的张忠谋先生会面，并开始一段持续 25 年的合作关係。我们坦诚面对错误、谦卑的寻求帮助，拯救 Nvidia 的存续。这些特质对于像你们这样最聪明、最成功的人而言，是最难养成的。2、追求愿景的艰苦过程，塑造我们的品格在 2007 年，我们宣布了 CUDA GPU 加速计算技术，我们的期望是让 CUDA成为一个程式设计模型，在科学运算、物理模拟到图像处理方面，都能提升应用程式的效能。 创建一个全新的运算模型非常困难，且在历史上实属罕见。自从 IBM System360 以来，CPU 的运算模型已经成为标准已有 60 年的时间。CUDA 需要开发人员撰写应用程式，并展示 GPU 的优势；开发人员需要一个大型的使用者基础；大型的 CUDA 使用者基础，需要市场上有人购买新的应用程式。因此，为了解决先有鸡还是先有蛋的问题。我们利用我们的游戏显卡 GPU GeForce，它已经拥有庞大的游戏市场，以建 立使用者基础。但 CUDA 的成本非常高，Nvidia 的利润在多年来遭受巨大的打击，我们的市值仅仅维持在 10 亿美元上下。我们多年的低迷表现，让股 东们对 CUDA 持怀疑态度，并希望我们专注于提高盈利能力。但我们坚持下来，我们相信加速运算的时代将会到来，我们创建了一个名为GTC 的会议，并在全球不辞辛劳的推广 CUDA 技术。然后 CT 重建、分子动力学、粒子物理学、流体动力学和图像处理等应用程式开始大量出现，我们的开发人员撰写算法，并加快了晶片运算速度。2014 年，Alex 在我们的 GPU 上进行了训练，开启 AI 的大爆炸，幸运的是，我们意识到了深度学习的潜力，我们冒著一切风险去追求深度学习。多年后，AI 革命开始了，Nvidia 成为了推动引擎。我们为 AI 发明了 CUDA，这个旅程锻造了我们的品格，承受痛苦和苦难，是在追求愿景的路上必经之痛。 3、学会放弃是迈向成功的核心关键 再讲一个故事，在 2010 年，Google 将 Android 系统打造成出色图形的平台，而手机行业也有调制解调器的晶片公司。Nvidia 优秀的运算能力，让 Nvidia成为 Android 系统良好的合作伙伴。我们取得成功、股价飙升，但竞争对手也很快就涌入，调制解调器制造商们也在学习如何生产运算晶片，而我们却 在学习调制解调器。因为手机市场庞大，我们能抢佔市占率。然而，我们却做出艰难的决定，放弃这块市场。因为 Nvidia 的使命，是创造出能解决“普通电脑解决的问题” 的电脑，我们应该专注在愿景上，发挥我们的独特贡献。我们的放弃获得了回报，我们创造了一个新的市场——机器人技术，拥有神经网路处理器和运行 AI 算法的安全架构。当时，这还是个看不见规模的市场。从巨大的从手机市场撤退，再创造一个不知道市场规模的机器人市场。然而，现在的我们拥有数十亿美元的自动驾驶、机器人技术的事业，也开创一个新的产业。“撤退”对像你们如此聪明且成功的人来说并不容易。然而，战略性的撤退、牺牲、决定放弃什麽是成功的核心，非常关键的核心。 跑吧！无论如何都要保持著奔跑！2023 年毕业的同学们，你们即将进入一个正在经历巨大变革的世界，就像我毕业时遇到个人电脑和晶片革命时一样，你们正处于 AI 的起跑线上。每个行业都将被革命、重生，为新思想做好准备 - 你们的思想。在 40 年的时间裡，我们创造了个人电脑、网路、移动设备、云端技术。现在的 AI 时代，你们将创造什么？无论是什么，像我们一样全力以赴去追求它，跑吧！不要慢慢走。不论是为了食物而奔跑，或不被他人当做食物而奔跑。你往往无法知道自己正处在哪一种情况，但无论如何，都要保持奔跑。在你的旅程中，带上一些我犯过的错、有过的经验。希望你们能谦卑的面对失败，承认错误并寻求帮助。你们将承受实现梦想所需的痛苦和苦难，并做出牺牲，致力于有意义的生活，冲刺你们人生的事业。2023 年毕业的同学们，我致以衷心向你们每一位祝贺。 加油！","news_type":1},"isVote":1,"tweetType":1,"viewCount":382,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}